<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>US6054478A - Antifungal sordaridin derivatives 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/US6054478A/en">
    <meta name="description" content="
     Compounds of the formula (I) ##STR1## and pharmaceutically acceptable salts or metabolically labile derivatives thereof, processes for their preparation, their use as antifungal agents and intermediates for use in their preparation. 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Antifungal sordaridin derivatives 
       ">
    <meta name="DC.date" content="1995-11-06" scheme="dateSubmitted">
    <meta name="DC.description" content="
     Compounds of the formula (I) ##STR1## and pharmaceutically acceptable salts or metabolically labile derivatives thereof, processes for their preparation, their use as antifungal agents and intermediates for use in their preparation. 
   
   ">
    <meta name="citation_patent_application_number" content="US:08/836,284">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/64/e0/07/bf6c6a46c00f6d/US6054478.pdf">
    <meta name="citation_patent_number" content="US:6054478">
    <meta name="DC.date" content="2000-04-25" scheme="issue">
    <meta name="DC.contributor" content="Jose J. Martin" scheme="inventor">
    <meta name="DC.contributor" content="Jesus Chicharro Gonzalo" scheme="inventor">
    <meta name="DC.contributor" content="Jose R. R. Gomez" scheme="inventor">
    <meta name="DC.contributor" content="Silvestre Garcia-Ochoa Dorado" scheme="inventor">
    <meta name="DC.contributor" content="Federico Gomez De Las Heras" scheme="inventor">
    <meta name="DC.contributor" content="Michael V. Hayes" scheme="inventor">
    <meta name="DC.contributor" content="Michael J. Dawson" scheme="inventor">
    <meta name="DC.contributor" content="Howard G. Wildman" scheme="inventor">
    <meta name="DC.contributor" content="Richard M. Hall" scheme="inventor">
    <meta name="DC.contributor" content="Glaxo Wellcome SA" scheme="assignee">
    <meta name="citation_reference" content="Alarcon, B. et al `Screening for New Compounds with Antiherpes Activity`. CA 102:39536, 1984." scheme="references">
    <meta name="citation_reference" content="Alarcon, B. et al Screening for New Compounds with Antiherpes Activity . CA 102:39536, 1984." scheme="references">
    <meta name="citation_reference" content="Hauser, D et al `Sordarin 1. Isolation and Degradation of Sordarin` CA 75:49503, 1971." scheme="references">
    <meta name="citation_reference" content="Hauser, D et al Sordarin 1. Isolation and Degradation of Sordarin CA 75:49503, 1971." scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Antifungal sordaridin derivatives 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA38061768" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">Compounds of the formula (I) ##STR1## and pharmaceutically acceptable salts or metabolically labile derivatives thereof, processes for their preparation, their use as antifungal agents and intermediates for use in their preparation.</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/20"><a id="link" href="#" class="style-scope state-modifier">C07H15/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Carbocyclic rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07H15/24"><a id="link" href="#" class="style-scope state-modifier">C07H15/24</a></state-modifier>
                  <span class="description style-scope classification-tree">Condensed ring systems having three or more rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/10"><a id="link" href="#" class="style-scope state-modifier">A61P31/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Antimycotics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/00"><a id="link" href="#" class="style-scope state-modifier">C12P17/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/02"><a id="link" href="#" class="style-scope state-modifier">C12P17/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxygen as only ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/06"><a id="link" href="#" class="style-scope state-modifier">C12P17/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/00"><a id="link" href="#" class="style-scope state-modifier">C12P19/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of compounds containing saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/44"><a id="link" href="#" class="style-scope state-modifier">C12P19/44</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of O-glycosides, e.g. glucosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 4 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Organic Chemistry"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Organic Chemistry
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">US6054478A</h2>
                  <p class="tagline style-scope patent-result">United States</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Patent</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/64/e0/07/bf6c6a46c00f6d/US6054478.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;methyl&quot;,&quot;compound&quot;,&quot;cdcl&quot;,&quot;cho&quot;,&quot;formula&quot;]" data-before="19941108"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/US6054478A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Jose J. Martin"><a id="link" href="#" class="style-scope state-modifier">Jose J. Martin</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Jesus Chicharro Gonzalo"><a id="link" href="#" class="style-scope state-modifier">Jesus Chicharro Gonzalo</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Jose R. R. Gomez"><a id="link" href="#" class="style-scope state-modifier">Jose R. R. Gomez</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Silvestre Garcia-Ochoa Dorado"><a id="link" href="#" class="style-scope state-modifier">Silvestre Garcia-Ochoa Dorado</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Federico Gomez De Las Heras"><a id="link" href="#" class="style-scope state-modifier">Federico Gomez De Las Heras</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Michael V. Hayes"><a id="link" href="#" class="style-scope state-modifier">Michael V. Hayes</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Michael J. Dawson"><a id="link" href="#" class="style-scope state-modifier">Michael J. Dawson</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Howard G. Wildman"><a id="link" href="#" class="style-scope state-modifier">Howard G. Wildman</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Richard M. Hall"><a id="link" href="#" class="style-scope state-modifier">Richard M. Hall</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    BASF Enzymes LLC
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1994</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0711783A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP94500174A</div>
                <div class="style-scope application-timeline">Filing date: 1994-11-08</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1995</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ATE183189T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AT95938407T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE69511424T2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">DE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DE69511424T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU3981095A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU39810/95A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO1996014327A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP1995/004332</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/SI0791007T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">SI</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: SI9530305T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0791007B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP95938407A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2136887T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES95938407T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK0791007T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK95938407T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JPH11502188A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP8515052A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6054478A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US08/836,284</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1999</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/GR3031781T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">GR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: GR990402873T</div>
                <div class="style-scope application-timeline">Filing date: 1999-11-08</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application US08/836,284 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">1995-11-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Glaxo Wellcome SA"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Glaxo Wellcome SA</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">1997-07-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="GLAXO WELLCOME S.A."><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to GLAXO WELLCOME S.A.</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).</div><div class="description-item style-scope application-timeline">Assignors: CHICHARRO GONZALO, JESUS, GOMEZ, JOSE RRAMON RUIZ, MARTIN, JOSE JULIO, GARCIA-OCHOA DORADO, SILVESTRE, GOMEZ DE LAS HEROS, FEDERICO, DAWSON, MICHAEL JOHN, HALL, RICHARD MALCOLM, WILDMAN, HOWARD GEOFFREY, HAYES, MICHAEL VICTOR</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2000-04-25</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2000-04-25</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6054478A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of US6054478A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">2005-03-11</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="DIVERSA CORPORATION"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to DIVERSA CORPORATION</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).</div><div class="description-item style-scope application-timeline">Assignors: GLAXO WELLCOME, S.A.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2015-11-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Expired - Fee Related</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (2)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (4)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (20)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;p=1&amp;u=/netahtml/PTO/srchnum.html&amp;r=1&amp;f=G&amp;l=50&amp;d=PALL&amp;s1=6054478.PN.">USPTO</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentcenter.uspto.gov/applications/08836284">USPTO PatentCenter</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://assignment.uspto.gov/patent/index.html#/patent/search/resultFilter?searchInput=6054478">USPTO Assignment</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&amp;NR=6054478A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/patent/US/6054478/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/US6054478">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES318024437" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    
    <div class="description-paragraph style-scope patent-text">This invention relates to novel sordarin derivatives having antifungal activity, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine, more particularly in the prevention or treatment of diseases in animals, including humans, caused by fungal infection.</div>
    <div class="description-paragraph style-scope patent-text">British Patent Specification No. 1,162,027 describes the preparation of an antibiotic, SL2266, by the cultivation of the strain NRRL 3196 of the fungus species Sordaria araneosa. SL 2266, later named sordarin, is reported to have fungistatic activity. The same research group also described in Helvetica Chimica Acta (1971), 51, 119-120 the degradation of sordarin to sordaricin. Published Japanese Patent Application No. J6 2040292A describes the preparation of an antibiotic, zofimarin, which is reported to have antifungal activity.</div>
    <div class="description-paragraph style-scope patent-text">Sordarin, sordaricin and zofimarin may be represented by formula (A) below ##STR2## where OR as ##STR3## describes sordarin; OR as OH describes sordaricin; and</div>
    <div class="description-paragraph style-scope patent-text">OR as ##STR4## describes zofimarin.</div>
    <div class="description-paragraph style-scope patent-text">Although sordarin and zofimarin exhibit antifungal activity, both compounds are only moderately active and have limited spectra of action when tested against a battery of fungal organisms. We now describe hereinafter a novel group of fungicidal sordarin derivatives which exhibit excellent antifungal activity and a broad spectrum of action. Thus, according to a first aspect of the present invention, we provide compounds of formula (I) ##STR5## and pharmaceutically acceptable salts and solvates (e.g. hydrates) or metabolically labile derivatives thereof,</div>
    <div class="description-paragraph style-scope patent-text">wherein R<sup class="style-scope patent-text">1</sup> represents hydrogen, halogen, hydroxyl or C<sub class="style-scope patent-text">1-4</sub> alkoxy;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2</sup> represents hydrogen, halogen, hydroxyl, C<sub class="style-scope patent-text">1-10</sub> alkoxy, C<sub class="style-scope patent-text">1-10</sub> alkylthio, C<sub class="style-scope patent-text">1-6</sub> alkoxyC<sub class="style-scope patent-text">1-4</sub> alkoxy, arylC<sub class="style-scope patent-text">1-6</sub> alkyloxy, arylC<sub class="style-scope patent-text">3-6</sub> alkenyloxy, azido, NR<sup class="style-scope patent-text">5</sup> COR<sup class="style-scope patent-text">5</sup> (where each R<sup class="style-scope patent-text">5</sup> is independently hydrogen or C<sub class="style-scope patent-text">1-6</sub> alkyl), OR<sup class="style-scope patent-text">6</sup> (where R<sup class="style-scope patent-text">6</sup> is a cyclic ether containing 4 to 8 atoms linked to the oxygen atom via a ring carbon atom adjacent to the ring oxygen atom) or a group ##STR6## where Y is oxygen, sulphur or NH, X is either a bond, an oxygen atom or a moiety NR<sup class="style-scope patent-text">8</sup> in which R<sup class="style-scope patent-text">8</sup> is hydrogen or C<sub class="style-scope patent-text">1-6</sub> alkyl, and R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">1-10</sub> alkyl optionally containing one or two double bonds, aryl, arylC<sub class="style-scope patent-text">1-4</sub> alkyl, arylC<sub class="style-scope patent-text">2-4</sub> alkenyl, haloC<sub class="style-scope patent-text">1-6</sub> alkyl or C<sub class="style-scope patent-text">1-6</sub> alkoxyC<sub class="style-scope patent-text">1-4</sub> alkyl), and R<sup class="style-scope patent-text">3</sup> represents hydrogen, or R<sup class="style-scope patent-text">2</sup> and R<sup class="style-scope patent-text">3</sup> may together with the carbon atom to which they are attached represent C═O or C═NOR<sup class="style-scope patent-text">9</sup> (where R<sup class="style-scope patent-text">9</sup> is C<sub class="style-scope patent-text">1-6</sub> alkyl); and</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">4</sup> represents hydroxyl, C<sub class="style-scope patent-text">1-6</sub> alkoxy or ##STR7## (where R<sup class="style-scope patent-text">7</sup> is as defined above); with the proviso that when R<sup class="style-scope patent-text">1</sup> represents a hydroxyl group in the axial configuration and R<sup class="style-scope patent-text">4</sup> is methoxy then R<sup class="style-scope patent-text">2</sup> cannot represent a group in the axial configuration selected from hydroxyl and OCOCH═<sup class="style-scope patent-text">Z</sup> CH--CH═<sup class="style-scope patent-text">E</sup> CHCH<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Suitable pharmaceutically acceptable salts of the compounds of formula (I) include inorganic base salts such as alkali metal salts (for example sodium and potassium salts) and ammonium salts and organic base salts. Suitable organic base salts include amine salts such as trialkylamine (e.g. triethylamine), dialkylamine (e.g. dicyclohexylamine), optionally substituted benzylamine (e.g. phenylbenzylamine or p-bromobenzylamine), procaine, ethanolamine, diethanolamine, N-methylglucosamine and tri(hydroxymethyl)methylamine salts and amino acid salts (e.g. lysine and arginine salts).</div>
    <div class="description-paragraph style-scope patent-text">References hereinafter to a compound of formula (I) includes that compound and its pharmaceutically acceptable salts.</div>
    <div class="description-paragraph style-scope patent-text">Other salts which are not pharmaceutically acceptable may be useful in the preparation of compounds of formula (I) and these form a further aspect of the invention.</div>
    <div class="description-paragraph style-scope patent-text">Metabolically labile derivatives of compounds of formula (I) are compounds which are converted in the body into compounds of formula (1). Examples of such derivatives include conventional metabolically labile esters formed from the free carboxylic acid in the molecule.</div>
    <div class="description-paragraph style-scope patent-text">It is to be understood that the present invention encompasses any individual isomers, including optical isomers, of compounds represented by formula (I) above as well as mixtures thereof, including wholly or partially racemic mixtures thereof.</div>
    <div class="description-paragraph style-scope patent-text">As used herein, the term "alkyl" as a group or part of a group means a straight or branched chain alkyl moiety comprising, for example, 1 to 8 carbon atoms. Suitable examples include methyl, ethyl, n-propyl, i-propyl, n-butyl, s-butyl, t-butyl, n-hexyl and n-octyl.</div>
    <div class="description-paragraph style-scope patent-text">As used herein, the term "aryl" as a group or part of a group means phenyl or heteroaryl each optionally substituted by one or more (e.g. 1, 2 or 3) atoms or groups selected from halogen, hydroxyl, C<sub class="style-scope patent-text">1-6</sub> alkyl, C<sub class="style-scope patent-text">1-6</sub> alkoxy or C<sub class="style-scope patent-text">1-4</sub> alkoxycarbonyl. The heteroaryl group may be a 5- or 6-membered heteroaromatic ring containing one or more heteroatoms selected from nitrogen, oxygen and sulphur. Suitable examples of heteroaryl groups include pyridyl, furyl, thienyl and pyrrolyl.</div>
    <div class="description-paragraph style-scope patent-text">The term "halogen" or "halo" means herein fluorine, chlorine, bromine or iodine.</div>
    <div class="description-paragraph style-scope patent-text">A haloC<sub class="style-scope patent-text">1-6</sub> alkyl group within R<sup class="style-scope patent-text">7</sup> means a C<sub class="style-scope patent-text">1-6</sub> alkyl group containing one or more (e.g. 1, 2 or 3) halogen atoms.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">1</sup> represents a C<sub class="style-scope patent-text">1-4</sub> alkoxy group it may be, for example, a methoxy group. R<sup class="style-scope patent-text">1</sup> may particularly represent hydrogen, fluorine, hydroxyl or methoxy.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">1</sup> is a halogen atom or a hydroxyl or C<sub class="style-scope patent-text">1-4</sub> alkoxy group, the R<sup class="style-scope patent-text">1</sup> moiety is preferably sited in the axial configuration. Particularly preferred are compounds of formula (I) in which R<sup class="style-scope patent-text">1</sup> is hydrogen or hydroxyl (especially when sited in the axial configuration).</div>
    <div class="description-paragraph style-scope patent-text">Examples of the group R<sup class="style-scope patent-text">2</sup> include halogen (e.g. fluorine), C<sub class="style-scope patent-text">1-10</sub> alkoxy (for example a C<sub class="style-scope patent-text">1-6</sub> alkoxy group such as methoxy, ethoxy, n-propoxy or n-hexyloxy), C<sub class="style-scope patent-text">1-6</sub> alkylthio (for example a C<sub class="style-scope patent-text">1-4</sub> alkylthio group such as methylthio), C<sub class="style-scope patent-text">1-4</sub> alkoxyC<sub class="style-scope patent-text">1-4</sub> alkoxy (for example a C<sub class="style-scope patent-text">1-4</sub> alkoxymethoxy group such as methoxymethoxy), arylC<sub class="style-scope patent-text">1-4</sub> alkyloxy (for example a phenylC<sub class="style-scope patent-text">1-4</sub> alkyloxy group such as benzyloxy), phenylC<sub class="style-scope patent-text">3-6</sub> alkenyloxy (for example OCH<sub class="style-scope patent-text">2</sub> CH═<sup class="style-scope patent-text">E</sup> CHPh), azido, NR<sup class="style-scope patent-text">5</sup> COR<sup class="style-scope patent-text">5</sup> (where each R<sup class="style-scope patent-text">5</sup> is independently hydrogen or a C<sub class="style-scope patent-text">1-4</sub> alkyl group such as methyl), OR<sup class="style-scope patent-text">6</sup> (where R<sup class="style-scope patent-text">6</sup> is, for example, a 2-tetrahydropyranyl group), OCOR<sup class="style-scope patent-text">7</sup> where R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">1-10</sub> alkyl (e.g. methyl, ethyl, n-propyl, i-propyl, n-butyl, s-butyl, t-butyl, 1-methylpentyl or n-heptyl), C<sub class="style-scope patent-text">2-10</sub> alkyl containing one or two double bond (for example a C<sub class="style-scope patent-text">3</sub> alkenyl group such as --C(CH<sub class="style-scope patent-text">3</sub>)═CH<sub class="style-scope patent-text">2</sub>, a C<sub class="style-scope patent-text">6</sub> alkenyl group such as --C(CH<sub class="style-scope patent-text">3</sub>)═C(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">3</sub> or a C<sub class="style-scope patent-text">5</sub> diene such as --CH═<sup class="style-scope patent-text">Z</sup> CH--CH═<sup class="style-scope patent-text">E</sup> CHCH<sub class="style-scope patent-text">3</sub>), aryl (e.g. phenyl or p-tolyl), arylC<sub class="style-scope patent-text">1-4</sub> alkyl (for example an arylmethyl group such as benzyl), arylC<sub class="style-scope patent-text">2-4</sub> alkenyl (for example an arylethenyl group such as PhCH═CH--), monohaloC<sub class="style-scope patent-text">1-4</sub> alkyl (for example a halopropyl group such as 3-chloropropyl), C<sub class="style-scope patent-text">1-6</sub> alkoxymethoxy (e.g. methoxymethoxy or n-butoxymethoxy), OCO<sub class="style-scope patent-text">2</sub> R<sup class="style-scope patent-text">7</sup> where R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">1-10</sub> alkyl (e.g. n-octyl), ##STR8## where R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">1-10</sub> alkyl (for example methyl or n-octyl) or arylC<sub class="style-scope patent-text">1-4</sub> alkyl (for example an arylmethyl group such as benzyl) and R<sup class="style-scope patent-text">8</sup> is hydrogen or C<sub class="style-scope patent-text">1-4</sub> alkyl (e.g. methyl), NHCO<sub class="style-scope patent-text">2</sub> R<sup class="style-scope patent-text">7</sup> where R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">1-6</sub> alkyl e.g. t-butyl or SCOR<sup class="style-scope patent-text">7</sup> where R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">1-6</sub> alkyl e.g. methyl.</div>
    <div class="description-paragraph style-scope patent-text">Alternatively, CR<sup class="style-scope patent-text">2</sup> R<sup class="style-scope patent-text">3</sup> may represent, for example, C═O or C═NOR<sup class="style-scope patent-text">9</sup> (where R<sup class="style-scope patent-text">9</sup> is a C<sub class="style-scope patent-text">1-4</sub> alkyl group, e.g. n-propyl).</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">4</sup> may particularly represent a C<sub class="style-scope patent-text">1-4</sub> alkoxy group such as methoxy or n-propoxy.</div>
    <div class="description-paragraph style-scope patent-text">A particular group of compounds of the invention are compounds of formula (Ia) ##STR9## and pharmaceutically acceptable salts and solvates (e.g. hydrates) thereof, wherein R<sup class="style-scope patent-text">1</sup> to R<sup class="style-scope patent-text">4</sup> are as defined in formula (I) above.</div>
    <div class="description-paragraph style-scope patent-text">Preferred compounds of the invention are those compounds of formula (I) or (Ia) in which R<sup class="style-scope patent-text">1</sup> represents hydrogen or hydroxyl.</div>
    <div class="description-paragraph style-scope patent-text">Further preferred compounds are those in which R<sup class="style-scope patent-text">2</sup> is in the axial configuration and R<sup class="style-scope patent-text">3</sup> is hydrogen. Particular R<sup class="style-scope patent-text">2</sup> groups include C<sub class="style-scope patent-text">1-6</sub> alkoxy, e.g. C<sub class="style-scope patent-text">1-4</sub> alkoxy such as methoxy or propoxy, C<sub class="style-scope patent-text">1-4</sub> alkoxymethoxy e.g. methoxymethoxy, C<sub class="style-scope patent-text">1-6</sub> alkylthio (e.g. C<sub class="style-scope patent-text">1-4</sub> alkylthio such as methylthio) azido, or OCOR<sup class="style-scope patent-text">7</sup> wherein R<sup class="style-scope patent-text">7</sup> is as defined herein above or more particular C<sub class="style-scope patent-text">5-8</sub> alkyl (e.g. n-heptyl, 1-methylpentyl), phenyl, p-tolyl, 2-phenylethenyl, 1-methylethenyl or 1-methylpent-1-enyl.</div>
    <div class="description-paragraph style-scope patent-text">Further preferred compounds are those in which R<sup class="style-scope patent-text">4</sup> is C<sub class="style-scope patent-text">1-4</sub> alkoxy (e.g. methoxy or propoxy).</div>
    <div class="description-paragraph style-scope patent-text">Particularly preferred compounds are those wherein R1 is hydrogen and R<sup class="style-scope patent-text">2</sup> is C<sub class="style-scope patent-text">1-4</sub> alkoxy or methoxymethoxy.</div>
    <div class="description-paragraph style-scope patent-text">Further particularly preferred compounds are those wherein R<sup class="style-scope patent-text">1</sup> is hydroxyl and R<sup class="style-scope patent-text">2</sup> is azido, C<sub class="style-scope patent-text">1-4</sub> alkylthio e.g. thiomethyl, or OCOR<sup class="style-scope patent-text">7</sup> wherein R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">4-8</sub> alkyl, phenyl, tolyl, 2-phenylethenyl, 1-methylethenyl or 1-methylpent-1-enyl.</div>
    <div class="description-paragraph style-scope patent-text">It is to be understood that the present invention covers all combinations of particular and preferred groups described hereinabove.</div>
    <div class="description-paragraph style-scope patent-text">The compounds of formula (I) are very active fungicides useful in combatting fungal infections in animals, including humans. For example, they may be used in the treatment of fungal infections caused by organisms such as species of Candida (e.g. Candida albicans, Candida alabrata, (Torulorsis glabrata), Candida tropicalis, Candida parapsilosis and Candida pseudotropicalis), Cryptococcus neoformans, Pneumocystis carinii, Asperalilius Sp (e.g. Aspergillus flavus and Asperaillus fumipatus), Coccidioides (e.g. Coccidioides immitis), Paracoccidioides (e.g. Paracoccidioides brasiliensis), Histoplasma (e.g. Histoplasma capsulatum) or Blastomyces (e.g. Blastomyces dermatitidis). They may also be used to treat other fungal infections caused by species of Candida, Trichophyton, Microsporum or Epidermorhyton (e.g. Trichophyton mentographytes, Trichophyton rubrum, Microsporum canis or Epidermorhyton floccosum), or in mucosal infections caused by Candida albicans.</div>
    <div class="description-paragraph style-scope patent-text">Compounds of formula (I) may also be used to treat other infections caused by species of filamentous fungi such as Geotrichum (e.g. Geotrichum clavatum), Trichosporon (e.g. Trichosporon beigelii), Blastoschizomyces (e.g. Blastoschizomyces capitatus), Sporothrix (e.g. Sporothrix schenckii), Scedosporium (e.g. Scedosoorium apiosperum), Cladosporium (e.g. Cladosporium carrionii) and Pityrosporum ovale.</div>
    <div class="description-paragraph style-scope patent-text">The compounds of formula (I) may also be used to treat infections caused by protozoa such as Toxoplasma, Cryptosporidium, Leishmania, Tripanosoma, Giardia and Trichomonas.</div>
    <div class="description-paragraph style-scope patent-text">The in vitro evaluation of the anti-fungal activity of compounds of the invention was performed on liquid or solid medium by the anti-fungal two-fold serial dilution technique of determining the minimum inhibitory concentration (MIC) of anti-fungal agent that inhibited development of growth after 24 to 48 hours of incubation at 37° C. In practice, a series of agar plates or broth microdilution panels containing two-fold dilutions of anti-fungal agent tested were inoculated with a standard culture of a clinically relevant pathogen, for example, candida albicans. The agar plates or broth microdulution panels were then examined for the presence or absence of growth of the fungus and the appropriate MIC values were noted.</div>
    <div class="description-paragraph style-scope patent-text">MFC values (defined as the lowest anti-fungal concentration that killed at least 99.9% of the initial inoculum in liquid medium) may also be determined by sub-culturing 0.01 and 0.1 μl of broth from the drug-free control well, the first well containing growth and each clear well on agar plates.</div>
    <div class="description-paragraph style-scope patent-text">The in vivo evaluation of compounds of formula (I) can be carried out at a series of dose levels by administration (e.g. subcutaneously, orally, intraperitoneally or intravenously) to mice or rats inoculated with a strain of Candida albicans. Untreated animals die within 3 to 9 days and the dose level at which the test compound provides 50% protection against the lethal effect of the infection is noted.</div>
    <div class="description-paragraph style-scope patent-text">In view of their antifungal activity, compounds of formula (I) recommend themselves for the treatment of a variety of fungal infections in human beings and animals. Such infections include superficial, cutaneous, subcutaneous and systemic mycotic infections such as respiratory tract infections, gastrointestinal tract infections, cardiovascular infections, urinary tract infections, CNS infections, candidiasis and chronic mucocandidiasis (e.g. thrush and vaginal candidiasis) and skin infections caused by fungi, cutaneous and mucocutaneous candidiasis, dermatophytoses including ringworm and tinea infections, athletes foot, paronychia, pityriasis versicolor, erythrasma, intertrigo, fungal nappy rash, candida vulvitis, candida balanitis and otitis extema. They may also be used as prophylactic agents to prevent systemic and topical fungal infections. Use as prophylactic agents may, for example, be appropriate as part of a selective gut decontamination regimen in the prevention of infection in immunocompromised patients (e.g. AIDS patients, patients receiving cancer therapy or transplant patients). Prevention of fungal overgrowth during antibiotic treatment may also be desirable in some disease syndromes or iatrogenic states.</div>
    <div class="description-paragraph style-scope patent-text">While it is possible that, for use in therapy, compounds of the invention may be administered as the raw chemical, it is preferable to present the active ingredient as a pharmaceutical formulation. The invention thus further provides a pharmaceutical formulation comprising compounds of formula (I) and physiologically acceptable salts thereof together with one or more pharmaceutically acceptable carriers thereof and, optionally, other therapeutic and/or prophylactic ingredients. The carrier(s) must be `acceptable` in the sense of being compatible with the other ingredients of the formulation and not deleterious to the recipient thereof.</div>
    <div class="description-paragraph style-scope patent-text">The compositions of the invention include those in a form especially formulated for oral, buccal, parenteral, implant, rectal, topical, ophthalmic or genito-urinary administration or in a form suitable for administration by inhalation or insufflation.</div>
    <div class="description-paragraph style-scope patent-text">Tablets and capsules for oral administration may contain conventional excipients such as binding agents, for example, syrup, acacia, gelatin, sorbitol, tragacanth, mucilage of starch or polyvinylpyrrolidone; fillers, for example, lactose, sugar, microcrystalline cellulose, maize-starch, calcium phosphate or sorbitol; lubricants, for example, magnesium stearate, stearic acid, talc, polyethylene glycol or silica; disintegrants, for example, potato starch or sodium starch glycollate or crosscarmellose sodium; or wetting agents such as sodium lauryl sulphate. The tablets which include chewable, dispersible or effervescent tablets may be coated according to methods well known in the art. Oral liquid preparations may be in the form of, for example, aqueous or oily suspensions, solutions, emulsions, syrups or elixirs, or may be presented as a dry product for constitution with water or other suitable vehicle before use. Such liquid preparations may contain conventional additives such as suspending agents, for example, sorbitol syrup, methyl cellulose, glucoselsugar syrup, gelatin, hydroxyethylcellulose, carboxymethyl cellulose, aluminium stearate gel or hydrogenated edible fats; emulsifying agents, for example, lecithin, sorbitan mono-oleate or acacia; non-aqueous vehicles (which may include edible oils), for example, almond oil, fractionated coconut oil, oily esters, propylene glycol or ethyl alcohol; and preservatives, for example, methyl or propyl p-hydroxybenzoates or sorbic acid.</div>
    <div class="description-paragraph style-scope patent-text">For buccal administration the composition may take the form of tablets or lozenges formulated in conventional manner.</div>
    <div class="description-paragraph style-scope patent-text">The composition according to the invention may be formulated for parenteral administration by injection or continuous infusion. Formulations for injection may be presented in unit dose form in ampoules, or in multi-dose containers with an added preservative. The compositions may take such forms as suspensions, solutions, or emulsions in oily or aqueous vehicles, and may contain formulatory agents such as suspending, stabilising and/or dispersing agents. Alternatively the active ingredient may be in powder form for constitution with a suitable vehicle, e.g. sterile, pyrogen-free water, before use.</div>
    <div class="description-paragraph style-scope patent-text">For administration by inhalation the compositions according to the invention are conveniently delivered in the form of an aerosol spray presentation from pressurised packs with the use of a suitable propellant, e.g. dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane, carbon dioxide or other suitable gas, or from a nebuliser. In the case of a pressurised aerosol the dosage unit may be determined by providing a valve to deliver a metered amount.</div>
    <div class="description-paragraph style-scope patent-text">Alternatively, for administration by inhalation the compositions according to the invention may take the form of a dry powder composition, for example a powder mix of the compound and a suitable powder base such as lactose or starch or as a modified physical form of the drug substance alone. The powder composition may be presented in unit dosage form in, for example, capsules or cartridges of e.g. gelatin, or blister packs from which the powder may be administered with the aid of an inhaler or insufflator.</div>
    <div class="description-paragraph style-scope patent-text">The compositions may take the form of a suppository, e.g. containing a conventional suppository base, or a pessary, e.g. containing a conventional pessary base.</div>
    <div class="description-paragraph style-scope patent-text">The compositions may also be formulated for topical administration in the form of ointments, creams, gels, lotions, shampoos, powders (including spray powders), pessaries, tampons, sprays, dips, aerosols, drops (e.g. eye, ear or nose drops) or pour-ons. Ointments and creams may, for example, be formulated with an aqueous or oily base with the addition of suitable thickening and/or gelling agents. Ointments for administration to the eye may be manufactured in a sterile manner using sterilised components. Pour-ons may, for example, be formulated for veterinary use in oils containing organic solvents, optionally with formulatory agents, e.g. stabilising and solubilising agents. Pessaries and tampons for vaginal insertion may be formulated using conventional techniques and, where appropriate, may contain an effervescent vehicle. Such compositions may also contain other active ingredients such as corticosteroids, antibiotics or antiparasitics as appropriate.</div>
    <div class="description-paragraph style-scope patent-text">Liquid preparations for intranasal delivery may take the form of solutions or suspensions and may contain conventional excipients such as tonicity adjusting agents, for example, sodium chloride, dextrose or mannitol; preservatives, for example benzalkonium chloride, thiomersal, phenylelklyl alcohol; and other formulating agents such as suspending, buffering, stabilising, dispersing and or flavouring agents.</div>
    <div class="description-paragraph style-scope patent-text">Transdermal administration may be affected by the design of a suitable system which promotes absorption of the active compound through the skin and would typically consist of a base formulation enclosed within an adhesive stick-on patch comprising backing films, membranes and release liners. Such systems may include absorption enhancers such as alcohols or work by promoting ionotophoresis.</div>
    <div class="description-paragraph style-scope patent-text">The composition according to the invention may also be formulated as a depot preparation. Such long acting formulations may be administered by implantation (for example subcutaneously or intramuscularly) or by intramuscular injection. Thus, for example, a compound of the invention may be formulated with suitable polymeric or hydrophobic materials (for example as an emulsion in an acceptable oil) or ion exchange resins, or as sparingly soluble derivatives, for example, as a sparingly soluble salt.</div>
    <div class="description-paragraph style-scope patent-text">When the compositions comprise dosage units, each unit will preferably contain 0.001 mg to 1000 mg, advantageously 0.01 mg to 400 mg, of active ingredient where a compound of the invention is to be administered orally. The daily dosage as employed for adult human treatment will preferably range from 0.001 mg to 5000 mg of active ingredient, most preferably from 0.01 mg to 2000 mg which may be administered in 1 to 4 daily doses, for example, depending on the route of administration and on the condition of the patient and the disease to be treated.</div>
    <div class="description-paragraph style-scope patent-text">The compound may be administered by intravenous infusion using, for example, up to 50 mg/kg/day of the active ingredient. The duration of treatment will be dictated by the rate of response rather than by arbitrary numbers of days.</div>
    <div class="description-paragraph style-scope patent-text">Compounds of the invention may also be used in combination with other therapeutic agents, and the invention thus provides, in a further aspect, a combination comprising a compound of the invention together with another therapeutically active agent.</div>
    <div class="description-paragraph style-scope patent-text">Thus for example the compounds of the invention may be used in combination with one or more other antifungal agents, such as a polienic derivative e.g. (Amphotericin B, Nystatin, a lipid formulation of Amphotericin B) an azole derivative e.g. (Fluconazole, Intraconazole, Ketoconazole, Miconazole, Clotrimazole, ZD-08070, UK-109496), 5-Fluorocytosine, a Pneumocandin or Echinocandin derivative such as Cilofungin, LY-303366, L-733560, and/or one or more immunomodulating agents such as an interferon e.g. (IFN-γ). interleukine e.g. (IL-1, IL-2, IL-3 and IL-8) and colony stimulating factors, [(G)-CSF, (M)-CSF and (GM)-CSF] and defensines. Particularly advantageous compounds for use with compounds of the invention include Intraconazole, Flucytosine, Fluconazole or Amphotericin B.</div>
    <div class="description-paragraph style-scope patent-text">When the compounds of the invention are administered in combination with another antifungal agent the compounds of the invention and the other fungal agent can be administered at the recommended maximum clinical dosage or at lower doses.</div>
    <div class="description-paragraph style-scope patent-text">The combinations referred to above may conveniently be presented for use in the form of a pharmaceutical formulation and thus pharmaceutical formulations comprising a combination as defined above together with a pharmaceutically acceptable carrier thereof comprise a further aspect of the invention. The individual components of such combinations may be administered either sequentially or simultaneously in separate or combined pharmaceutical formulations.</div>
    <div class="description-paragraph style-scope patent-text">When a compound of the invention is used in combination with a second therapeutic agent against the same condition the dose of each compound may differ from that when the compound is used alone. Appropriate doses will be readily appreciated by those skilled in the art.</div>
    <div class="description-paragraph style-scope patent-text">According to another aspect of the present invention, we provide a compound of formula (I) or a physiologically acceptable salt thereof or a pharmaceutical composition comprising a compound of formula (I) or a physiologically acceptable salt thereof as defined above for use in therapy, particularly for the treatment of fungal infections in animals (especially humans).</div>
    <div class="description-paragraph style-scope patent-text">According to another aspect of the present invention, we provide the use of a compound of formula (I) or a physiologically acceptable salt thereof in the manufacture of a medicament for the treatment of fungal infections in a human or non-human animal patient.</div>
    <div class="description-paragraph style-scope patent-text">According to a further aspect of the present invention, we provide a method of treatment of the human or non-human animal body to combat fungal diseases, which method comprises administering to said body an effective amount of a compound of formula (I) or a physiologically acceptable salt thereof.</div>
    <div class="description-paragraph style-scope patent-text">It will be appreciated by those skilled in the art that references herein to treatment extend to prophylaxis as well as the treatment of established conditions or infections.</div>
    <div class="description-paragraph style-scope patent-text">The compounds of the invention may be prepared by the processes described below.</div>
    <div class="description-paragraph style-scope patent-text">Thus, a general process (A) for the preparation of a compound of formula, (I) comprises reacting a compound of formula (II) ##STR10## (in which R<sup class="style-scope patent-text">1a</sup> is as defined for R<sup class="style-scope patent-text">1</sup> in formula (I) above or is a protected hydroxyl group, R<sup class="style-scope patent-text">4a</sup> is as defined for R<sup class="style-scope patent-text">4</sup> in formula (I) above or is a protected hydroxyl group, A is a group CHO or a protected derivative thereof and R<sup class="style-scope patent-text">p</sup> is hydrogen or a carboxyl protecting group) to replace one or more of the free hydroxyl groups with one or more of R<sup class="style-scope patent-text">1</sup>, R<sup class="style-scope patent-text">2</sup> /R<sup class="style-scope patent-text">3</sup> and R<sup class="style-scope patent-text">4</sup>, followed by the removal of any protecting groups present.</div>
    <div class="description-paragraph style-scope patent-text">A first embodiment of process (A) comprises alkylating or alkenylating a compound of formula (II), followed by the removal of any protecting groups present to provide a compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> is C<sub class="style-scope patent-text">1-10</sub> alkoxy, C<sub class="style-scope patent-text">1-6</sub> alkoxyC<sub class="style-scope patent-text">1-4</sub> alkoxy, arylC<sub class="style-scope patent-text">1-6</sub> alkyloxy, arylC<sub class="style-scope patent-text">3-6</sub> alkenyloxy or OR<sup class="style-scope patent-text">6</sup> and R<sup class="style-scope patent-text">1a</sup> and R<sup class="style-scope patent-text">4a</sup> are as defined for R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">4</sup> in formula (I) above. It will be appreciated that by using appropriate alkylation and alkenylation conditions and protecting groups where necessary, one is able to selectively alkylate or alkenylate the relevant free hydroxyl group(s) without affecting any other labile groups present in a compound of formula (II).</div>
    <div class="description-paragraph style-scope patent-text">The alkylation or alkenylation reaction may be effected using standard methodology, for example by treating a compound of formula (II) with a strong base such as an alkali metal hydride (e.g. sodium hydride) in a solvent such as an ether (e.g. tetrahydrofuran), followed by the addition of a suitable alkyl or alkenyl halide, optionally in the presence of a tetraalkylammonium halide (e.g. tetra-n-butylammonium fluoride or iodide). The reaction may conveniently be effected at any suitable temperature, for example from room temperature to the reflux temperature of the solvent.</div>
    <div class="description-paragraph style-scope patent-text">Alternatively, the reaction may be carried out by treating a compound of formula (II) with a tin oxide (e.g. dibutyltin oxide) in a hydrocarbon solvent (e.g. refluxing toluene), followed by the addition of an alkylhalide and a fluoride salt (e.g. tetra-n-butylammonium fluoride) in a suitable solvent such as an ether (e.g. tetrahydrofuran), and heating the mixture in the range of about 30° to 80° C.</div>
    <div class="description-paragraph style-scope patent-text">The introduction of a C<sub class="style-scope patent-text">1-6</sub> alkoxyC<sub class="style-scope patent-text">1-6</sub> alkyl group may conveniently be effected using somewhat milder condition than those conditions described above. Thus, for example, a compound of formula (II) may be treated with a suitable alkoxyalkyl halide in the presence of a mild base such as a tertiary amine (e.g. diisopropylethylamine) at a temperature in the range of about 0° to 40° C. The base may also conveniently be the solvent for the reaction.</div>
    <div class="description-paragraph style-scope patent-text">The introduction of a group R<sup class="style-scope patent-text">6</sup> may conveniently be effected by treating a compound of formula (II) with a cyclic ether containing one double bond in the ring 2,3-position. The reaction may conveniently be effected in a suitable solvent such as a halogenated hydrocarbon (e.g. dichloromethane) in the presence of a mild acid such as pyridinium p-toluenesulphonate at about room temperature.</div>
    <div class="description-paragraph style-scope patent-text">According to a further embodiment of process (A), a compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> represents a group ##STR11## may be prepared by treating a suitably protected compound of formula (II) with an acylating agent, followed by the removal of any protecting groups present. Thus, when X represents a bond or an oxygen atom, the acylation reaction may be effected using any conventional method. For example, one method for preparing compounds in which X is a bond comprises treating a compound of formula (II) with a carboxylic acid R<sup class="style-scope patent-text">7</sup> CO<sub class="style-scope patent-text">2</sub> H in the presence of an activating agent such as dicyclohexylcarbodiimide and a suitable base such as 4-dimethylaminopyridine in a solvent such as a halogenated hydrocarbon (e.g. dichloromethane) at about room temperature. Alternatively, the reaction with a carboxylic acid R<sup class="style-scope patent-text">7</sup> CO<sub class="style-scope patent-text">2</sub> H may be effected in the presence of 2-chloro-1-methylpyridinium iodide and a suitable base system such as 4-dimethylaminopyridine optionally also comprising a tertiary amine such as triethylamine, conveniently in a halogenated hydrocarbon solvent (e.g. dichloromethane) at a temperature of from about 20° to the reflux temperature of the solvent. An activated acid such as a carboxylic acid halide (for example a carboxylic acid chloride R<sup class="style-scope patent-text">7</sup> COCl) or a carboxylic anhydride such as acetic anhydride may also be used, whereby the acylation may be effected either by directly reacting a compound of formula (II) with the acid halide in the presence of a suitable base such as 4-dimethylaminopyridine, pyridine or a trialkylamine (e.g. triethylamine) or a mixture of suitable bases in a suitable solvent such as acetonitrile or dichloromethane or by addition of the acid halide (R<sup class="style-scope patent-text">7</sup> CO)<sub class="style-scope patent-text">2</sub> O following pre-treatment of a compound of formula (II) with a tin oxide (e.g. dibutyltin oxide) in a hydrocarbon solvent (e.g. refluxing toluene). Similar conditions using a haloformate (for example a chloroformate R<sup class="style-scope patent-text">7</sup> OCOCl) may conveniently provide compounds in which R<sup class="style-scope patent-text">2</sup> represent OCO<sub class="style-scope patent-text">2</sub> R<sup class="style-scope patent-text">7</sup>.</div>
    <div class="description-paragraph style-scope patent-text">When X represents NH, the acylation reaction may conveniently be effected using a suitable isocyanate R<sup class="style-scope patent-text">7</sup> NCO in the presence of a tin catalyst (e.g. a dialkyltin diacetate such as dibutyltin diacetate) and in a solvent such as an aromatic hydrocarbon (e.g. toluene) conveniently under reflux.</div>
    <div class="description-paragraph style-scope patent-text">When X represents NAlkyl, the acylation reaction may conveniently be effected using a reagent HalCONR<sup class="style-scope patent-text">7</sup> R<sup class="style-scope patent-text">8</sup> (where Hal is a halogen atom, e.g. chlorine) in the presence of a strong base such as an alkali metal amide (e.g. lithium diisopropylamide) and in a solvent such as an ether (e.g. tetrahydrofuran) conveniently at a temperature in the range of about 0° C. to room temperature.</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment of process (A), a compound of formula (I) in which R<sup class="style-scope patent-text">1</sup> is hydroxyl and R<sup class="style-scope patent-text">2</sup> is azido or C<sub class="style-scope patent-text">1-10</sub> alkylthio may be prepared from a compound of formula (II) in which R<sup class="style-scope patent-text">1a</sup> is hydroxyl, R<sup class="style-scope patent-text">4a</sup> is C<sub class="style-scope patent-text">1-6</sub> alkoxy, A is a group CHO or a protected derivative thereof and R<sup class="style-scope patent-text">p</sup> is a carboxyl protecting group via a compound of formula (III) or (IV) ##STR12## (wherein A and R<sup class="style-scope patent-text">p</sup> are as defined just above and R<sup class="style-scope patent-text">4</sup> is C<sub class="style-scope patent-text">1-6</sub> alkoxy, e.g. methoxy), followed by the removal of any protecting groups present.</div>
    <div class="description-paragraph style-scope patent-text">The nucleophilic ring opening of the epoxide in (III) or (IV) may conveniently be effected by the addition of an alkali metal azide (e.g. lithium azide) or an alkali metal thioalkoxide (e.g. sodium thiomethoxide) in a suitable solvent such as dimethylformamide. The reaction with an azide may conveniently be effected at an elevated temperature, for example within the range of about 80° to 120° C. The reaction with a thioalkoxide may conveniently be effected at about room temperature. It will be appreciated that the nucleophilic ring opening reaction provides compounds in which the R<sup class="style-scope patent-text">1</sup> hydroxyl group is in the opposite plane to the R<sup class="style-scope patent-text">2</sup> azido or C<sub class="style-scope patent-text">1-10</sub> alkylthio group. The particular configuration will depend upon the choice of a compound of formula (III) or (IV) as the starting material.</div>
    <div class="description-paragraph style-scope patent-text">In a further embodiment of process (A), a compound of formula (I) in which R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> both represent hydrogen atoms may conveniently be prepared from a suitably protected compound of formula (II) in which R<sup class="style-scope patent-text">1a</sup> is a hydroxyl group by treating said compound with a reducing system capable of converting the 2', 3'-diol group to a 2',3'-ene group and thereafter hydrogenating the unsaturated compound in the presence of a palladium catalyst (e.g. palladium-on-carbon), followed, where necessary, by the removal of any protecting groups remaining. The initial reaction may conveniently be effected by treating the diol with zinc and iodine following the addition of a triarylphosphine (e.g. triphenylphosphine) and imidazole. The reaction may be carried out, for example, in a solvent such as refluxing toluene.</div>
    <div class="description-paragraph style-scope patent-text">Compounds of formulae (III) and (IV) may conveniently be prepared treating a compound of formula (II) in which R<sup class="style-scope patent-text">1a</sup> is hydroxyl, R<sup class="style-scope patent-text">4a</sup> is C<sub class="style-scope patent-text">1-6</sub> alkoxy, A is a group CHO or a protected derivative hereof and R<sup class="style-scope patent-text">p</sup> is a carboxyl protecting group to convert the free hydroxyl groups to leaving groups such as alkyl- or arylsulphonyloxy groups followed by treatment with a strong base such as an alkali metal hydride (e.g. sodium hydride) in a suitable solvent such as dimethylformamide, conveniently at about room temperature. Alternatively, sodium in an alcoholic solvent (e.g. methanol) may be used to form the epoxide ring. In this instance the base system is added to a solution of the reactive intermediate in a suitable solvent such as a halogenated hydrocarbon (e.g. dichloromethane) and the reaction conveniently carried out at a temperature of from about room temperature to reflux. The reaction provides a mixture of compounds of formulae (III) and (IV) which may conveniently be separated by flash column chromatography.</div>
    <div class="description-paragraph style-scope patent-text">The conversion of the free hydroxyl groups in appropriate compounds of formula (II) to leaving groups may be effected using conventional methodology. Thus, for example, alkyl- or arylsulphonyloxy groups may be introduced by reaction with an alkyl- or arylsulphonyl halide in the presence of a suitable solvent such as a halogenated hydrocarbon (e.g. dichloromethane) and optionally also comprising an amine base (e.g. 4-dimethylaminopyridine). The reaction may conveniently be carried out at about room temperature.</div>
    <div class="description-paragraph style-scope patent-text">According to a further embodiment of process (A), one or more free hydroxyl groups in a compound of formula (II) may be converted to a halogen atom using conventional displacement methods. Thus, for example, replacement with iodine may conveniently be effected by treatment with iodine in the presence of triphenylphosphine and imidazole in a suitable solvent such as an aromatic hydrocarbon (e.g. toluene) at an elevated temperature, for example under reflux. Replacement with fluorine may conveniently be effected by treatment with a suitable fluorinating agent such as diethylaminosulfur, trifluoride (DAST) in the presence of a solvent such as a halogenated hydrocarbon (e.g. dichloromethane) or an aromatic hydrocarbon (e.g. toluene). The reaction may conveniently be effected about room temperature.</div>
    <div class="description-paragraph style-scope patent-text">Another embodiment of process (A) comprises oxidising a compound of formula (II) followed by the removal of any protecting groups present to provide a compound of formula (I) in which CR<sup class="style-scope patent-text">2</sup> R<sup class="style-scope patent-text">3</sup> represents C═O. The oxidation reaction may conveniently be effected using a suitable oxidising agent such as dimethylsulfoxide in the presence of trifluoroacetic anhydride. The oxidation conveniently taken place in the presence of a suitable solvent such as a halogenated hydrocarbon (e.g. dichloromethane), optionally comprising a suitable amine base (e.g. triethylamine), at a reduced temperature (e.g. from about -78° to 0° C.).</div>
    <div class="description-paragraph style-scope patent-text">Another general process (B) comprises an interconversion reaction wherein a compound of formula (I) is prepared from a different compound of formula (I) or a protected derivative thereof.</div>
    <div class="description-paragraph style-scope patent-text">According to a first embodiment of process (B), a protected derivative of a3 compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> is azido may be converted to a compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> is NR<sup class="style-scope patent-text">5</sup> COR<sup class="style-scope patent-text">5</sup>. The R<sup class="style-scope patent-text">2</sup> conversion may conveniently be effected by reducing the azido group to NH<sub class="style-scope patent-text">2</sub> by hydrogenation, for example in the presence of a suitable palladium catalyst (e.g. palladium on charcoal), and then acylating the amine under conventional conditions, for example by addition of a carboxylic acid anhydride in the presence of a suitable base (e.g. pyridine), followed, when R<sup class="style-scope patent-text">5</sup> is C<sub class="style-scope patent-text">1-6</sub> alkyl, by alkylation by treating the amide with a suitable base (e.g. sodium hydride) in a solvent such as an ether (e.g. tetrahydrofuran) and then adding a suitable alkylating agent such as an alkyl halide.</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment of process (B), a compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> is an azido group or the group SCOR<sup class="style-scope patent-text">7</sup> may be prepared by treating a protected derivative of a corresponding compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> is a halogen atom (e.g. iodine) with an alkali metal azide (e.g. lithium azide) or a salt e.g. sodium or cesium salt of the thiocarboxylic acid R<sup class="style-scope patent-text">7</sup> COSH in a solvent such as dimethylformamide at an elevated temperature (e.g. 50° to 120° C.), followed by the removal of any protecting groups present.</div>
    <div class="description-paragraph style-scope patent-text">A further embodiment of process (B) comprises reducing a compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> is a halogen atom (e.g. iodine) to provide, following the removal of any protecting groups present, a corresponding compound of formula (I) in which R<sup class="style-scope patent-text">2</sup> is hydrogen. The reduction may conveniently be effected using a suitable reducing agent such as a tin hydride (e.g. a trialkyltin hydride such as tributyltin hydride) in the presence of an activating agent such as azobis (isobutyronitrile) in a solvent such as refluxing toluene.</div>
    <div class="description-paragraph style-scope patent-text">A further embodiment of process (B) comprises alkylating a protected derivative of a corresponding compound of formula (I) in which R<sup class="style-scope patent-text">1</sup> and/or R<sup class="style-scope patent-text">4</sup> is hydroxyl under the conditions described in the first embodiment of process (A) hereinabove.</div>
    <div class="description-paragraph style-scope patent-text">In a further embodiment of process (B), a compound of formula (I) in which CR<sup class="style-scope patent-text">2</sup> R<sup class="style-scope patent-text">3</sup> is a group C═NOR<sup class="style-scope patent-text">9</sup> may be prepared by treating a protected derivative of a corresponding compound of formula (I) in which CR<sup class="style-scope patent-text">2</sup> R<sup class="style-scope patent-text">3</sup> is C═O with a reagent R<sup class="style-scope patent-text">9</sup> ONH<sub class="style-scope patent-text">2</sub> or a salt thereof (e.g. the hydrochloride salt) in a suitable solvent (e.g. pyridine) at an elevated temperature (e.g. from about 60° to 100° C.), followed by the removal of any protecting groups present.</div>
    <div class="description-paragraph style-scope patent-text">In any of the aforementioned procedures where an alkyl moiety is introduced as a group or part of a group, it may be appropriate to first introduce the corresponding unsaturated moiety and thereafter reduce the alkenyl group to the desired alkyl group, for example by hydrogenation in the presence of a palladium catalyst (e.g. 10% palladium on charcoal) at about room temperature.</div>
    <div class="description-paragraph style-scope patent-text">Many of the above-mentioned procedures require the removal of one or more protecting groups as a final step to provide the desired compound of formula (I). Thus, a further general process (C) comprises deprotecting a protected derivative of a compound of formula (I). Suitable carboxyl protecting groups and hydroxyl protecting groups for use herein include any conventional protecting group, for example as described in "Protective Groups in Organic Chemistry", Ed. J. F. W. McOmie (Plenum Press, 1973) or "Protective Groups in Organic Synthesis" by Theodora W. Greene (John Wiley and Sons, 1991). Examples of suitable carboxyl protecting groups include aralkyl groups such as diphenylmethyl and silyl groups (e.g. trimethylsilylethyl). Examples of suitable hydroxyl protecting groups include arylalkyl groups such as p-methoxybenzyl, acyl groups such as acetyl and ester group such as 2,2,2-trichloroethoxycarbonyl or benzyloxycarbonyl. Aldehyde groups may conveniently be protected in the form of cyclic ketals.</div>
    <div class="description-paragraph style-scope patent-text">The protecting groups may be removed using conventional techniques. Thus, a diphenylmethyl group may conveniently be removed using trifluoroacetic acid or by hydrogenolysis in the presence of a palladium catalyst (e.g. 10% palladium on charcoal). Trifluoroacetic acid may conveniently be employed where other groups are present which are sensitive to hydrogenation. A p-methoxybenzyl group may conveniently be removed using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. Silyl groups such as trimethylsilylethyl may conveniently be removed using fluoride ions. Cyclic ketal groups may conveniently be converted to aldehyde group by the addition of a suitable acid such as hydrochloric acid. An acyl group such as acetyl may conveniently be removed under basic conditions, for example using an alkoxide (e.g. sodium methoxide). An ester group such as 2,2,2-trichloroethoxycarbonyl may conveniently be removed by adding zinc and potassium dihydrogen phosphate.</div>
    <div class="description-paragraph style-scope patent-text">Compounds of formula (II) may conveniently be prepared from sordarin or 4'-demethylsordarin, a compound of formula (V) ##STR13## Thus, for example, compounds of formula (II) may be prepared from sordarin or 4'-demethylsordarin by appropriate protection using conventional methods as described above, followed where necessary by converting one or more of the hydroxyl groups to other groups specified in formula (II) above.</div>
    <div class="description-paragraph style-scope patent-text">When the carboxyl group in sordarin or a compound of formula (V) is protected with a diphenylmethyl group the protection reaction may conveniently be carried out by treating a solution of sordarin or a compound of formula (V) in an alcoholic solvent (e.g. methanol) or a halogenated hydrocarbon (e.g. dichloromethane) or a mixture of such solvents with diphenyldiazomethane, conveniently added as a solution in a halogenated hydrocarbon solvent (e.g. dichloromethane).</div>
    <div class="description-paragraph style-scope patent-text">When a hydroxyl group in a carboxyl protected derivative of sordarin or a compound of formula (V) is protected with a p-methoxybenzyl group this group may be introduced by reaction with a tin oxide (e.g. dibutyltin oxide) in a hydrocarbon solvent (e.g. refluxing toluene), followed by the addition of a p-methoxybenzyl halide in the presence of an fluoride salt (e.g. tetrabutylammonium fluoride). When protected with a benzyloxycarbonyl group, this group may be introduced by reaction with a benzylhaloformate in the presence of a suitable amine base such as 4-dimethylaminopyridine and in a solvent such as a halogenated hydrocarbon (e.g. dichloromethane) or acetonitrile.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">1a</sup> in a compound of formula (II) is hydrogen such compounds may conveniently be prepared from sordarin or 4'-demethylsordarin by appropriate protection of labile groups followed by removal of the 2'-hydroxyl group. Removal of the hydroxyl group to provide a compound in which R<sup class="style-scope patent-text">1a</sup> is hydrogen may conveniently be effected in two steps comprising (i) forming an S-alkyldithiocarbonate by treatment with a strong alkali metal base (e.g. sodium hydride), in the presence of imidazole, and in a suitable solvent such as an ether (e.g. tetrahydrofuran) at a reduced temperature (e.g. about 0° C.), and then adding carbon disulphide and an alkylhalide (e.g. methyliodide) at about room temperature and (ii) removing this group by treating a solution of the intermediate compound in a hydrocarbon solvent (e.g. toluene) at an elevated temperature (e.g. about 80° to 120° C.) with a hydride reducing agent (e.g. a trialkyltin hydride such as tributyltin hydride), optionally in the presence of an activating agent [e.g. azobis(isobutyronitrile)].</div>
    <div class="description-paragraph style-scope patent-text">Compounds of formulae (II), (III), (IV) and (V) are novel intermediates and form further individual aspects of the present invention. The compound of formula (V), 4'-demethylsordarin, represents a particular aspect of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">Base salts of compounds of formula (I) may be conveniently formed by treating a compound of formula (I) with an appropriate salt or base. Thus, for example, salts may conveniently be prepared by treating a compound of formula (I) with a salt or a base selected from sodium or potassium hydroxide, hydrogen carbonate, carbonate or acetate (e.g. potassium hydroxide, potassium hydrogen carbonate, sodium hydrogen carbonate or potassium acetate), ammonium acetate, calcium acetate and L-lysine as appropriate. The salt may, for example, be prepared by adding the appropriate salt or base (if necessary as an aqueous solution) to a solution or suspension of the compound of formula (I) in a suitable solvent such as an alcohol (e.g. methanol) or dioxane at temperatures of for example 0° C. to 80° C. and conveniently at about room temperature.</div>
    <div class="description-paragraph style-scope patent-text">Pharmaceutically acceptable salts may also be prepared from other salts, including other pharmaceutically acceptable salts of the compounds of formula (I), using conventional methods.</div>
    <div class="description-paragraph style-scope patent-text">The novel compound of formula (V) may conveniently be prepared according to the fermentation process described hereinafter or by demethylating sordarin using a biotransformation procedure. It is to be understood that such processes for the preparation of the compound of formula (V) represent further aspects of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">The fermentation process comprises cultivating a microorganism capable of producing the compound of formula (V) and thereafter isolating the compound of formula (V) from the culture.</div>
    <div class="description-paragraph style-scope patent-text">Microorganisms capable of producing the compound of formula (V) will conveniently be mutant strains of Sordaria araneosa which can be identified by screening survivors of mutagenesis by analysing a test sample obtained from fermentation of the microorganism using standard methodology. In particular, the microorganism to be conveniently used is a mutant strain of Sordairia araneosa deposited in the permanent culture collection of the CAB International Mycological Institute, Genetic Resource Reference Collection, Bakeham Lane, Egham, Surrey TW20 9TY, England. The strain was received by the Institute on Jun. 10, 1994 and was subsequently given the accession number IMI 362184 and dates of acceptance and confirmation of viability of Jun. 13 and 21 1994 respectively. The Institute is an International Depository authority recognised under the Budapest Treaty. The characteristics thus far identified for IMI 362184 are given in Example 46.</div>
    <div class="description-paragraph style-scope patent-text">The present invention provides in a further aspect the microorganism IMI 362184 per se and mutants thereof.</div>
    <div class="description-paragraph style-scope patent-text">Mutants of the IMI 362184 may arise spontaneously or may be produced by a variety of methods including those outlined in Techniques for the Development of Microorganisms by H I Adler in "Radiation and Radioisotopes for Industrial Microorganisms", Proceedings of the Symposium, Vienna 1973, p241, International Atomic Energy authority. Such methods include ionising radiation, chemical methods, e.g. treatment with N-methyl-N'-nitro-N-nitrosoguanidine (NTG), heat, genetic techniques, such as recombination and transformation, and selective techniques for spontaneous mutants.</div>
    <div class="description-paragraph style-scope patent-text">The preparation of the compound of formula (V) by fermentation may be effected by conventional means i.e. by culturing a suitable organism in the presence of assimilable sources of carbon, nitrogen and mineral salts, and thereafter isolating the desired product.</div>
    <div class="description-paragraph style-scope patent-text">Assimilable sources of carbon, nitrogen and minerals may be provided by either simple or complex nutrients. Sources of carbon will generally include glucose, maltose, starch, glycerol, molasses, dextrin, lactose, sucrose, fructose, galactose, myo-inositol, D-mannitol, soya bean oil, carboxylic acids, amino acids, glycerides, alcohols, alkanes and vegetable oils. Sources of carbon will generally comprise from 0.5 to 10% by weight of the fermentation medium. Fructose, glucose and sucrose represent preferred sources of carbon.</div>
    <div class="description-paragraph style-scope patent-text">Sources of nitrogen will generally include soya bean meal, corn steep liquors, distillers solubles, yeast extracts, cottonseed meal, peptones, ground nut meal, malt extract, molasses, casein, amino acid mixtures, ammonia (gas or solution), ammonium salts or nitrates. Urea and other amides may also be used. Sources of nitrogen will generally comprise from 0.1 to 10% by weight of the fermentation medium.</div>
    <div class="description-paragraph style-scope patent-text">Nutrient mineral salts which may be incorporated into the culture medium include the generally used salts capable of yielding sodium, potassium, ammonium, iron, magnesium, zinc, nickel, cobalt, manganese, vanadium, chromium, calcium, copper, molybdenum, boron, phosphate, sulphate, chloride and carbonate ions.</div>
    <div class="description-paragraph style-scope patent-text">Cultivation of the organism will generally be effected at a temperature of from 20° to 40° C., preferably from 20 to 35° C., especially about 25° C., and will desirably take place with aeration and agitation e.g. by shaking or stirring. The medium may initially be inoculated with a small quantity of mycelium and/or spores. The vegetative inoculum obtained may be transferred to the fermentation medium, or to one or more seed stages where further growth takes place before transfer to the principal fermentation medium. The fermentation will generally be carried out in the pH range 3.5 to 9.5, preferably 4.5 to 7.5. It may be necessary to add a base or an acid to the fermentation medium to keep the pH to within the desired range. Suitable bases which may be added include alkali metal hydroxides such as aqueous sodium hydroxide or potassium hydroxide. Suitable acids include mineral acids such as hydrochloric, sulphuric or phosphoric acid.</div>
    <div class="description-paragraph style-scope patent-text">The fermentation may be carried out for a period of 4-30 days, preferably about 5-15 days. An antifoam may be present to control excessive foaming and added at intervals as required. Carbon and/or nitrogen sources may also be fed into the fermentation medium as required.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula (V) is associated mainly with the cells and may be brought into solution either by addition of an acid and a water-miscible organic solvent, or more preferably by addition of a base (e.g. sodium hydroxide). Cells may be separated from these solutions either by centrifugation, conventional filtration or membrane filtration. The liquor may be optionally thereafter treated with an acid such as sulphuric acid until the pH is below 6 (e.g. about pH 4.5).</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula (V) may be isolated and purified by a variety of fractionation techniques, for example adsorption-elution, precipitation, fractional crystallisation, solvent extraction and liquid-liquid partition which may be combined in various ways.</div>
    <div class="description-paragraph style-scope patent-text">Adsorption onto a solid support followed by elution has been found to be particularly suitable for isolating and purifying the compound of formula (V).</div>
    <div class="description-paragraph style-scope patent-text">Suitable solid supports include silica; a non-functional macroreticular adsorption resin, for example cross-linked styrene divinyl benzene polymer resins such as CG161 and Amberlite XAD-2, XAD4, XAD-16 or XAD-1180 resins (Rohm &amp; Haas Limited) or Kastell S112 (Montedison); a substituted styrene-divinyl benzene polymer such as Diaion SP207 (Mitsubishi); an anion exchanger [e.g. IRA-958 or MacroPrep High Q (BioRad)], an organic solvent-compatible cross-linked dextran such as Sephadex LH20 (Pharmacia UK Limited), or on reverse phase supports such as hydrocarbon linked silica, e.g. C<sub class="style-scope patent-text">18</sub> -linked silica.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula (V) may also be isolated and purified by the use of a liquid anion exchanger such as LA 2.</div>
    <div class="description-paragraph style-scope patent-text">Suitable solvents for the elution of the compound of formula (V) will, of course, depend on the nature of the absorbent. When using a polymer resin such as XAD-16 water-miscible solvents such as methanol, acetone, isopropanol or acetronitrile in various proportions in water may be particularly suitable.</div>
    <div class="description-paragraph style-scope patent-text">The presence of the compound of formula (V) during the extraction/isolation procedures may be monitored by conventional techniques such as high performance liquid chromatography (HPLC) or UV spectroscopy or by utilising the optical rotation or other property of the compound.</div>
    <div class="description-paragraph style-scope patent-text">Where the compound of formula (V) is obtained in the form of a solution in an organic solvent, for example after purification by absorption/elution, the solvent may be removed by conventional procedures, e.g. by evaporation, to yield the required compound. If desired, the compound may be further purified by chromatographic techniques such as countercurrent chromatography using a coil extracter such as a multi-layer coil extracter or high performance liquid chromatography or supercritical fluid chromatography on adsorbents such as carbon, alumina, vanadium, polymeric resins or silica, with or without bonded phases. Suitable solvents/eluents for the chromatographic purification/separation of the compound of formula (V) will of course depend on the nature of the adsorbent. When using a C8 bonded silica, mixtures of acetonitrile and water are particularly suitable. Alternatively, the compound may be further purified by solvent extraction, for example using an appropriate organic solvent such as a ketone (e.g. acetone or methyl ethyl ketone), a halogenated hydrocarbon, an alcohol (e.g. methanol), a diol (e.g. propane-1,2-diol or butane-1,3-diol) or an ester (e.g. methyl acetate or ethyl acetate). In a further alternative, solutions of compound (V) may be further purified by treatment with adsorbents that selectively remove impurities when added at appropriate levels (e.g. DEAE-cellulose) or by crystallisation (e.g. from a mixture of acetonitrile and water) or using a combination of the above procedures.</div>
    <div class="description-paragraph style-scope patent-text">The biotransformation of sordarin to 4'-demethylsordarin, the compound of formula (V), may be effected by incubating sordarin in a culture comprising a suitable organism and sources of carbon and nitrogen, including those sources specified hereinabove, and thereafter isolating the compound of formula (V) from the culture.</div>
    <div class="description-paragraph style-scope patent-text">Microorganisms capable of demethylating sordarin at the 4'-position may readily be identified by using a small scale test and analysing a test sample obtained using standard methodology, for example, using HPLC. Examples of microorganisms which have been identified as sordarin demethylators include Streptomyces capreolus ATCC 31963, Streptomyces avermitilis ATCC 31272, Streptomyces armentosus NRRL 3176, Streptomyces antibioticus ATCC 31771, Streptomyces rimosus ATCC 23955, Streptomyces platensis ATCC 29778, Streptomyces mashuensis ATCC 23934, Streptomyces eurythermus ATCC 14975, Nocardia orientalis ATCC 43491 and Cunninghamella echinulata var elegans ATCC 36112.</div>
    <div class="description-paragraph style-scope patent-text">Cultivation of the organism will generally be effected at a temperature of from 20° to 40° C., preferably from 20° to 35° C., especially about 28° C., and will desirably take place with aeration and agitation, e.g. by shaking or stirring. The medium may initially be inoculated with a small quantity of mycelium and/or spores. The vegetative inoculum obtained may be transferred to the fermentation medium or to one or more seed stages where further growth (e.g. over about 1-3 days) takes place before transfer to the principal fermentation medium. The principal fermentation medium will also comprise sordarin and the fermentation will generally be carried out in a pH range of 3.5 to 9.5, preferably 4.5 to 7.5. It may be necessary to add a base or an acid to the fermentation medium to keep the pH to within the desired range. Suitable bases which may be added include alkali metal hydroxides such as aqueous sodium hydroxide or potassium hydroxide. Suitable acids include mineral acids such as hydrochloric, sulphuric or phosphoric acid. Fermentation may be carried out over a period of 2 to 5 days, preferably about 3 days. An antifoam may be present to control excess foaming and added at intervals as required. Carbon and/or nitrogen sources may also be fed into the fermentation medium as required.</div>
    <div class="description-paragraph style-scope patent-text">The separation and isolation of the compound of formula (V) from the fermentation broth may be effected by the general procedures previously described. When it is desired to lower the pH of the liquor to below pH 6 (e.g. to about pH 2.5) this may conveniently be achieved by the addition of an acid such as orthophosphoric acid.</div>
    <div class="description-paragraph style-scope patent-text">It will be appreciated that biotransformation may be effected according to a number of alternative methods. For example, cells may be grown and harvested prior to addition to a solution of sordarin in, for example, buffer, spent fermentation medium or water. It is also feasible that the appropriate enzymes could be isolated and used (with appropriate co-enzymes) or the enzymes cloned and over-expressed.</div>
    <div class="description-paragraph style-scope patent-text">As stated hereinabove, sordarin is a known compound, which may be obtained using procedures described in the relevant art. Thus, for example, the preparation of sordarin by the cultivation of Sordaria araneosa NRRL 3196 (also deposited in the ATCC as ATCC 36386) is described in British Patent Specification No. 1,162,027. Specific examples of the preparation of sordarin using similar procedures are reported hereinafter.</div>
    <div class="description-paragraph style-scope patent-text">Sordaricin may conveniently be prepared under fermentation conditions similar to those described for preparing sordarin using Sordaria araneosa NRRL 3196 or a suitable mutant thereof, with isolation of the desired compound using appropriate chromatographic means. One such mutant has been deposited in the permanent culture collection of the CAB International Mycological Institute, Genetic Resource Reference Collection, Bakeham Lane, Egham, Surrey TW20 9TY, England. The strain was received and accepted by the Institute on Aug. 11, 1994 and was subsequently given the accession number IMI 362947 and a date of confirmation of viability of Aug. 19, 1994. The Institute is an International Depository authority recognised under the Budapest Treaty. The characteristics thus far identified for IMI 362947 are given in Example 47.</div>
    <div class="description-paragraph style-scope patent-text">The present invention provides in a further aspect the microorganism IMI 362947 per se and mutants therof.</div>
    <div class="description-paragraph style-scope patent-text">Processes for obtaining mutants of IMI 362947 and its genetic material will be similar to those described hereinabove for the manipulation of IMI 362184.</div>
    <div class="description-paragraph style-scope patent-text">Sordaricin may also be prepared from sordarin using a biotransformation procedure. The biotransformation may conveniently be effected by incubating sordarin in a culture comprising a suitable organism and sources of carbon and nitrogen, including those sources specified hereinabove, and thereafter isolating sordaricin from the culture.</div>
    <div class="description-paragraph style-scope patent-text">Microorganisms capable of converting sordarin to sordaricin may readily be identified by using a small scale test and analysing a test sample obtained using standard methodology, for example, using HPLC. We have identified one such microorganism and deposited it with the National Collections of Industrial and Marine Bacteria Limited (NCIMB), 23 St. Machar Drive, Aberdeen AB2 1RY, Scotland. The strain was received by the NCIMB on Aug. 4, 1994 and was the same day accepted for deposit for patent purposes and the viability of the microorganism confirmed. The microorganism, which is a Coryneform species having the characteristics given in Example 48, has been assigned the accession number NCIMB 40675. The NCIMB is an International Depository authority recognised under the Budapest Treaty.</div>
    <div class="description-paragraph style-scope patent-text">The invention thus provides in another aspect the microorganism NCIMB 40675 per se and mutants thereof.</div>
    <div class="description-paragraph style-scope patent-text">According to another aspect of the present invention we provide the genetic material of NCIMB 40675 and mutants thereof that participates in the bioconversion of sordarin to sordaricin.</div>
    <div class="description-paragraph style-scope patent-text">Processes for obtaining mutants of NCIMB 40675 and its genetic material will be similar to those described hereinabove for the manipulation of IMI 362184.</div>
    <div class="description-paragraph style-scope patent-text">Cultivation of the NCIMB 40675 will generally be effected at a temperature of from 20° to 40° C., preferably from 20° to 35° C., especially about 28° C., and will desirably take place with aeration and agitation, e.g. by shaking or stirring. The medium may initially be inoculated with a small quantity of mycelium and/or spores. The vegetative inoculum obtained may be transferred to the fermentation medium or to one or more seed stages where further growth (e.g. over about 1-3 days) takes place before transfer to the principal fermentation medium. The principal fermentation medium will also comprise sordarin and the fermentation will generally be carried out in a pH range of 3.5 to 9.5, preferably about 7.5. It may be necessary to add a base or an acid to the fermentation medium to keep the pH to within the desired range. Suitable bases which may be added include alkali metal hydroxides such as aqueous sodium hydroxide or potassium hydroxide. Suitable acids include mineral acids such as hydrochloric, sulphuric or phosphoric acid. Fermentation may be carried out over a period of 4 to 8 days, preferably about 6 days. An antifoam may be present to control excess foaming and added at intervals as required. Carbon and/or nitrogen sources may also be fed into the fermentation medium as required.</div>
    <div class="description-paragraph style-scope patent-text">It will be appreciated that biotransformation may be effected according to a number of alternative methods. For example cells may be grown and harvested prior to addition to a solution of sordarin in, for example, buffer, spent fermentation medium or water. It is also feasible that the appropriate enzymes could be isolated and used or the enzymes cloned and overexpressed.</div>
    <div class="description-paragraph style-scope patent-text">The separation and isolation of sordaricin from the fermentation broth may be effected by the general procedures previously described. When it is desired to lower the pH of the liquor to about pH 6 this may conveniently be achieved by the addition of an acid such as orthophosphoric acid.</div>
    <div class="description-paragraph style-scope patent-text">It is to be understood that the fermentation and bioconversion processes described hereinabove for preparing sordaricin represent further aspects of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">The examples hereinafter illustrate aspects of the present invention and are not intended to limit the invention in any way.</div>
    
    
    <heading class="style-scope patent-text">PREPARATION 1</heading>
    <div class="description-paragraph style-scope patent-text">Production of sordarin</div>
    <div class="description-paragraph style-scope patent-text">A culture of Sordaria araneosa NRRL3196 (ATCC36386) was grown on an agar medium until mature growth occurred. 6 mm diameter plugs of the agar containing the growth were transferred to sterile water or Brain Heart Infusion broth (Oxoid)+10% glycerol and stored at ambient temperature or -140° C. respectively. A suspension containing 2 of these agar plugs was used to inoculate a 250 ml Erlenmyer flask containing 50 ml of medium FS.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
Medium FS            g/L                                                  
______________________________________                                    
Peptone(Oxoid L34)   10                                                   
  Malt extract (Oxoid L39)        21                                      
  Glycerol (Glycerine CP)         40                                      
  Junlon 110 (Honeywell &amp; Stein)   1                                      
  Distilled water                                                         
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The culture was incubated at 25° C. for 5 days on a rotary shaker operated at 250 rpm with a 50 mm diameter orbital motion. Aliquots (2 ml) of the developed inoculum were used to inoculate further 250 ml Erlenmyer flasks containing medium FS (50 ml) which were incubated as described above. 80 ml of the bulked shake flask developed inoculum was used to inoculate each of two 7L fermenters containing 5L of medium FS. The fermentations were controlled to a temperature of 25C. The culture was agitated at 400 rpm and aerated at 2 Lpm. After 3 days fermentation, 10L of culture was used to inoculate a 780L fermenter containing 500L of medium SM55VAR.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
SM55VAR              g/L                                                  
______________________________________                                    
Glucidex 32D (Roquette Frere)                                             
                     74                                                   
  Peptone (Oxoid L37)            10                                       
  Proflo (Traders Protein)       30                                       
  Beet molasses                  15                                       
  MgSO.sub.4.7H.sub.2 O(BDH)                5                             
  CaCO.sub.3 (BDH)                    5                                   
  FeSO.sub.4.7H.sub.2 O(Sigma)             2                              
  ZnSO.sub.4.7H.sub.2 O(BDH)               0.04                           
  L-trytophan(Sigma)            2                                         
  PPG2000 (K &amp; K Greef)          0.5                                      
  Silicone 1520 (Dow Corning)    0.04                                     
  Distilled water                                                         
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The fermentation was controlled to a temperature of 25° C. The broth was agitated at 300-350 rpm and aerated at 200 Lpm. 70% (w/v) Meritose (Tunnel Refineries) solution was fed to the culture to maintain a positive residual glucose concentration. Distilled water was fed to maintain a culture volume of 500L. PPG2000 antifoam was added on demand to control foaming. Whole broth extracts (in aqueous acetonitrile +1% trifluoroacetic acid) were assayed for presence of sordarin by reverse phase HPLC. The culture was harvested after 11 days when the extract of a broth sample indicated a sordarin titre of 0.6 g/L. Fermentation broth was made 0.1M with respect to sodium hydroxide and after storage at ambient temperature overnight was filtered through Dicalite on a rotary vacuum filter (1% Dicalite was added to the broth as filter aid). The filtrate was adjusted to pH 6-7 with concentrated sulphuric acid and the solution was applied to XAD16 resin (10 volumes of filtrate/volume resin). The adsorbent was washed with water and acetone:water (1:3) in both cases to give a clear effluent before sordarin was eluted with acetone:water (3:1; 2 column volumes collected). Flow rate throughout the process was between 1-2 column volumes/hr. The eluate was concentrated to a small volume (8.5L). The concentrate was adjusted to pH 3 with phosphoric acid and stood overnight at ambient temperature to allow precipitated sordarin to settle. Supernatant was decanted then centrifuged and the supernatant was discarded. Centrifuge pellets and precipitate were taken up in 75% aqueous acetonitrile to give 3.9L of a dark brown solution. To this was added 1.0L 0.2M NH<sub class="style-scope patent-text">4</sub> H<sub class="style-scope patent-text">2</sub> PO<sub class="style-scope patent-text">4</sub> with stirring, and the solution was adjusted to pH 4.0 with phosphoric acid, to give a final volume of 5.0L with approximate composition 60% acetonitrile -0.1M NH<sub class="style-scope patent-text">4</sub> H<sub class="style-scope patent-text">2</sub> PO<sub class="style-scope patent-text">4</sub>. The crude sordarin solution (5.0L) from above was subjected to preparative HPLC in 10 injections (450-550 ml each) on a column (15 cm ×25 cm) of 7 mm Kromasil C8 in mobile phase of 50% acetonitrile -0.1M NH<sub class="style-scope patent-text">4</sub> H<sub class="style-scope patent-text">2</sub> PO4, pH 4 (50L acetonitrile made up to 100 L with water containing 575 g NH<sub class="style-scope patent-text">4</sub> H<sub class="style-scope patent-text">2</sub> PO<sub class="style-scope patent-text">4</sub> and 40 ml H<sub class="style-scope patent-text">3</sub> PO<sub class="style-scope patent-text">4</sub>), flow-rate 600ml/min, detection by UV absorbance (λ210 nm). The fraction eluting between 15.4 and 19.2 min was collected. Pooled fractions from the 10 injections (23L) were diluted with water to 50L and this solution was pumped back through the Kromasil column at 28L/h. The column was washed with water (25L) then eluted with 90% acetonitrile (10L). The eluate was evaporated to a residue of 1300 ml which was freeze-dried to yield the title compound as a buff powder (105.6 g). MS and NMR analysis of the product showed equivalence with an authentic sample of sordarin.</div>
    <heading class="style-scope patent-text">PREPARATION 2</heading>
    <div class="description-paragraph style-scope patent-text">Production of sordarin potassium salt</div>
    <div class="description-paragraph style-scope patent-text">Sordaria araneosa NRRL3196 (ATCC36386) was maintained in Brain Heart Infusion broth (Oxoid)+10% glycerol at -140° C. as described in Preparation 1. A suspension containing 2 agar plugs was used to inoculate a 250 ml Erlenmyer flask containing 50 ml of medium FS. The culture was incubated at 25° C. for 5 days on a rotary shaker operated at 250 rpm with a 50 mm diameter orbital motion. Aliquots (2 ml) of the developed inoculum were used to inoculate further 250 ml Erlenmyer flasks containing medium FS (50 ml) and incubated as described above. 80 ml of the bulked shake flask developed inoculum was used to inoculate each of two 7L fermenters containing 5L of medium FS. The fermentations were controlled to a temperature of 25° C. The culture was agitated at 400 rpm and aerated at 2 Lpm. After 3 days fermentation, 10L of culture was used to inoculate a 780L fermenter containing 500L of medium</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
SD1                  g/L                                                  
______________________________________                                    
Meritose (Tunnel refineries)                                              
                     22                                                   
  Lactose                         20                                      
  Glucidex 32D (Roquette Frere)   30                                      
  Arkasoy (The British Arkady Co.) 20                                     
  CSL                             20                                      
  FeCl.sub.3.6H.sub.2 O                      0.05                         
  NH.sub.4 H.sub.2 PO.sub.4                        5                      
  ZnSO.sub.4.7H.sub.2 O(BDH)                0.1                           
  PPG2000                         0.5                                     
  Distilled water                                                         
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The fermentation was controlled to a temperature of 25° C. The broth was agitated at 350 rpm and aerated at 200 Lpm. Distilled water was fed to maintain a culture volume of 500L. Whole broth extracts were assayed for presence of sordarin by reverse phase HPLC. The culture was harvested after 6 days when the extract of a broth sample indicated a sordarin titre of 1.3 g/L. A 50L sample of harvest broth was made 0.1M with respect to sodium hydroxide and stored at 4° C. overnight. Cells were removed by vacuum filtration through a bed of Dicalite adding an additional 2% Dicalite to the broth as filter aid. The filtrate was adjusted to approximately pH 6 with concentrated sulphuric acid. Broth extract was pumped through a bed of Amberchrom CG161 resin at 320 ml/min (0.64 bed volumes per min). The effluent was monitored by HPLC. After 45 min (equivalent to a pumped volume of 14.4L) sordarin began to break through and pumping was halted. The adsorbent was washed with water (2L) then 25% v/v acetone in water (2L). Sordarin was eluted with 75% v/v acetone in water (1.5L). The 75% v/v acetone eluate was evaporated to about 200 ml by rotary evaporation at 40° C. 200 ml butan-1-ol was added and the evaporation continued until a viscous oil remained (containing some butan-1-ol). The oily residue was extracted with hot methanol (2×500 ml). Extracts were combined, filtered (Whatman no 1 paper) then evaporated at 40 to 45° C. to give a viscous oil. This was extracted with hot acetone (2×500 ml). Acetone extracts were combined, filtered and evaporated to a viscous oil. Propan-2-ol (350 ml) was added and the oil dissolved at 45° C. to give a clear brown solution. A solution of potassium-2-ethylhexanoate (39% wow solution in propan-2-ol, 54 g) was weighed into a 500 ml conical flask. The sordarin-containing solution in propan-2-ol was poured into the conical flask, the contents mixed, and left to stand for 4h at room temperature. The solution was seeded with sordarin potassium salt (about 5 mg) and the stoppered flask was stored for 3 days at 4° C. The off-white solid which formed was filtered under vacuum (No 4 sinter funnel) and the filter cake was washed with propan-2-ol (about 20-30 ml). The solid was transferred to a crystallising dish and dried in vacuo over P<sub class="style-scope patent-text">2</sub> O<sub class="style-scope patent-text">5</sub> for 16h to give the titled compound (10.5 g).</div>
    <heading class="style-scope patent-text">PREPARATION 3</heading>
    <div class="description-paragraph style-scope patent-text">Production of sordarin potassium salt</div>
    <div class="description-paragraph style-scope patent-text">500 litres of culture broth was prepared as in Preparation 1. The broth was made 0.1M with respect to sodium hydroxide and after 4 days at 0° C. was filtered through a bed of Dicalite on a rotary vacuum filter. 1% Dicalite was added to the broth as filter aid. The pH of the filtrate was adjusted from pH 9.16 to pH 7.5 with concentrated sulphuric acid. Filtrate (10L) was adjusted to pH 6 with H<sub class="style-scope patent-text">3</sub> PO<sub class="style-scope patent-text">4</sub> and applied to a bed (200 ml) of XAD-16 resin packed in water at a flow-rate of 1-1.5 bed volumes/h. The resin bed was washed with water (1 bed volume) then with 25% aqueous isopropanol (2.5 bed volumes) before elution with neat isopropanol. After a fore-run of 50 ml the isopropanol eluate was collected as 100 ml fractions. Sordarin-rich fractions 2-6 inclusive were pooled and evaporated to half volume. Isopropanol was added to bring the volume back to 500 ml, then the evaporation to half volume repeated to remove residual water by azeotropic distillation. After a third evaporation to half volume the residue was filtered and the filter was washed with isopropanol. To the combined filtrate and washings (400 ml) was added a solution of potassium 2-ethylhexanoate (8 g) in isopropanol (100 ml). The mixture was seeded with sordarin potassium salt and stood for several days at 4° C. whilst a slow crystallisation took place. Crystals were filtered on a No. 3 sinter, washed with a little ice-cold isopropanol and dried in vacuo to yield the title compound as a pale brown powder (4.85 g).</div>
    <heading class="style-scope patent-text">PREPARATION 4</heading>
    <div class="description-paragraph style-scope patent-text">Production of 4'-demethylsordarin</div>
    <div class="description-paragraph style-scope patent-text">(i) IMI 362184 was maintained in Brain Heart Infusion broth (Oxoid)+10% glycerol at -140° C. as described in Preparation 1. A suspension containing 2 agar plugs was used to inoculate a 250 ml Erlenmyer flash containing 50 ml of medium FS. The culture was incubated at 25° C. for 5 days on a rotary shaker operated at 250 rpm with a 5 mm diameter orbital motion. Aliquots (2 ml) of the developed inoculum were used to inoculate further 250 ml Erlenmyer flasks containing medium FS (50 ml) and incubated as described above. 80 ml of the bulked shake flash developed inoculum was used to inoculate each of two 7L fermenters containing 5L of medium FS. The fermentations were controlled to a temperature of 25° C. The culture was agitated at 400 rpm and aerated at 2 Lpm. After 3 days fermentation, 10L of culture was used to inoculate a 780L fermenter containing 500L of medium SM55VAR (as described in Preparation 1). The fermentation was controlled to a temperature of 25° C. The broth was agitated at 350 rpm and aerated at 500 Lpm. 70% w/v Meritose (Tunnel Refineries) solution was fed to the culture to maintain a positive residual glucose concentration. Distilled water was fed to maintain a culture volume of 500L. Whole broth extracts were assayed for presence of 4'-demethylsordarin by reverse phase HPLC. The culture was harvested after 10 days when the extract of a broth sample indicated a 4'-demethylsordarin titre of 0.8 g/L. Fermentation broth was made 0.1M with respect to sodium hydroxide and after 1 hour at ambient temperature was filtered through Dicalite on a rotary vacuum filter (1% Dicalite was added to the broth as filter aid). The filtrate was adjusted to pH 4.5 with concentrated sulphuric acid and the solution was applied to XAD16 resin (20 g product/L resin). The adsorbent was washed with 0.1% phosphoric acid (10 column volumes) and acetonitrile:water 1:4 (6 column volumes) before the product was eluted with acetonitrile:water (1:1; 2 column volumes). Flow rate throughout the process was between 1-2 column volumes/hr. The eluate was concentrated to dryness with the addition of butan-1-ol and the solid was extracted with methanol (12L) followed by acetone (10L) at 60° C. Insoluble material was removed at each stage by filtration through a no 3 glass sinter and the extracts concentrated to dryness as before. The solid was crystallised from acetonitrile:water (3:7) before being recrystallised from the same solvent and dried to constant weight over P<sub class="style-scope patent-text">2</sub> O<sub class="style-scope patent-text">5</sub> to give the title compound (244.0 g), which by proton NMR analysis showed equivalence with an authentic sample of 4'-demethylsordarin.</div>
    <div class="description-paragraph style-scope patent-text">(ii) The fermentation procedure in (i) above was followed, and after the broth was made 0.1M with respect to sodium hydroxide this was ultrafiltered through ETNA 10A membrane (10 kDalton cut-off). After diafiltration with water the bulked permeate was a clear solution. After adjustment to pH 5.2, using concentrated sulphuric acid, the permeate was loaded to a column of XAD16 resin at a rate of 2 column volumes per hour to give a final loading of 32 g 4'-demethylsordarin per litre of resin. The column was washed at a rate of 2 column volumes per hour, first with 0.1% v/v phosphoric acid and then with 20% v/v acetonitrile/water (10 column volumes of each). The column was eluted with 65% acetonitrile/water at 2 column volumes per hour. A forerun of 0.75 column volumes was discarded. 85% of the loaded 4'-demethylsordarin was recovered in the next 1.6 column volumes of eluate. The rich eluate was treated by stirring for 5 minutes with 2% w/v of DE52 cellulose, which was removed by filtration. An aliquot of DE52 treated eluate was concentrated to 62% of the original volume (43% acetonitrile) using a rotary evaporator. The concentrated eluate was held at 4° C. for 15 hours to crystallise and the solids formed collected by filtration through a glass sinter. The crystals were washed with four cake volumes of 30% v/v acetonitrile/water and dried at 30° C. in vacuo. The title compound (1.94 g) was recovered from the concentrated eluate as a pale grey solid.</div>
    <heading class="style-scope patent-text">PREPARATION 5</heading>
    <div class="description-paragraph style-scope patent-text">Screen for microorganisms capable of demethylating sordarin at the 4' position</div>
    <div class="description-paragraph style-scope patent-text">Microorganisms capable of demethylating sordarin at the 4'-position could be identified by growing them at 28° C. (bacteria) or 25° C. (fungi) in 10 ml volumes of SB1 (bacteria) or FB1 (fungi) in 50 ml conical flasks shaken at 250 rpm. After 2 days, sordarin was added to a final concentration of 0.5 mg/ml (from a 200 mg/ml stock solution in 80% ethanol) and the flasks were then incubated for a further 3 days. A 500 μl sample of whole culture was mixed in an Eppendorf tube with 500 μl of 80% acetonitrile/2% trifluoroacetic acid and left to extract at room temperature for 30 minutes. The extract supernatant, obtained by centrifuging samples in a microfuge was assayed by isocratic HPLC for the presence of 4'-demethylsordarin. 4'-demethyl sordarin eluted at 3.35 mins with a mobile phase of 35% acetonitrile in water, flow rate 2 ml/min, using a Spherisorb C<sub class="style-scope patent-text">6</sub> column (5 μm, 15 cm ×4.6 mm). By this method, the following microorganisms were identified as sordarin demethylators:</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
Streptomyces capreolus  ATCC 31963                                        
  Streptomyces avermitilis                   ATCC 31272                   
  Streptomyces armentosus                    NRRL 3176                    
  Streptomyces antibioticus                 ATCC 31771                    
  Streptomyces rimosus                        ATCC 23955                  
  Streptomcyes platensis                     ATCC 29778                   
  Streptomyces mashuensis                    ATCC 23934                   
  Streptomyces eurythermus                   ATCC 14975                   
  Nocardia orientalis                       ATCC 43491                    
  Cunninghamella echinulata var elegans      ATCC 36112                   
______________________________________                                    
                g/L                                                       
______________________________________                                    
  SB1 Medium                                                              
  Arkasoy                       25                                        
  Yeast extract                   5                                       
  KH.sub.2 PO.sub.4                  5                                    
  Glucose                       20                                        
  Distilled Water                                                         
  pH 7                                                                    
  FB1 Medium                                                              
  Soya oil                     30                                         
  Arkasoy                     10                                          
  Yeast extract                5                                          
  K.sub.2 HPO.sub.4               5                                       
  Glucose                     20                                          
  Distilled Water                                                         
  pH 5.5                                                                  
______________________________________                                    
</pre>
    
    <heading class="style-scope patent-text">PREPARATION 6</heading>
    <div class="description-paragraph style-scope patent-text">Production of 4'-demethylsordarin by biotransformation of sordarin</div>
    <div class="description-paragraph style-scope patent-text">0.3ml of a spore suspension of Streptomyces capreolus ATCC 31963 (in 15%, v/v glycerol stored at -20° C.) was inoculated into 30 ml SB1 medium in a 250 ml Erlenmeyer flask to give a seed culture which was incubated at 28° C. and 250 rpm on a rotary shaker. After 4 days, 0.5 ml of this was used to inoculator 35 ml SB1 in a 250 ml flask which was grown for 48 hours at 28° C., 250 rpm. At this stage, the culture was aliquoted as 10 ml amounts into 50 ml Erlenmeyer flasks which were fed with 5 mg sordarin (from a 200 mg/ml stock solution in ethanol). Incubation was continued for a further 3 days. 80% v/v acetonitrile in water (14 ml) was added to whole broth (14 ml) and the mixture was kept at room temperature and occasionally agitated. After 30 minutes, the cells were removed by centrifugation. Acetonitrile was removed by evaporation and the pH of the aqueous solution was adjusted to 2.5 with orthophosphoric acid. The solution was passed through a column containing Amberlite XAD-16 resin (bed volume 5 ml). The adsorbent was washed sequentially with water (10 ml), 10% v/v acetonitrile in water (20 ml), 30% v/v acetonitrile in water (10 ml), 50% v/v acetonitrile in water (20 ml) and 90% v/v acetonitrile in water (10 ml). Fractions were monitored by HPLC; 4'-demethylsordarin was located in the 50% v/v acetonitrile in water eluate. The fraction containing 4'-demethylsordarin was evaporated to dryness in vacuo at the room temperature and the residue was re-dissolved in 35% v/v acetonitrile in water (15 ml). 4'-demethylsordarin was purified by preparative HPLC:</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
Column    Spherisorb 5 micron C6 25 cm ×  2.5 cm                    
  Flow rate         25 ml/min                                             
  Detection        UV at 210 nm                                           
  Mobile Phase     350 ml acetonitrile made up to 1000 ml with 0.05M      
                ammonium dihydrogen phosphate in water. pH                
       adjusted to 2.5 with orthophosphoric acid                          
  Injection volume 4.5 ml                                                 
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">4'-Demethylsordarin was eluted after 10.0 minutes under these conditions. The pooled fractions from four HPLC runs were diluted 1:1 with water then pumped back onto the silica (after washing this with acetonitrile and re-equilibrating with water). The adsorbent was washed with water (200 ml) and adsorbed product was eluted with 95% v/v acetonitrile in water (200 ml). The acetonitrile/water eluate was evaporated to remove organic solvent, and the aqueous solution freeze dried to yield 4'-demethylsordarin (1.5 mg) as a white powder.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H,CDCl<sub class="style-scope patent-text">3</sub>); 9.74(s,1H); 6.08(brd,3,1H); 4.70(d,1.5,1H); 4.16(d,9.5,1H); 4.08(dd,4.5,3.5,1H); 3.88(dd,4.5,1.5,1H); 3.75(dq,8.5,6,1H); 3.62(d,9.5,1H); 3.68(dd,8.5,3.5,1H); 2.65(m,1H); 2.34(m,1H); 1.32(d,6,3H); 1.30(d,12.5,1H); 1.23(m,1H); 1.04(d,7,3H); 0.99(d,7,3H); 0.81(d,7,3H)</div>
    <heading class="style-scope patent-text">INTERMEDIATE 1</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α,3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a[(6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of sordarin (10.0 g) in dichloromethane (150 ml) was treated dropwise with a solution of diphenyidiazomethane in dichloromethane (0.35M, 85 ml). The resulting solution was stirred at room temperature for 24 hours. The solvent was removed under reduced pressure and the residue was purified by flash column chromatography on silica gel eluting with hexane:ethyl acetate (4:1) and (2:1). The fractions were combined and evaporated to yield the title compound (11.8 g) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 10.00 (s, 1H, CHO), 7.63 (m, 10H, 2Ph), 7.26 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.30 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.92 (d, 1H, H-1', J=0.9 Hz), 4.84 (t, 1H, H-3', J=3.3 Hz),4.03 and 4.35 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.88 (m, 1H, H-2'), 3.70 (dq, 1H, H-5', J=6.3 and 9.3 Hz), 3.41 (s, 3H, 4'--OMe), 3.20 (dd, 1H, H4', J=3.3 and 9 Hz), 2.75 (t, 1H, H-1).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 2</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-Benzyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 1 (0.6 mmol) in dry tetrahydrofuran (15 ml) under nitrogen was treated with sodium hydride (1.5 mmol). After 30 minutes, a solution of benzyl bromide (0.7 mmol) in dry tetrahydrofuran (5 ml) was added. The mixture was stirred under reflux for 4.5 hours and then poured into water:ethyl acetate (1:1;100 ml). The organic phase was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (3:1) as eluent. Appropriate fractions were concentrated to give the title compound (249 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.76 (s, 1H, CHO), 7.33 (m, 15H, 3×Ph), 6.99 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.03 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.84 and 4.64 (AB system, 1H, 1H, CHPh<sub class="style-scope patent-text">2</sub>, J=12.6 Hz), 4.62 (d, 1H, H-1', J=1.2 Hz), 4.12 (m, 2H, H-3' and 8a-CHa), 3.66 (m, 3H, H-2', H-5' and 8a-CHb), 3.21 (dd, 1H, H4', J=3.3 and 9.3 Hz), 2.70 (t, 1H, H-1, J=3.9 Hz), 2.92 (d, 1H, OH, J=9.9 Hz), 2.21 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 3</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-hexyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 1 (0.6 mmol) in dry tetrahydrofuran (15 ml) under nitrogen was treated with sodium hydride (1.5 mmol). After 30 minutes, a solution of hexyl iodide (0.7 mmol) in dry tetrahydrofuran (5 ml) was added. The mixture was stirred under reflux for 36 hours and then poured into water:ethyl acetate (1:1;100 ml). The organic phase was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (2:1) as eluent to give the title compound (124 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 10.01 (s, 1H, CHO), 7.60 (m, 10H, 2×Ph), 7.26 (s, 1H, CH-Ph<sub class="style-scope patent-text">2</sub>), 6.31 (dd, 1H, H-2, J=1.5 and 3.3 Hz), 4.87 (s, 1H, H-1', J=1.2 Hz), 4.40 (t, 1H, H-3', J=3.3 Hz), 4.35 and 3.94 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 4.04 (m, 2H, H-2' and H-5'), 3.80 (m, 2H, OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub>), 3.44 (dd, 1H, H-4', J=3.3 and 9 Hz), 3.01 (t, 1H, H-1, J=3.6 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 4</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-2,3,4-tri-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 1 (0.6 mmol) in dry tetrahydrofuran (20 ml) under nitrogen was treated with sodium hydride (1.5 mmol). After 30 minutes, methyl iodide (112 μl) was added. The mixture was stirred at room temperature for 4 hours and poured into ethyl acetate:water (1:1;100 ml). The organic phase was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (3:1) as eluent. Appropriate fractions were concentrated to give the title compound (195 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.77 (s, 1H, CHO), 7.37 (m, 10H, 2×Ph), 6.99 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.05 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.55 (d, 1H, H-1', J=0.9 Hz), 4.07 and 3.69 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=8.7 Hz), 3.71 (m, 2H, H-2' and H-3'), 3.43 (dd, 1H, H-5', J=0.6 and 3.9 Hz), 3.57 (s, 3H, 2'--OCH<sub class="style-scope patent-text">3</sub>), 3.51 (s, 3H, 3'--OCH<sub class="style-scope patent-text">3</sub>), 3.16 (dd, 1H, H4', J=3 and 9.3 Hz), 2.75 (t,1H, H-1, J=3.9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 5</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of 4'-demethylsordarin (10 g) in methanol (20 ml) was added dropwise at room temperature a solution of diphenyidiazomethane (90 ml) in methylene chloride, and the mixture was stirred for 6 hours. The solvent was evaporated to dryness and the residue chromatographed in a silica gel flash column with n-hexane:ethyl acetate (3:1) as eluent to give the title compound (12.6 g) as a pale yellow foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.05 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.65 (d, 1H, H-1', J=1.5 Hz), 4.09, 3.76 (2d, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 4.01 (m, 1H, H-2'), 3.84 (m, 1H, H-3'), 3.75 (m, 1H, H-5'), 3.69 (m, 1H, H-4'), 2.73 (t, 1H, H-1, J-4.2 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 6</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3,4-O-isopropylidene-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-(1H)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 5 (650 mg) in 15 ml of 2,2-dimethoxypropane:acetone (1:2) was added p-toluensulphonic acid (10 mg). The solution was stirred at room temperature for 1.5 hours, then potassium carbonate (1.0 g) was added, the stirring continued for 30 minutes and the solvent evaporated to dryness. The crude mixture was partitioned between ethyl acetate (50 ml) and water (25 ml), the aqueous phase was extracted with ethyl acetate (2×50 ml), the organic phase was washed with brine, dried over magnesium sulphate and evaporated to dryness. The residue was flash chromatographed on silica gel eluting with ethyl acetate:hexane (1:3) to give the title compound (600 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.45-7.24 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.06 (dd, 1H, H-2, J=1.5 and 3.3 Hz), 4.57 (d, 1H, H-1', J=3.0 Hz), 4.30 (dd, 1H, H-3', J=3.6 and 5.7 Hz), 4.07 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.95-3.93 (m, 1H, H-2'), 3.85 (dd, 1H, H4', J=5.7 and 9.3 Hz), 3.75 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.44 (dq, 1H, H-5', J<sub class="style-scope patent-text">d</sub> =9.3 Hz, J<sub class="style-scope patent-text">q</sub> =6.3 Hz), 2.73 (t, 1H, H-1, J=3.6 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 7</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3,4-O-isopropylidene-2-O-(methylthio)thiocarbonyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Intermediate 6 (100 mg) and imidazole (1 mg) were dissolved in dry tetrahydrofuran (4 ml) under nitrogen atmosphere. Sodium hydride (5 mg) was added and the suspension was stirred at room temperature for 0.5 hours Carbon disulfide (2.7 ml) was added, the stirring continued for 20 minutes and methyl iodide (18 ml) was added. After 2 hours the reaction was stopped by addition of 1N ammonium chloride (20 ml). The mixture was extracted with ethyl acetate (3×25 ml), the organic phase was washed with brine, dried over magnesium sulphate and the solvent evaporated to dryness. The residue was purified in a flash chromatography column on silica gel eluting with ethyl acetate:hexane (1:9) to give the title compound (110 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.96 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.01 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 6.90 (dd, 1H, H-2', J-2.4 and 5.4 Hz), 4.85 (d, 1H, H-1', J=2.4 Hz), 4.53 (dd, 1H, H-3', J=5.4 and 6.3 Hz), 4.00 (dd, 1H, H-4', J=6.3 and 8.7 Hz), 3.93 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.65 (dq, 1H, H-5', J<sub class="style-scope patent-text">d</sub> =8.7, J<sub class="style-scope patent-text">q</sub> =6.3 Hz), 2.68 (t, <sub class="style-scope patent-text">1</sub> H, H-1, J=3.9 Hz), 2.59 (s, 3H, CH<sub class="style-scope patent-text">3</sub> S).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 8</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-3,4-O-isopropylidene-β-D-allopyranosyloxy)methyl]-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Intermediate 7 (95 mg) was dissolved in dry toluene (5 ml) under nitrogen atmosphere and heated at 110° C. A solution of tributyltin hydride (64 ml) in dry toluene (5 ml) was added dropwise over 1.5 hours with stirring. The heating was continued for another 1.5 hours, methanol (2 ml) was added and the solvent evaporated to dryness. Flash chromatography of the residue on silica gel eluting with ethyl acetate:hexane (1:9) gave the title compound (42 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.98 (1H, s, CHPh<sub class="style-scope patent-text">2</sub>), 6.05 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.54 (dd, 1H, H-1', J=2.7 and 9.3 Hz), 4.39 (dt, 1H, H-3', J<sub class="style-scope patent-text">d</sub> =2.7 Hz, J<sub class="style-scope patent-text">t</sub> =3.6 Hz), 4.04 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz),3.67 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.65 (dd, 1H, H4', J=3.6 and 8.7 Hz), 3.44 (dq, 1H, H-5', J<sub class="style-scope patent-text">d</sub> =6.3 Hz, J<sub class="style-scope patent-text">q</sub> =8.7 Hz), 2.75 (t, 1H, J=3.9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 9</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 8 (1.5 g) in a mixture of tetrahydrofuran (30 ml) and methanol (15 ml) was added dropwise at room temperature a 1N solution of hydrochloric acid (15 ml) with vigorous stirring. Once the reaction was concluded (TLC control), saturated sodium bicarbonate (50 ml) and ethyl acetate (200 ml) were added and the mixture partitioned. The organic layer was washed with water (2×100 ml) and dried over magnesium sulfate. Elimination of the solvent gave a residue which was flash chromatographed over silica gel eluting with hexane:ethyl acetate (5:1) and (2:1) to give the title compound (1.1 g) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.05 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.64 (dd, 1H, H-1', J=2.1 and 9.6 Hz), 4.11 (m, 1H, H-3'), 4.06 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.3 Hz), 3.70 (m, 2H, H-5' and 8aCH<sub class="style-scope patent-text">2</sub>), 3.34 (m, 1H, H-4'), 2.75 (t, 1H, H-1, J=3.6 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 10</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-4-O-methyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A suspension of Intermediate 9 (380 mg) and dibutyltin oxide (225 mg) in dry toluene (15 ml) was refluxed for 2 hours in a flask fitted with a Dean Stark condenser, under nitrogen. The mixture was allowed to stand at room temperature and methyl iodide (200 μl) and a 1M solution of tetrabutylammonium fluoride in tetrahydrofuran (3 ml, 3 mmol) were added consecutively in several portions. The mixture was heated at 40° C. for 24 hours, under nitrogen. The solvent was then evaporated in vacuo and the residue purified by silica gel flash chromatography eluting with hexane:acetone (10:1) to afford the title compound (220 mg) together with the corresponding 3-O-methyl compound which eluted with a lower Rf.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 7.32 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.64 (dd, 1H, H-1', J-1.8 and 9.6 Hz), 4.25 (q, 1H, H-3', J=3.3 Hz), 4.52 and 3.67 (2d, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.69 (m, 1H, H-5'), 3.41 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 2.87 (dd, 1H, H4', J=3.3 and 9.3 Hz), 2.75 (t, 1H, H-1).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 11</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-4-O-methyl-3-O-methyloxymethyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 10 (200 mg) in diisopropylethylamine (4 ml) at 0° C. under nitrogen was added a large excess of methyloxymethyl chloride (0.2 to 1 ml). The mixture was stirred for 1 hour at 0° C. and 24 hours at room temperature. The reaction was quenched with the addition of methanol, 10% sodium bicarbonate and hydrochloric acid, and stirring was continued for 2 hours. Water (50 ml) and ethyl acetate (50 ml) were added and the organic layer was separated and dried over magnesium sulphate. Removal of the solvent gave the title compound (200 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCO<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.04 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.74 (AB system, 2H, OCH<sub class="style-scope patent-text">2</sub> OCH<sub class="style-scope patent-text">3</sub>, J=6.6 Hz), 4.61 (dd, 1H, H-1', J=2.1 and 9.3 Hz), 4.20 (m, 1H, H-3'), 4.04 and 3.69 (2d, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 3.81 (m, 1H, H-5'), 3.41 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.40 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 2.88 (dd, 1H, H-4', J=3 and 9.6 Hz), 2.75 (t, 1H, H-11, J=3.9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 12</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 1 (9.7 mmol) in dry methanol (40 ml) was treated with ethylene glycol (110 ml), trimethylorthoformate (3.25 ml) and a catalytic amount of p-toluenesulfonic acid. The mixture was heated at 40° C. for 3 hours. After cooling, the mixture was poured into ethyl acetate:aqueous sodium hydrogen carbonate (1:1; 500 ml) and the water layer was thoroughly extracted with ethyl acetate. The combined organic layers were washed with water and brine, and dried. After removal of the solvent, the residue was purified by flash chromatography using hexane:ethyl acetate (6:1) as eluent to give the title compound (6.1 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.43 and 7.30 (m,m, 4H, 6H, 2×Ph), 6.94 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.83 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.07 (s, 1H, 4-CH), 4.63 (d, 1H, H-1', J=1.5 Hz), 4.20 (t, 1H, H-3', J=3.3 Hz), 4.07 (d, 1H, 8a-CHa, J=9.3 Hz), 3.84 (m, 6H, H-2', 8a-CHb and OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.71 (m, 1H, H-5'), 3.42 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.21 (dd, 1H, H4', J=3 and 9 Hz), 2.63 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.54 (t, 1H, H-1, J=3.9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 13</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[[6-Deoxy-4-O-methyl-2,3-di-O-(p-tolylsulfonyl)-β-D-altropyranosyloxy]methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 12 (3.88 mmol) and 4-dimethylaminopyridine (9 mmol) in dry dichloromethane (15 ml) was added dropwise a solution of p-toluenesulfonyl chloride (8 mmol) in dry dichloromethane (15 ml). After stirring for one day, the mixture was washed with water and the organic layer was evaporated. The residue was purified by flash chromatography using hexane:ethyl acetate (4:1) as eluent. Appropriate fractions were combined and evaporated to dryness to give the title compound (3.1 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.88 and 7.30 (m,m, 4H, 14H, Ar), 6.90 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.64 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.01 (s, 1H, 4-CH), 4.98 (dd, 1H, H-3', J=3 and 4.2 Hz), 4.59 (m, 2H, H-1' and H-2'), 3.94 and 3.53 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.82 (m, 4H, OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.68 (m, 1H, H-5'), 3.18 (dd, 1H, H4', J=3 and 9 Hz), 2.83 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 2.55 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.48 and 2.45 (s,s, 3H, 3H, 2×CH<sub class="style-scope patent-text">3</sub> Ar).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 14</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3-Anhydro-6-deoxy-4-O-methyl-β-D-allopyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 13 (2.87 mmol) in dry dichloromethane (20 ml), under nitrogen atmosphere at 0° C., was treated with a solution of sodium methoxide (20 mmol) in methanol (20 ml). After three days the solvent was evaporated to dryness and the residue was dissolved in dichloromethane:water (1:1; 100 ml). The organic layer was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (7:1) as eluent. Appropriate fractions eluting with the higher Rf were combined and evaporated to give the title compound (680 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.44 and 7.29 (m,m, 4H, 6H, 2×Ph), 6.93 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.86 (dd, 1H, H-2, J=0.9 and 3.3 Hz), 5.08 (s, 1H, 4-CH), 4.59 (s, 1H, H-1'), 4.03 (d, 1H, 8a-CHa, J=9 Hz), 3.83 (m, 5H, 8a-CHb and OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.49 (m, 4H, H4' and OCH<sub class="style-scope patent-text">3</sub>), 3.33 (m, 3H, H-2', H-3' and H-5'), 2.64 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.58 (t, 1H, H-1, J=3.9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 15</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3-Anhydro-6-deoxy-4-O-methyl-β-D-mannopyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Appropriate fraction from the Intermediate 14 preparation eluting at the lower, Rf were combined and evaporated to give the title compound (912 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.43 and 7.29 (m, m, 4H, 6H, 2×Ph), 6.95 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.86 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.07 (s, 1H, 4-CH),4.66 (s, 1H, H-1'), 4.11 (d, 1H, 8a-CHa, J=9.3 Hz), 3.82 (m, 5H, 8a-CHb and OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.49 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.24 (d, 1H, H-2', J=3.9 Hz), 3.16 (m, 1H, H-5'), 3.12 (m, 2H, H-3' and H-4'), 2.62 (m, 2H, H-1 and CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 16</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-Azido-3,6-dideoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 15 (0.7 mmol) and lithium azide (2.9 mmol) in dry dimethylformamide (10 ml) was heated for 45 hours at 100° C. After cooling, the mixture was poured into ethyl acetate:water (1:1;100 ml) and the organic phase was evaporated. The residue was purified by flash chromatography using hexane:ethyl acetate (4:1) as eluent. Appropriate fractions were combined and concentrated to give the title compound (359 mg).</div>
    <div class="description-paragraph style-scope patent-text">(<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.43 and 7.30 (m,m, 4H, 6H, 2×Ph),6.93 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.83 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.07 (s, 1H, 4-CH), 4.50 (d, 1H, H-1', J=1.5 Hz), 4.14 (m, 1H, H-2'), 4.03 (d, 1H, 8a-CHa), 3.79 (m, 7H, H-3', H-5', 8a-CHb and OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.45 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.36 (dd, 1H, H4', J=3.3 and 8.1 Hz), 2.64 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.49 (t, 1H, H-1, J=4.2 Hz), 2.36 (d, 1H, 2'--OH, J=3.3 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 17</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-4-O-methyl-3-methylthio-β-D-altropyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A mixture of Intermediate 15 (0.58 mmol) and sodium thiomethoxide (3 mmol) in dry dimethylformamide (5 ml) was stirred for 48 hours and then poured into ethyl acetate:water (1:1;100 ml). The organic phase was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (4:1) as eluent. Appropriate fractions were combined and evaporated to give a mixture which was dissolved in dry dichloromethane (10 ml) and treated with 4-dimethylaminopyridine (0.7 mmol). After stirring for 20 minutes at -20° C. under nitrogen atmosphere, trichloroethoxycarbonyl chloride (0.35 mmol) was added. After 90 minutes, the mixture was washed with water, the organic phase was evaporated and the residue was purified by flash chromatography using hexane:ethyl acetate (4:1) as eluent to give a solid which was dissolved in tetrahydrofuran (10 ml) and treated with 1M aqueous potassium phosphate (0.3 ml) and zinc (4.6 mmol). The mixture was stirred overnight at room temperature, filtrated and washed with water. The organic phase was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (5:1) as eluent to give the title compound (40 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.44 and 7.30 (m, m, 4H and 6H, 2×Ph), 6.94 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.85 (dd, 1H, H-2, J=0.9 and 3.3 Hz), 5.07 (s, 1H, 4-CH), 4.69 (d, 1H, H-1', J=1.5 Hz), 4.04 (d, 1H, 8a-CHa, J=9Hz), 3.94 (m, 1H, H-2'), 3.82 (m, 5H, 8a-CHb and OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.73 (m, 1H, H-5'), 3.47 (dd, 1H, H-4', J=4.2 and 8.4 Hz), 3.40 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.33 (t, 1H, H-3', J=4.2 Hz), 2.63 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.52 (t,1 H, H-1, J=4.2 Hz), 2.44 (d,1H, 2'--OH, J=3.6 Hz), 2.23 (s, 3H, SCH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 18</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-Azido-3,6-dideoxy-4-O-methyl-β-D-glucopyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 14 (0.2 mmol) and lithium azide (0.7 mmol) in dry dimethylformamide (5 ml) was heated for 48 hours at 100° C. After cooling, the mixture was poured into ethyl acetate:water. (1:1;50 ml). The organic phase was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (3:1) as eluent. Appropriate fractions were combined and concentrated to give the title compound (71 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.31 (m, 10H, 2×Ph), 6.92 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.84 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.08 (s, 1H, 4-CH), 4.04 (m, 2H, H-1' and 8a-CHa), 3.84 (m, 5H, 8a-CHb and OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.32 (m, 3H, H-2', H-3' and H-5'), 2.74 (t, 1H, H-4', J=9 Hz), 2.66 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.54 (t 1H, H-1, J=3.6 Hz), 2.30 (d, 1H, 2'--OH, J=1.8 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 19</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-4-O-methyl-3-methylthio-β-D-glucopyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 14 (0.3 mmol) and sodium thiomethoxide (1 mmol) in dry dimethylformamide (5 ml) was stirred for 26 hours and then poured into ethyl acetate:water (1:1;100 ml). The organic phase was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (4:1) as eluent to give the title compound (134 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7,33 (m,10H, 2×Ph), 6.93 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.86 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.08 (s, 1H, 4-CH), 4.10 (m, 2H, H-1', and 8a-CHa), 3.84 (m, 5H, 8a-CHb and OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 3.60 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.30 (m, 3H, H-2', H-3' and H-5'), 2.80 (m, 1H, H-4'), 2.65 (m, 2H, H-1 and CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.21 (s, 3H, SCH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 20</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Acetyl-3-acetylamino-3,6-dideoxy-4-O-methyl-β-D-glucopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a mixture of Intermediate 18 (0.4 mmol) in methanol (40 ml) and 1N hydrochloric acid (10 ml) was added 10% palladium on charcoal (70 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 20 psi of hydrogen for 2 hours at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was dissolved in dichloromethane (5 ml) and treated with pyridine (3 ml) and acetic anhydride (0.6 mmol). The mixture was heated for 48 hours at 40° C. and then cooled and washed with water. The organic phase was evaporated and the residue purified by flash chromatography using dichloromethane:methanol (20:1) as eluent to give the title compound (167 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 6.00 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.55 (d, 1H, NH, J=9.3 Hz), 4.66 (dd, 1H, H-2', J=7.8 and 10.5 Hz), 4.28 (m, 2H, H-1' and H-3'), 4.06 and 3.54 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 3.49 (m, 4H, OCH<sub class="style-scope patent-text">3</sub> and H-5'), 2.82 (t, 1H, H4', J=9.6 Hz), 2.58 (t, 1H, H-1, J=4.2 Hz), 2.32 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.01 and 1.99 (s,s, 3H, 3H, 2×CH<sub class="style-scope patent-text">3</sub> CO).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 21</heading>
    <div class="description-paragraph style-scope patent-text">[1R(1α, 3aβ, 4β, 4aβ, 7β, 7aβ, 8aβ)] 8a-[(2,3,6-Trideoxy-3-iodo-β-D-glucopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Intermediate 9 (2.0 g), triphenylphosphine (3.4 g) and imidazole (186 mg) were refluxed in toluene (50 ml) with stirring and then treated with iodine (610 mg), added in small portions. Refluxing was continued for 4 hours. The reaction mixture was cooled, decanted into excess aqueous sodium hydrogen carbonate and sodium thiosulfate in a separating funnel. The mixture was shaken until the iodine was consumed. The toluene phase was washed with water, dried over magnesium sulfate and concentrated. The residue was purified by flash column chromatography eluting with hexane:ethyl acetate (15:1) and (5:1) to give the title compound (1.65 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.04 (dd, 1H, H-2, J-1.2 and 3.3 Hz), 4.25 (dd, 1H, H-1', J=1.8 and 9.3 Hz), 4.08 (m, 1H, H-4'), 3.67 and 4.01 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.40 (m, 1 H, H-3'), 3.32 (m 1H, H-5'), 2.74 (t, 1H, H-1, J=4.2 Hz), 2.32 and 2.53 (2m, 2H, 2H-240 ).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 22</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)]-[(3-Azido-2,3,6-trideoxy-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 21 (300 mg) in dry dimethylformamide was treated with lithium azide (60 mg). The reaction mixture was heated at 70° C. for 18 hours. The solvent was removed under reduce pressure and the residue was purified by flash column chromatography eluting with hexane:ethyl acetate (4:1) to afford the title compound (246 mg) as a pale yellow syrup.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 7.25-7.45 (m, 10H, 2Ph<sub class="style-scope patent-text">2</sub>), 6.97 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.07 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.52 (dd, 1H, H-1', J=1.4 and 9.3 Hz), 4.07 (q, 1H, H-3', J=3.6 Hz), 3.68 and 4.02 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.59 (dq, 1H, H-5', J=6.3 and 9 Hz), 3.40 (dd, 1H, H4', J=3.6 and 9 Hz), 2.74 (t, 1H, H-1, J=3.6 Hz), 2.06-2.12 and 1.73-4.82 (2m, 2H, 2H-2').</div>
    <heading class="style-scope patent-text">INTERMEDIATE 23</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-Azido-4-Azido-4-O-methyl-2,3,6-trideoxy-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a stirred solution of Intermediate 22 (140 mg) in dry tetrahydrofuran (10 ml) at 0° C. was added sodium hydride (97%, 6 mg). The mixture was stirred for 30 minutes under nitrogen, before methyl iodide (0.7 ml) was added. Stirring was continued for a further 5 hours at which time the reaction was quenched with methanol (3 ml). The solvent was evaporated to dryness under reduce pressure and the residue was purified by flash column chromatography eluting with hexane:ethyl acetate (6:1) to afford the title compound (56 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.06 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.50 (dd, 1H, H-1', J=2.1 and 9.3 Hz), 4.22 (m, 1H, H-3'), 3.67 and 4.03 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.76 (dq, 1H, H-5', J=6 Hz and 9 Hz), 3.44 (s, 3H, 4'--OMe), 3.01 (dd,1H, H-4', J=3.3 and 9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 24</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 1 (3 mmol) in dry dichloromethane (15 ml) at 0° C. under nitrogen atmosphere was added 4-dimethylaminopyridine (6.3 mmol). After stirring for 15 minutes, the mixture was cooled to -20° C. and a solution of benzylchloroformate (3.6 mmol) in dry dichloromethane (15 ml) was added dropwise. The solvent was evaporated and the residue purified by flash chromatography using hexane:ethyl acetate (3:1) as eluent to give the title compound (1.2 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.70 (s, 1H, CHO), 7.35 (m, 15H, 3×Ph), 6.96 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.99 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.18 (AB system, 2H, OCH2Ph, J=12 Hz), 5.00 (dd, 1H, H-2', J=1.5 and 4.2 Hz), 4.70 (d, 1H, H-1', J=1.8 Hz), 4.13 (m, 1H, H-3'), 4.01 and 3.66 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.75 (m, 1H, H-5'), 3.40 (s, 3H, OMe), 3.17 (dd, 1H, H4', J=3.3 and 8.4 Hz), 2.62 (t, 1H, H-1, J=3.6 Hz), 2.43 (d, 1H, OH, J=2.4 Hz), 2.21 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 25</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-3-O-(2-tetrahydropyranyl)-.beta.-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A mixture of Intermediate 24 (0.300 g) and 2,3-dihydropyran (0.138 ml) in dichloromethane (10 ml) containing pyridinium p-toluenesulphonate (0.019 g) was stirred at room temperature for 20 hours. After removal of the solvent in vacuo, the residue was chromatographed on silica gel flash column eluting with 1% dichloromethane in methanol to afford the title compound (0.208 g) as a 3:2 diastereomeric mixture.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>) only major diastereomer: 9.72 (s, 1H, CHO), 7.43 to 7.25 (m, 15H, 3'Ph), 6.97 (s, 1H, Ph<sub class="style-scope patent-text">2</sub> CH), 6.00 (dd, 1H, H-2, J=1.2 and 3.0 Hz), 5.16 (sist AB, 2H, PhCH<sub class="style-scope patent-text">2</sub> OCO), 5.04 (dd, 1H, H-2', J=1.2 and 4.2 Hz), 4.80 (m, 1H, H-1"), 4.68 (brs, 1H, H-1'), 4.21 (dd, 1H, H-3', J=3.0 and 4.5 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 26</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3,6-Trideoxy-2,3-difluoro-4-O-methyl-β-D-glucopyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 12 (500 mg) in anhydrous dichloromethane (8 ml) at -40° C. was treated with diethylaminosulfur trifluoride (DAST, 0.35 ml). The cooling bath was removed and the mixture was stirred overnight at room temperature. The mixture was cooled to -20° C., the reaction quenched by addition of methanol (2 ml) and then concentrated under reduced pressure. Flash chromatography on silica gel eluting with hexane:ethyl acetate (20:1), (10:1) and (4:1) gave the title compound (140 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.26-7.46 (m, 10H, 2Ph), 6.89 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.87 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.07 (s, 1H, CH-dioxolane), 4.58-4.70 and 4.41-4.52 (2m, 1H, H-2', J<sub class="style-scope patent-text">HF</sub> =53.1 and 17.1, J<sub class="style-scope patent-text">HH</sub> =8.7 and 8.1 Hz), 4.23 (d, 1H, H-1', J=8.4 Hz), 4.30-4.40 and 4.12-4.21 (2m, 1H, H-3', J<sub class="style-scope patent-text">HF</sub> =53.1 and 15.3 Hz, J<sub class="style-scope patent-text">HH</sub> =8.1 Hz), 4.05 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.77-3.89 (m, 4H, of 2CH<sub class="style-scope patent-text">2</sub> in dioxolane protecting group and 1H of 8aCH<sub class="style-scope patent-text">2</sub>), 3.55 (d, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>, J<sub class="style-scope patent-text">HF</sub> =1.2 Hz), 3.20-3.30 (m, 1H, H-5'), 2.96-3.07 (dq, 1H, H4', J<sub class="style-scope patent-text">HF</sub> =13.2 Hz, J<sub class="style-scope patent-text">HH</sub> =8.4 and 9.6 Hz), 2.60-2.70 (m, 2H, H-1 and 2CH isopropyl).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 27</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3,6-Trideoxy-4-O-methyl-3-oxo-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of trifluoroacetic anhydride (0.1 ml) in dry dichloromethane (5 ml) at -60° C. under nitrogen was treated with dimethylsulfoxide (0.06 ml). After 10 minutes, a solution of Intermediate 10 (0.39 mmol) in dry dichloromethane (5 ml) was added followed, after 60 minutes, by triethylamine (0.24 ml). The mixture was stirred at -60° C. to -20° C. for 2 hours and washed with water. After removal of the solvent, the residue was purified by flash chromatography using hexane:ethyl acetate (3:1) as eluent to give the title compound (131 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 7.35 (m, 10H, 2×Ph), 6.97 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.03 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.46 (dd, 1H, H-1', J=2.7 and 8.9 Hz), 4.07 and 3.71 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.42 (m, 2H, H4' and H-5'), 2.70 (m, 3H, H-1 and CH<sub class="style-scope patent-text">2</sub> --2'), 2.25 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 1.43 (d, 3H, CH<sub class="style-scope patent-text">3</sub> --6', J=5.7 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 28</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-2-O-benzyloxycarbonyl-4-O-methyl-3-oxo-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of trifluoroacetic anhydride (65 μl) in dry dichloromethane (2 ml) under nitrogen atmosphere at -60° C. were added dropwise dimethylsulphoxide (33 μl) and a solution of Intermediate 24 (250 mg) in dichloromethane. The resulting solution was stirred for 40 minutes, triethylamine (0.20 ml) was added and the reaction mixture kept at -20° C. overnight. The mixture was then poured into water, the aqueous phase extracted with dichloromethane, the organic phase washed with brine, dried (magnesium sulphate) and evaporated to dryness. Flash chromatography on silica gel eluting with ethyl acetate:hexane (2:8) afforded the title compound (152 mg) as a foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.69 (s, 1H, CHO), 7.43-7.25 (m, 10H, 2Ph), 6.95 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.91 (dd, 1H, H-2, J=1.5 and 3.3 Hz), 5.27 (d, 1H, PhCH<sub class="style-scope patent-text">2</sub> O, J=12.0 mHz), 5.20 (d, 1H, PhCH<sub class="style-scope patent-text">2</sub> O, J=12.0 Hz), 4.99 (dd, 1H, H-2', J=1.2 and 7.8 Hz), 4.37 (d, 1H, H-1', 7.8 Hz), 4.07 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.71 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=12.0 Hz), 3.53 (s, 3H, 4'--O--CH<sub class="style-scope patent-text">3</sub>), 3.51 (dd, 1H, H-4', J=1.2 and 9.6 Hz), 3.42 (dq, 1H, H-5', J<sub class="style-scope patent-text">d</sub> =9.6 Hz, J<sub class="style-scope patent-text">q</sub> =6.0 Hz), 2.62 (t, 1H, H-1, J=3.9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 29</heading>
    <div class="description-paragraph style-scope patent-text">[1R(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-2-O-benzyloxycarbonyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (2.03 g) in methanol (18 ml) were added ethylene glycol (30 ml), methyl orthoformate (2.5 ml) and p-toluensulphonic acid (31 mg), and the resulting solution was stirred under nitrogen atmosphere at 35° C. for 3 hours. The solution was then partitioned between 10% sodium bicarbonate and ethyl acetate (100 ml), and the aqueous phase was extracted with more ethyl acetate (2×100 ml), washed with brine, dried (magnesium sulphate) and evaporated to dryness. The residue was flash chromatographed on silica gel eluting with hexane:ethyl acetate (6:4) to yield the title compound (2.3 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.46-7.20 (m, 10H, 2Ph), 6.92 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>),5.97 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.22 (d, 1H, BnCH<sub class="style-scope patent-text">2</sub> O, J=12.3 Hz), 5.14 (d, 1H, BnCH<sub class="style-scope patent-text">2</sub> O, J=12.3 Hz), 5.05 (s, 1H, OCHO), 4.99 (dd, 1H, H-2', J=1.8 and 4.5 Hz), 4.69 (d, 1H, H-1', J=1.8 Hz), 4.19-4.15 (m, 1H, H-3'), 4.01 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.89-3.74 (m, 5H, H-5', 2CH<sub class="style-scope patent-text">2</sub> O), 3.71 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.40 (s, 3H, 4--O--CH<sub class="style-scope patent-text">3</sub>), 3.17 (dd, 1H, H4', J=3.3 and 8.4 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 30</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-2-O-benzyloxycarbonyl-4-O-methyl-3-oxo-β-D-allopyranosyloxy)methyl]-4-(dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of trifluoroacetic anhydride (0.64 ml) in dry dichloromethane (5 ml) under nitrogen atmosphere at -60° C. were added dropwise dimethylsulphoxide (0.35 ml) and a solution of Intermediate 29 (1.9 g) in dry dichloromethane (10 ml). The resulting solution was stirred for 1 hour, triethylamine (1.24 ml) was added and stirring was continued for 2 hours allowing the temperature to reach -20° C. The reaction mixture was partitioned between water and dichloromethane (100 ml), and the organic phase was washed with brine and dried (magnesium sulphate). The solution was then concentrated to 40 ml, triethylamine (2 ml) was added and the solution stirred for 2 hours at room temperature. The solvent was then evaporated off and the residue flash chromatographed on silica gel eluting with ethyl acetate:hexane (2:8) to obtain the title compound (1.6 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.45-7.22 (m, 10H, CHPh<sub class="style-scope patent-text">2</sub>), 5.73 (dd, 1H, H-2, J=1.5 and 3.9 Hz), 5.28-5.19 (m, 2H, AB system, OCH<sub class="style-scope patent-text">2</sub> Ph), 5.08 (s, 1H, OCHO), 4.99 (dd, 1H, H-2', J=1.2 and 8.1 Hz), 4.37 (d, 1H, H-1', J=8.1 Hz), 4.06 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.88-3.78 (m, 4H, 2×CH<sub class="style-scope patent-text">2</sub> O), 3.52 (s, 3H, 4--O--CH<sub class="style-scope patent-text">3</sub>), 3.76 (d, 1H, BaCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.46-3.39 (m, 1H, H-5').</div>
    <heading class="style-scope patent-text">INTERMEDIATE 31</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-2-O-benzyloxycarbonyl-3-allyloxyimine-4-O-methyl-β-D-allopyranosyloxy)methyl]-4-(1,3-dioxolan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A mixture of Intermediate 30 (250 mg) and O-allylhydroxylamine hydrochloride (109 mg) in dry pyridine (5 ml) was stirred at 80° C. for 4 hours. The solvent was evaporated to dryness and the residue flash chromatographed on silica gel eluting with hexane:ethyl acetate (85:15) to obtain the title compound (193 mg) as a mixture of Z:E isomers in a 3:1 ratio.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 7.43-7.21 (m, 10H, 2Ph), 6.91 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.0-5.8 (m, 1H, HC=C), 5.67 (d, 1H, H-2, J=6.6 Hz), 5.63 (dd, 1H, H-2, J=1.2 and 2.4 Hz), 5.30-5.06 (m, 5H,2×H--C=C, OCHO, OCH<sub class="style-scope patent-text">2</sub> Ph), 4.74 (d, 1H, H-1', J=6.6 Hz), 4.68-4.58 (m, 2H, OCH<sub class="style-scope patent-text">2</sub> C=C), 4.04-3.75 (m, 6H, H-4', H-5' 2×OCH<sub class="style-scope patent-text">2</sub>), 3.97 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.66 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 3.26 (s, 3H, 4--O--CH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 32</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ7β, 7aα, 8aβ)] 8a-[(3-O-Benzoyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 1 (500 mg) and dibutyltin oxide (246 mg) in dry toluene (15 ml) was refluxed for 2 hours in a flask fitted with a Dean-Stark condenser under nitrogen atmosphere. The reaction mixture was allowed to cool to room temperature and then treated with benzoyl chloride (95 μl) and triethylamine (0.32 ml). After stirring for 2 hours under reflux, the reaction mixture was concentrated under reduced pressure and the residue purified by flash column chromatography eluting with hexane:ethyl acetate (8:1 to 3:1). The appropriate fractions were combined and the solvents evaporated to yield the the title compound (300 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 8.05 and 7.26-7.59 (2m, 2H and 13H, 3Ph), 6.99 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.30 (dd, 1H, H-2, J=3.3 and 1.2 Hz), 5.73 (dd, 1H, H-3', J=3 and 0.9 Hz), 4.69 (d, 1H, H-1', J=1.2 Hz), 3.79 and 4.10 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.94-3.85 (m, 2H, H-2' and H-5'), 3.38 (s, 3H, 4'OMe), 3.41 (dd, 1H, H-4', J=3 and 9 Hz), 2.73 (t, 1H, H-1, J=3.9 Hz), 2.38 (d, 1H, 2'--OH, J=3.3 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 33</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A mixture of Intermediate 1 (3 mmol) and dibutyltin oxide (3.9 mmol) in dry toluene (40 ml) was stirred under reflux in a flask fitted with a Dean-Stark condenser for 2 hours. The mixture was cooled and 4-dimethylaminopyridine (3.2 mmol) and benzyloxycarbonyl chloride (3.3 mmol) were added. After 30 minutes, the solvent was evaporated and the residue purified by flash column chromatography on silica gel eluting with hexane:ethyl acetate (15:1 to 3:1). Appropriate fractions were combined and concentrated to give the title compound (356 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.36 (m, 15H, 3×Ph), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.03 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.32 (dd, 1H, H-3', J=3 and 3.9 Hz), 5.22 and 5.15 (d,d, 1H, 1H, OCH<sub class="style-scope patent-text">2</sub> Ph, J=12 Hz), 4.61 (d, 1H, H1', J=1.5 Hz), 4.07 and 3.73 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.85 (m, 1H, H-2'), 3.75 (m, 1H, H-5'), 3.27 (dd, 1H, H4', J=3.3 and 9.3 Hz), 2.71 (t, 1H, H-1, J=3.9 Hz), 2.32 (d 1H, OH, J=3 Hz), 2.22 (m,1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 34</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-2-O-(2,2,2-trichloethoxycarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a cold (0° C.) solution of Intermediate 1 (200 mg) and 4-dimethylaminopyridine (100 mg) in acetonitrile (10 ml) was added dropwise a solution of 2,2,2-trichloroethyl chloroformate (50 μl) in acetonitrile (10 ml), and the mixture was stirred at 0° C. until all the starting material was consumed (tic analysis 2:1 hexane:ethyl acetate). The solvent was removed under vacuum and the residue partitioned between ethyl acetate (50 ml) and 1N aqueous hydrochloric acid (50 ml). The organic layer was washed successively with water and brine, then dried over sodium sulphate, filtered and concentrated. The residue was purified by flash chromatography on silica gel eluting with hexane:ethyl acetate (3:1) to give the title compound (175 mg) as a colourless gum which was triturated with hexane to afford a white solid.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.97 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.04 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.03 (dd, 1H, H-2', J=1.5 and 4.2 Hz), 4.84, 4.75 (2d, 2H, Cl<sub class="style-scope patent-text">3</sub> CCH<sub class="style-scope patent-text">2</sub> O, J<sub class="style-scope patent-text">AB</sub> =12 Hz), 4.72 (d, 1H, H-1'), 4.2 (m, 1H, H-3'), 4.05, 3.68 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.82-3.71 (m, 1H, H-5'), 3.43 (s, 31H, OCH<sub class="style-scope patent-text">3</sub>), 3.21 (dd, 1H, H4', J=3 and 8.4 Hz), 2.70 (m, 1H, H-1), 2.47 (d, 1H, OH3', J=2.1 Hz), 2.28-2.16 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 35</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-3-O-butoxyacetyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (400 mg) in dry dichloromethane (15 ml) at room temperature were added 4-dimethylaminopyridine (67 mg) and a solution of butoxyacetyl chloride (0.1 ml) in dichloromethane (5 ml). After stirring for 1 hour the solvent was removed and the residue purified by flash column chromatography eluting with hexane:ethyl acetate (5:1) to give the title compound (350 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.25-7.43 (m, 15H, 3Ph), 6.96 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.97 (dd, 1H, H-2, J=3.3 and 0.9 Hz), 5.53 (dd, 1H, H-3', J=4.8 and 3.3 Hz), 5.18 (AB system, 2H, CH<sub class="style-scope patent-text">2</sub> --Ph, J=12 Hz), 4.93 (dd, 1H, H-2', J=1.5 and 4.8 Hz), 4.63 (d, 1H, H-1', J=1.5 Hz), 4.13 (AB system, 2H, OCH<sub class="style-scope patent-text">2</sub> CO<sub class="style-scope patent-text">2</sub>, J=14 Hz), 3.66 and 3.99 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.73 (m, 1H, H-5'), 3.53 (m, 2H, CH2O), 3.32 (s, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.24 (dd, 1H, H-4', J=8.4 and 3 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 36</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-3-O-octanoyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (600 mg) and 4-dimethylaminopyridine (276 mg) in dry dichloromethane (30 ml) at room temperature was added octanoyl chloride (170 μl) and the mixture was stirred for 3 hours. The solution was washed with water (2×50 ml), dried over magnesium sulfate and concentrated under reduced pressure. The residue was purified by flash cromatography eluting with hexane:ethyl acetate (4:1) to give the title compound (490 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.45-7.25 (m, 15H, 3Ph), 6.97 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.97 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.46 (dd, 1H, H-3', J=3 and 4.5 Hz), 5.18 (AB system 2H, CH<sub class="style-scope patent-text">2</sub> Ph, J=12 Hz), 4.90 (dd, 1H, H-2', J=1.5 and 4.8 Hz), 4.63 (d, 1H, H-1', J=1.8), 3.98 and 3.67 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=8.7 Hz), 3.74 (m, 1H, H-5'), 3.32 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.22 (dd, 1H, H4', J=3 and 8.1 Hz), 2.57 (t, 1H, H-1, J=3.9 Hz), 2.37 (dt, 2H, CH<sub class="style-scope patent-text">2</sub> CO, J=1.8 and 7.5 Hz), 1.4-1.2 (m, 5CH<sub class="style-scope patent-text">2</sub> and 6'CH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 37</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-3-O-methoxyacetyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (400 mg) in dry dichloromethane (15 ml) at room temperature were added 4-dimethylaminopyridine (70 mg) and methoxyacetyl chloride (51 μl) in dichloromethane (5 ml). After stirring for 2 hours the solvent was removed and the residue purified by flash column chromatography eluting with hexane:ethyl acetate (5:1) to give the title compound (352 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.20-7.42 (m, 15H, 3Ph), 6.96 (s, 1Ha, CHPh<sub class="style-scope patent-text">2</sub>), 5.97 (dd, 1H, H-2, J=3.3 and 0.39 Hz), 5.54 (dd, 1H, H-3', J=4.5 and 3 Hz), 5.18 (AB system, 2H, CH2Ph, J=12 Hz), 4.93 (dd, 1H, H-2', J=4.5 and 1.5 Hz), 4.63 (d, 1H, H-1', J=1.5 Hz), 4.10 (AB system, 2H, OCH<sub class="style-scope patent-text">2</sub> CO<sub class="style-scope patent-text">2</sub>, J=12 Hz), 3.66 and 3.98 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.72 (dq, 1H, H-5', J=9 and 6 Hz), 3.34 (s, 3H, 4'OCH<sub class="style-scope patent-text">3</sub>), 3.45 (s, 3H, CH<sub class="style-scope patent-text">3</sub> OCH<sub class="style-scope patent-text">2</sub> CO<sub class="style-scope patent-text">2</sub>), 3.24 (dd, 1H, H-4', J=9 and 3 Hz), 2.57 (t, 1H, H-1, J=3.9 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 38</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-((E)-2-methyl-2-hexenoyl)-2-O-(2,2,2-trichloroethoxycarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A mixture of trans-2-methyl-2-hexenoic acid (61 mg), triethylamine (167 ml), Intermediate 34 (227 mg), 2-chloro-1-methylpyridinium iodide (123 mg) and a catalytic amount of 4-dimethylaminopyridine in dry dichloromethane (10 ml) was refluxed for 10 minutes. A further quantity of 4-dimethylaminopyridine (88 mg) was added and reflux continued for 2.5 hours. The solvent was removed in vacuo and the residue partitioned between ethyl acetate (50 ml) and water (50 ml). The organic layer was washed successively with aqueous hydrochloric acid (1N, 30 ml), saturated aqueous sodium hydrogen carbonate solution (30 ml) and brine (30 ml), then dried (Na<sub class="style-scope patent-text">2</sub> SO<sub class="style-scope patent-text">4</sub>), filtered and concentrated in vacuo. The residue was flash chromatographed over silica gel eluting with hexane:ethyl acetate (8:1) and the required fractions combined and evaporated to give the title compound (205 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">(<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.82 (m, 1H, RO<sub class="style-scope patent-text">2</sub> C(CH<sub class="style-scope patent-text">3</sub>)=CH--R), 6.03 (m, 1H, H-2), 5.54 (m, 1H, H-3'), 5.0 (m, 1H, H-2'), 4.84, 4.76 (2d, 2H, Cl<sub class="style-scope patent-text">3</sub> CCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =12 Hz), 4.67 (d, 1H, H-1', J=1.5 Hz), 4.05, 3.71 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.8 (m, 1H, H-5'), 3.37 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.32 (m, 1H, H4'), 2.68 (bt, 1H, H-1, J=3.6 Hz), 2.3-2.12 (m, 3H, CHMe<sub class="style-scope patent-text">2</sub> and RO<sub class="style-scope patent-text">2</sub> CC(CH<sub class="style-scope patent-text">3</sub>)=CH--CH<sub class="style-scope patent-text">2</sub> --R).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 39</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-((E)-2-methyl-2-hexenoyl)-2-O-(2,2,2-trichloroethoxycarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 38 (194 mg) in a (20:1) trifluoroacetic acid:water mixture (5 ml) at 0° C. was stirred for 45 minutes. The solvent was removed in vacuo and the residue co-evaporated with toluene (2×10 ml) to a yellow oil. This was purified by preparative tic (Merck 5717) eluting with dichloromethane:methanol (20:1) and washing the product off the silica gel with ethyl acetate:methanol (6:1). Removal of solvent gave the title compound (138 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 6.81 (m, 1H, RO<sub class="style-scope patent-text">2</sub> CC(CH<sub class="style-scope patent-text">3</sub>)=CH--R), 6.05 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.55 (dd, 1H, H-3', J=3 and 4.5 Hz), 5.02 (dd, 1H, H-2', J=1.5 and 4.5 Hz), 4.81 (m, 2H, Cl<sub class="style-scope patent-text">3</sub> CCH<sub class="style-scope patent-text">2</sub>), 4.70 (d, 1H, H-1', J=1.5 Hz), 4.17, 3.57 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.8 (m, 1H, H-5'), 3.36 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.31 (m, 1H, H-4'), 2.59 (m, 1H, H-1), 2.32 (m, 1H, CHMe<sub class="style-scope patent-text">2</sub>), 2.17 (m, 2H, RO<sub class="style-scope patent-text">2</sub> C--C(CH<sub class="style-scope patent-text">3</sub>)=CH--CH<sub class="style-scope patent-text">2</sub> --R).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 40</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-3-O-(4-chlorobutyryl)-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (500 mg) and 4-dimethylaminopyridine (457 mg) in dry dichloromethane (25 ml) at room temperature was added 4chlorobutyryl chloride (141 μl) and the mixture was stirred for 24 hours. The solution was washed with water (2×50 ml), dried over magnesium sulfate, and concentrated under reduced pressure. The residue was purified by flash cromatography eluting with hexane:ethyl acetate (3:2) to give the title compound (360 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.7 (s, 1H, CHO), 7.45-7.24 (m, 15H, 3Ph), 6.97 (s, 1H,CHPh<sub class="style-scope patent-text">2</sub>), 5.97 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.46 (dd, 1H, H-3', J=3 and 4.5 Hz), 5.18 (AB system, 2H, CH<sub class="style-scope patent-text">2</sub> Ph, J=12 Hz), 4.91 (dd, 1H, H-2', J=1.5 and 4.5 Hz), 4.64 (d,1 H, H-1', J=1.8 Hz), 3.99 and 3.67 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=8.7 Hz), 3.75 (dd, 1H, H-5', J=6.3 and 8.4 Hz), 3.60 (t, 2H, CH<sub class="style-scope patent-text">2</sub> CO, J=6.6 Hz), 3.26 (s, 3H, OCH,<sub class="style-scope patent-text">3</sub>), 3.22 (dd, 1H, H-4', J=3.0 and 8.4 Hz), 2.58 (m, 3H, 1 H, H-1 and 2H, CH<sub class="style-scope patent-text">2</sub> Cl).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 41</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aβ, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-3-O-(2-methylpropanoyl)-.beta.-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of isobutyryl chloride (0.054 ml) in dichloromethane (5 ml) was added to a mixture of Intermediate 24 (0.415 g) and 4-dimethylaminopyridine (0.064 g) in dichloromethane (10 ml). The reaction mixture was stirred for 20 hours. Water (15 ml) was added into the mixture and the organic layer was separated. The solvent was removed in vacuo and the residue was chromatographed on silica gel flash column eluting with hexane:ethyl acetate (3:1) to give the title compound (0.276 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.30 (m, 15H, 3×Ph), 6.97 (s, 1H, Ph<sub class="style-scope patent-text">2</sub> CH), 5.97 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.40 (dd, 1H, H-3', J=3.0 and 4.5 Hz), 5.18 (AB system, 2H, PhCH<sub class="style-scope patent-text">2</sub> OCO), 4.90 (dd, 1H, H-2', J=1.5 and 4.8 Hz), 4.62 (d, 1H, H-1, J=1.8 Hz), 3.98 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.0 Hz), 3.75 (m, 1H, H-5'), 3.67 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.0 Hz), 3.32 (s, 3H, OMe), 3.22 (dd, 1H, H-4', J=3.0 and 8.1 Hz), 2.62 (m, 2H, H-1 and (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub> CHCO<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 42</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8β)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-3-O-propionyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Propionic acid (54 μl), 2-chloro-1-methylpyridinium iodide (184 mg), triethylamine (250 μl), Intermediate 24 (285 mg), 4-dimethylaminopyridine (132 mg) and dry dichloromethane (20 ml) were mixed and stirred at room temperature for 18 hours. The solvent was removed in vacuo and the residue chromatographed on silica gel eluting with hexane:ethyl acetate (4:1). The appropriate fractions were combined and the solvent was evaporated to give the title compound (285 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.44-7.22 (m, 15H, 3Ph), 6.96 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.97 (dd, 1H, H-2, J=1.5 and 3.3 Hz), 5.46 (dd, 1H, H-3', J=3 and 4.8 Hz), 5.22, 5.14 (2d, 2H, PhCH2O, J<sub class="style-scope patent-text">AB</sub> =12 Hz), 4.91 (dd, 1H, H-2', J=1.5 and 4.8 Hz), 4.63 (d, 1H, H-1', J=1.5 Hz), 3.99, 3.67 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =8.7 Hz), 3.75 (m, 1H, H-5'), 3.33 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.23 (dd, 1H, H-4', J=3 and 8.4 Hz), 2.57 (m, 1H, H-1), 2.4 (dq, 2H, RO<sub class="style-scope patent-text">2</sub> CCH<sub class="style-scope patent-text">2</sub> --Me, J=7.5 Hz (q) and 1.2 Hz (d)), 2.22 (m, 1H, CHMe<sub class="style-scope patent-text">2</sub>),1.16 (t, 3H, RO<sub class="style-scope patent-text">2</sub> CCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">3</sub>, J=7.5 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 43</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-3-O-(trans-4-methyl-1-cyclohexanecarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A mixture of trans-4-methyl-1-cyclohexanecarboxylic acid (102 mg), 2-chloro-1-methylpyridinium iodide (184 mg), triethylamine (250 μl), Intermediate 24 (285 mg) and 4-dimethylaminopyridine (132 mg) in dry dichloromethane (20 ml) was stirred at room temperature for 15 hours. The solvent was removed in vacuo and the residue purified by column chromatography on silica gel eluting with hexane:ethyl acetate (4:1). The required fractions were combined and evaporated to give the title compound (310 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.44-7.22 (m, 15H, 3Ph), 6.97 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.97 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.43 (dd, 1H, H-3', J=3.3 and 4.8 Hz), 5.21, 5.14 (2d, 2H, Ph-CH<sub class="style-scope patent-text">2</sub> --O, J<sub class="style-scope patent-text">AB</sub> =12 Hz), 4.89 (dd, 1H, H-2', J=1.8 and 4.8 Hz), 4.62 (d, 1H, H-1', J=1.8 Hz), 3.99, 3.68 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.75 (m, 1H, H-5'), 3.31 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.21 (dd, 1H, H4', J=3.3 and 8.4 Hz), 2.57 (m, 1H, H-1), 2.34-2.16 (m, 2H, CHMe<sub class="style-scope patent-text">2</sub> +RO<sub class="style-scope patent-text">2</sub> C--CH--(cyclohexane)), 0.89 (d, 3Haprox, H<sub class="style-scope patent-text">3</sub> C-cyclohexane-CO<sub class="style-scope patent-text">2</sub> R).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 44</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-trans-Cinnamoyl-6-deoxy-4-O-methyl-2-O-(2,2,2-trichloroethoxycarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A cold (0° C.) solution of Intermediate 34 (75 mg) in dry dichloromethane (4 ml) under nitrogen was treated with 4-dimethylaminopyridine (50 mg) and trans-cinnamoyl chloride (30 mg). The mixture was stirred at room temperature until all the starting material was consumed (5 hours). The reaction was quenched with water and the mixture stirred for 15 minutes and then partitioned between ethyl acetate (50 ml) and 1N aqueous hydrochloric acid (50 ml). The organic layer was washed successively with water and brine, then dried (Na<sub class="style-scope patent-text">2</sub> SO<sub class="style-scope patent-text">4</sub>), filtered and concentrated. The residue material was flash chromatographed using hexane to 3:1 hexane:ethyl acetate as eluent to give the title compound (90 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 7.74 (d, 1H, PhCH=CH--CO<sub class="style-scope patent-text">2</sub> R, J=15.9 Hz), 7.6-7.2 (m, 15H, 3Ph), 6.98 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.49 (d, 1H, PhCH=CH--CO<sub class="style-scope patent-text">2</sub> R), 6.04 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.60 (dd, 1H, H-3', J=3.3 and 4.5 Hz), 5.06 (dd, 1H, H-2', J=1.5 and 4.5 Hz), 4.9-4.7 (m, 3H, Cl<sub class="style-scope patent-text">3</sub> CCH<sub class="style-scope patent-text">2</sub> O, H-1'), 4.07, 3.72 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.94-3.82 (m, 1H, H-5'), 3.44-3.32 (m, 4H, --OCH<sub class="style-scope patent-text">3</sub>, H4'), 2.7 (t, 1H, H-1, J=3.6 Hz), 2.3-2.18 (m, 1H, --CHMe<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 45</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-trans-Cinnamoyl-6-deoxy-4-O-methyl-2-O-(2,2,2-trichlorethoxycarbonyl)-62-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A suspension of Intermediate 44 (295 mg) in trifluoroacetic acid:water (4:1;10 ml) at 0° C. was stirred for 1.5 hours. The solvent was removed in vacuo and the crude co-evaporated with toluene (3×5 ml). The residue was flash chromatographed on silica gel eluting with dichloromethane:methanol (99:1 to 95:5) and appropriate fractions were combined and concentrated to give the title compound (200 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.74 (d, 1H, Ph--CH=CH--CO<sub class="style-scope patent-text">2</sub> R, J=15.9 Hz), 7.6-7.36 (m, 5H, Ph), 6.48 (d, 1H, Ph--CH=CH--CO<sub class="style-scope patent-text">2</sub> R, J=15.9 Hz), 6.06 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.61 (dd, 1H, H-3', J=3.3 and 4.5 Hz), 5.07 (dd, 1H, H-2', J=1.5 and 4.5 Hz), 4.82 (s, 2H, Cl<sub class="style-scope patent-text">3</sub> CCH<sub class="style-scope patent-text">2</sub> O), 4.77 (d, 1H, H-1', J=1.5 Hz), 4.15, 3.61 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.95-3.80 (m, 1H, H-5'), 3.40 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.35 (dd, 1H, H-4', J=3.3 and 8.4 Hz), 2.62 (m, 1H, H-1), 2.32 (m, 1H, --CHMe<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 46</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-Omethacryloyl-4-O-methyl-2-O-(2,2,2-trichloroethoxycarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A mixture of Intermediate 34 (100 mg), triethylamine (80 μl), methacrylic acid (21 μl), 2-chloro-1-methylpyridinium iodide (68 mg) and a catalytic amount of 4-dimethylaminopyridine in dry dichloromethane (10 ml) was refluxed under nitrogen for 5 minutes. A further quantity of 4-dimethylaminopyridine (45 mg) was added and reflux was continued until all the starting material was consumed (tic control 4:1 hexane:ethyl acetate). The solvent was removed in vacuo and the residue partitioned between ethyl acetate (50 ml) and 1N aqueous hydrochloric acid (50 ml). The organic layer was washed successively with saturated aqueous sodium hydrogen carbonate solution, water and brine, then dried (Na<sub class="style-scope patent-text">2</sub> SO<sub class="style-scope patent-text">4</sub>), filtered and concentrated in vacuo. The residue was purified by flash chromatography eluting with hexane:ethyl acetate (4:1) to give the title compound (60 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.98 (s, 1H, Ph<sub class="style-scope patent-text">2</sub> CH--), 6.16 (bs, 1H, Ha--C=C), 6.03 (m, 1H, H-2), 5.65 (m, 1H, Hb--C=), 5.53 (dd, 1H, H-3', J=3 and 4.8 Hz), 5.01 (dd, 1H, H-2', J=1.5 and 4.8 Hz), 4.84, 4.76 (2d, 2H, Cl<sub class="style-scope patent-text">3</sub> CCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =11.7 Hz), 4.67 (d, 1H, H-1', J=1.5 Hz), 4.04, 3.7 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.8 (m, 1H, H-5'), 3.36 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.31 (dd, 1H, H4', J=3.3 and 8.4 Hz), 2.68 (m, 1H, H-1), 2.23 (m, 1H, CHMe<sub class="style-scope patent-text">2</sub>), 1.97 (s, 3H, H<sub class="style-scope patent-text">3</sub> C--C=).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 47</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-methacryloyl-4-O-methyl-2-O-(2,2,2-trichloroethoxycarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A suspension of Intermediate 46 (150 mg) in trifluoroacetic acid:water (4:1;7 ml) at 0° C. was stirred for 1.5 hours. The solvent was removed in vacuo and the residue co-evaporated with toluene (3×3 ml). The residue was flash chromatographed on silica gel eluting with dichloromethane:methanol (25:1) and appropriate fractions were combined and evaporated to give the title compound (115 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 6.15 (m, 1H, Ha--C=C), 6.05 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.65 (m, 1H, Hb--C=C), 5.54 (dd, 1H, H-3', J=3 and 4.5 Hz), 5.02 (dd, 1H, H-2', J=1.8 and 4.5 Hz), 4.81 (s, 2H, Cl<sub class="style-scope patent-text">3</sub> CCH<sub class="style-scope patent-text">2</sub>), 4.70 (d, 1H, H-1', J=1.8 Hz), 4.1, 3.59 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.81 (m, 1H, H-5'), 3.36 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.31 (dd, 1H, H4', J=3 and 8.4 Hz), 2.62 (m, 1H, H-1), 2.31 (m, 1H, CHMe<sub class="style-scope patent-text">2</sub>), 1.97 (s, 3H, H<sub class="style-scope patent-text">3</sub> C--C=C).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 48</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-3-O-octyloxycarbonyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (400 mg) and 4-dimethylaminopyridine (238 mg) in dry dichloromethane (50 ml) at room temperature was added octyl chloroformate (127 μl) and the mixture was stirred for 3 hours. The solution was washed with water (2×50 ml), dried over magnesium sulfate, and concentrated under reduced pressure. The residue was purified by flash chromatography eluting with hexane:ethyl acetate (4:1) to give the title compound (320 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.45-7.20 (m, 15H, 3Ph), 6.96 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.97 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.26 (dd, 1H, H-3', J=3 and 4.2 Hz), 5.18 (AB system, 2H, CH<sub class="style-scope patent-text">2</sub> --Ph, J=12 Hz), 5.00 (dd, 1H, H-2', J=1.5 and J=4.2 Hz), 4.69 (d, 1H, H-1', J=1.5 Hz), 4.15 (t, 2H, CH<sub class="style-scope patent-text">2</sub> OCO, J=6.6 Hz), 4.00 and 3.66 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=8.7 Hz), 3.78 (dd, 1H, H-5', J=6 and 9 Hz), 3.37 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.30 (dd, 1H, H4', J=3 and 8.4 Hz).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 49</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-2-O-benzyloxycarbonyl-4-O-methyl-3-O-octylaminocarbonyl-.beta.-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (250 mg) and octyl isocyanate (62 mg) in dry toluene (10 ml) was added a catalytic amount (5 drops) of dibutyltin diacetate, and the mixture was refluxed under nitrogen for 1 hour. The solvent was evaporated to dryness and the residue chromatographed on a silica gel flash column using hexane:ethyl acetate (7:3) as eluent to give the title compound (280 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.70 (s, 1H, CHO), 6.96 (s. 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.96 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.32 (m, 1H, H-3'), 5.17 (AB system, 2H, --CH<sub class="style-scope patent-text">2</sub> OPh, J=12.0 Hz), 4.98 (dd, 1H, H-2', J=1.8 and 5.1 Hz), 4.75 (t, 1H, --NH--C=O--), 4.62 (d, 1H, HI-1', J=1.8 Hz), 3.98 and 3.65 (2d, 2H, 8a-CH2, J=9 Hz), 3.74 (m, 1H, H-5'), 3.37 (s, 3H, 4'--OCH3), 3.25 (dd, 1H, H-4', J=3 and 8.1 Hz), 3.18 (m, 2H, --CH<sub class="style-scope patent-text">2</sub> --NH--CO<sub class="style-scope patent-text">2</sub>), 2.58 (t, 1H, H-1').</div>
    <heading class="style-scope patent-text">INTERMEDIATE 50</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-benzylaminocarbonyl-2-O-benzyloxycarbonyl-4-O-methyl-.beta.-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 24 (240 mg) and benzyl isocyanate (54 mg) in dry toluene (10 ml) was added a catalytic amount of dibutyltin diacetate, and the stirred mixture was refluxed under nitrogen for 6 hours. The solvent was evaporated to dryness and the residue chromatographed on a silica gel flash column eluting with hexane:ethyl acetate (5:1) to give the title compound (140 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 5.96 (dd, 1H, H-2, J=0.6 and 2.7 Hz), 5.37 (dd, 1H, H-3', J=3 and 4.8 Hz), 5.18 (AB system, 2H, O--CHPh<sub class="style-scope patent-text">2</sub>, J=12 Hz), 5.12 (t, 1H, CH<sub class="style-scope patent-text">2</sub> --NH--CO<sub class="style-scope patent-text">2</sub>), 4.98 (dd, 1H, H-2', J=0.3 and 1.2 Hz), 4.61 (d, 1H, H-1', J=1.2 Hz), 4.38 (m, 2H, NH--CH<sub class="style-scope patent-text">2</sub> --Ph), 3.98 and 3.64 (2d, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.74 (m, 1H, H-5'), 3.38 (s, 3H, 4'--OCH), 3.26 (dd, 1H, H-4', J=3 and 8.1 Hz), 2.57 (t, 1H, H-1).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 51</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2-O-Benzyloxycarbonyl-6-deoxy-3-O-dimethylaminocarbonyl-4-O-methyl-.beta.-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 24 (0.500 g) in tetrahydrofuran (10 ml) was added via cannula to a solution of lithium diisopropylamide solution in tetrahydrofuran (5 ml) [prepared from duisopropylamine (0.115 ml) and 2.5M n-butyllithium in hexane (0.33 ml) at 0° C.]. Dimethylaminocarbonyl chloride (0.06 ml) was then added and the reaction mixture was stirred at 0° C. for 1 hour and then maintained at room temperature for 18 hours. The mixture was diluted with ethyl acetate (20 ml) and water (10 ml) and the organic layer was separated and dried (sodium sulfate). The solvent was evaporated in vacuo and the residue was chromatographed on a silica gel flash column eluting with hexane:ethyl acetate (2:1) to give the title compound (0.171 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.43 to 7.26 (m,15H, 3×Ph), 6.96 (s, 1H, Ph<sub class="style-scope patent-text">2</sub> CH), 5.97 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.35 (dd, 1H, H-2', J=3.0 and 4.8 Hz), 5.17 (m, 2H, PhCH<sub class="style-scope patent-text">2</sub> OCO), 4.98 (dd, 1H, H-3', J=1.5 and 4.8 Hz), 4.61 (d, 1H, H-1', J=1.8 Hz), 3.97 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.0 Hz), 3.75 (m, 1H, H-5'), 3.66 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.0 Hz), 3.36 (s, 3H, OMe), 3.25 (dd, 1H, H4', J=5.1 and 3.0 Hz), 2.93 (s, 3H, CH<sub class="style-scope patent-text">3</sub> N), 2.91 (s, 3H, CH<sub class="style-scope patent-text">3</sub> N), 2.58 (m, 1 H, H-1).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 52</heading>
    <div class="description-paragraph style-scope patent-text">(a) [1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3,6,-Trideoxy-2,3-didehydro-4-O-methyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester and</div>
    <div class="description-paragraph style-scope patent-text">(b) [1R-(1α, 3aβ, 4β, 4aβ, 7β7aα, 8aβ)] 8a-[(3,6-Dideoxy-3-iodo-4-O-methyl-β-altro and mannopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl esters</div>
    <div class="description-paragraph style-scope patent-text">Intermediate 1 (1.5 g), triphenylphosphine (2.4 g) and imidazole (640 mg) were refluxed in toluene (50 ml) with stirring and zinc (40 mg) was added. Then, iodine (1.75 g) was added in small portions. The reaction mixture was refluxed for 4 hours, cooled, decanted into 10% aqueous sodium hydrogen carbonate (50 ml) and 5% aqueous sodium thiosulfate (20 ml) and then shaken until the iodine was consumed. The toluene phase was extracted with water, dried over sodium sulfate and concentrated. The residue was purified by flash column chromatography eluting with hexane:ethyl acetate (10:1 to 6:1) to afford title compound (a) with the higher Rf as a colourless syrup (185 mg) and title compound (b) (as a mixture of 3'-iodo isomers) with the lower Rf as a pale yellow foam (375 mg).</div>
    <div class="description-paragraph style-scope patent-text">(a) δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.24-7.45 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.01-6.09 (m, 2H, H-2 and H-3'), 4.97 (dd, 1H, H-1', J=1.8 and 3.6 Hz), 3.74 and 4.00 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.64 (m, 1H, H-5'), 3.49 (m, 1H, H4'), 3.40 (s, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>).</div>
    <div class="description-paragraph style-scope patent-text">(b) δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.26-7.45 (m, 10H, 2Ph), 6.98 and 6.99 (2s, 1H, CHPh<sub class="style-scope patent-text">2</sub> of both isomers), 6.03 and 6.08 (2dd, 1H, H-2 of both isomers), 4.35 and 4.99 (2s, 1H, H-1' of each isomer), 4.75 (t, 1H, H-3' of isomer B), 4.14 (m, 1H, H-2' of isomer B), 4.06 (m, 1H, Ha-8aCH<sub class="style-scope patent-text">2</sub> of both isomers and 1H, H3' of isomer A), 3.75 (m, 1H, Hb-8aCH<sub class="style-scope patent-text">2</sub> of both isomers), 3.72 (m, 1H, H-5' of isomer B), 3.34 and 3.56 (2s, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.30 (m, 2H, H-4' and H-5' of isomer A), 2.57 (m, 1H, H4' of isomer B).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 53</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">To a degassed solution of Intermediate 52(b) (115 mg) in toluene (15 ml) under nitrogen, tributyltin hydride (0.08 ml) and azobis(isobutyronitrile) (15 mg) were added. After 1 hour under reflux, the solvent was removed in vacuo to give a syrup, which was purified by flash chromatography eluting with hexane:ethyl acetate (6:1) to yield the title compound (62 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh<sub class="style-scope patent-text">2</sub>), 6.04 (dd, 1 H, H-2, J=1.2 and 3.3 Hz), 4.32 (d, 1H, H-1', J=1.2 Hz), 3.76 and 4.08 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.87 (m, 1H, H-2'), 3.36 (s, 3H, 4'--O--CH<sub class="style-scope patent-text">3</sub>), 3.34 (m, 1H, H-5'), 3.21 (dq, 1H, H4', J=13.2 and 4.5 Hz), 2.74 (t, 1H, H-1, J=3.6 Hz), 2.38-2.45 (m, 1H, H-3'a), 2.23 (m, 2H, CHMe<sub class="style-scope patent-text">2</sub> and 2'--OH).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 54</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4b, 4aβ, 7β, 7aα, 8aβ)] 8a-(((2,3,6-Trideoxy-4-O-acetyl-3-acetylthio-β-D-allopyranosyl)oxy)methyl)-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Cesium thioacetate (1.4 mmol) was prepared in situ, by addition of cesium carbonate (494 mg) to a solution of thioacetic acid (0.1 ml) in dry methanol (5 ml). After 30 minutes, the solvent was stripped off and the crude product was dissolved in dry dimethylformamide (5 ml). The intermediate 21 (500 mg) was added to this solution, dissolved in 3 ml of dimethylformamide. The reaction mixture was stirred at room temperature for 2 days, and after this time, the solvent was evaporated in vacuo, and the crude product purified by flash column chromatography on silica gel, eluting with hexane:ethyl acetate 3:1 to give pure title compound (100 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 7.33 (m, 10H, 2Ph), 6.98 (s, 1H, CH--Ph<sub class="style-scope patent-text">2</sub>), 6.05 (d, 1 H, H-2, J=2.4 Hz), 4.75 (dd, 1H, H-1', J=8.1 and 3.9 Hz), 4.43 (dd, 1H, H-3', J=5.1 and 3.9 Hz), 4.31 (dd, 1H, H4', J=8.7 and 4.5 Hz), 3.99 (d, 1H, H-8a, J=9.3 Hz), 3.72 (dq, 1H, H-5', J=8.1 and 6.0 Hz), 3.67 (d, 1H, H-8a, J=9.3 Hz), 2.72 (t, 1H, H-1, J=3.9 Hz), 2.35 (s, 3H<sub class="style-scope patent-text">3</sub>), 2.24 (m, 1H, --CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.00 (s, 3H, CH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 55</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4b, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-)-benzoyl-2,6-dideoxy-4-O-methyl-β-allopyranosyloxy) methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Intermediate 10 (200 mg) and dimethylaminopyridine (126 mg) were solved in 20 ml of dry dichloromethane. Benzoyl chloride (146 mg) in 5 ml of dry dichloromethane was added dropwise and the reaction mixture was refluxed for 6 hours. The mixture of reaction was washed with a saturated solution of sodium bicarbonate (50 ml), water (50 ml) and brine (50 ml), dried over magnesium sulphate and evaporated to dryness. The residue was chromatographied with mixtues of hexane:ethyl acetate to give the title compound (180 mg, 78% yield) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (1H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 8.07, 7.6-7.2 (dd, m, 2H, 13H, Ph--CO+, PL2--CH), 6.99 (s, 1H, Ph<sub class="style-scope patent-text">2</sub> CH), 6.02 (dd, 1H, H-2, J-3.6 and 1.9 Hz), 5.7 (c, 1H, H-3'), 4.7 (dd, 1H, H-1'), 4.04, 3.71 (dd, 1H, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, 8bCH<sub class="style-scope patent-text">2</sub>, J=10 Hz), 3.9-3.8 (m, 1H, H-5'), 3.36 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.04 (dd, 1H, H4', J=3.6 and 7.5 Hz), 2.7 (t, 1H, H-1).</div>
    <heading class="style-scope patent-text">INTERMEDIATE 56</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4b, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-acetyl-2,6-dideoxy-4-O-methyl-β-allopyranosyloxy) methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid, diphenylmethyl ester</div>
    <div class="description-paragraph style-scope patent-text">Intermediate 10 (150 mg), acetic anhydre (0.12 ml, 120 mg) and dimethylaminopyridine (141 mg) were solved in dry dichloromethane (25 ml) and stirred overnight at room temperature under nitrogen atmosphere. The solvent was eliminated and the residue purified by flash chromatography with hexane:ethyl acetate 9:1, to give the title compound (140 mg, 85% yield) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 7.45, 7.24 (m, 10H, (Ph)<sub class="style-scope patent-text">2</sub> CH)), 6.98 (s, 1H, (Ph)<sub class="style-scope patent-text">2</sub> CH)), 6.05 (dd, 1H, H-2, J=1.8 and 2.16 Hz), 5.51 (c, 1H, H-3'), 4.55 (dd, 1H, H-1', J=0.6 and 7.2 Hz), 4.02, 3.6 (d, d, 1H, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=10.8 Hz), 3.72 (m, 1H, H-5'), 3.34 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 2.90 (dd, 1H, H4'), 2.73 (t, 1H, H-1), 2.11 (s, 3H, CH<sub class="style-scope patent-text">3</sub> CO).</div>
    <heading class="style-scope patent-text">EXAMPLE 1</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-(3-phenylprop-2(E)-enyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A solution of sordarin (1 mmol) in dry tetrahydrofuran (20 ml) under nitrogen was treated with sodium hydride (3.8 mmol). After 30 minutes, a solution of cinnamyl bromide (1.1 mmol) in dry tetrahydrofuran (5 ml) was added. The mixture was stirred for 3 days, and then diluted with ethyl acetate and washed with water. The organic phase was evaporated and the residue purified by flash chromatography eluting with dichloromethane:methanol (30:1) to give the title compound (73 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.80 (s, 1H, CHO), 7.33 (m, 5H, Ph), 6.58 (d, 1H, H-3", J=15.9 Hz), 6.31 (m, 1H, H-2"), 6.00 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.66 (d, 1H, H-1', J=1.2 Hz), 4.36 (m, 2H, CH<sub class="style-scope patent-text">2</sub> --1"), 4.24 and 3.47 (d,d 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 4.17 (t, 1H, H-3', J=3.9 Hz), 3.68 (m, 1H, H-2'), 3.65 (m, 1H, H-5'), 3.19 (dd, 1H, H4', J=3.3 and 9.3 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 175.1 (CO<sub class="style-scope patent-text">2</sub> H), 148.3 (C-3), 136.6, 133.0, 128.6, 128.5, 127.7, 126.5 and 126.2 (Ph, C-2" and C-3"), 130.4 (C-2), 98.8 (C-1'), 80.0 (C-4'), 75.8 (C-5'), 74.3 (8a-CH<sub class="style-scope patent-text">2</sub>), 73.3 (C-3a), 73.0 (C-2"), 68.5 (C-3'), 66.5 (C-2').</div>
    <heading class="style-scope patent-text">EXAMPLE 2</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-Benzyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 2 (0.3mmol) in water (3 ml) at 0° C. was treated with trifluoroacetic acid (7 ml). The mixture was stirred for 30 minutes and then poured into water:ether (1:1; 50 ml). The organic phase was evaporated and the residue purified by flash chromatography using dichloromethane:methanol (20:1) as eluent to give the title compound (115 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.81 (s, 1H, CHO), 7.36 (m, 5H, Ph), 6.03 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 4.86 and 4.59 (AB system, 1H, 1H, CH<sub class="style-scope patent-text">2</sub> Ph, J=12.6 Hz), 4.66 (d, 1H, H-1', J=0.9 Hz), 4.21 and 3.50 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 4.05 (t, 1H, H-3', J=3.6 Hz), 3.65 (m, 2H, H-2' and H-5'), 3.19 (dd, 1H, H-4', J=3.3 and 9.3 Hz), 2.57 (t, 1H, H-1, J=3.6 Hz), 2.32 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 175.1 (CO<sub class="style-scope patent-text">2</sub> H), 148.4 (C-3), 138.2 (Cipso), 130.3 (C-2), 128.2, 127.9, 127.6 (Ph), 98.7 (C-1'), 79.8 (C-4'), 75.8 (C-5'), 74.3 and 74.1 (8a-CH<sub class="style-scope patent-text">2</sub> and CH<sub class="style-scope patent-text">2</sub> Ph), 65.6 (C-8a), 66.3 (C-3'), 65.3 (C-2'), 57.3 (OCH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 3</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-hexyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 3 (0.14 mmol) in methanol (20 ml) was added 10% palladium on charcoal (20 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 6 psi of hydrogen for 30 minutes at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash chromatography using dichloromethane:methanol (25:1) as eluent to give the title compound (64 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.83 (s, 1H, CHO), 6.03 (d, 1H, H-2, J=3 Hz), 4.64 (d, 1H, H-1', J=1.2 H), 4.28 and 3.41 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 4.14 (t, 1H, H-3', J=3.6 Hz), 3.64 (m, 2H, H-2' and H-5'), 3.52 (m, 2H, OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub>), 3.15 (dd, 1H, H4', J=3 and 9.3 Hz), 2.52 (m, 1H, H-1), 2.31 (m, 11H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 174.3 (CO<sub class="style-scope patent-text">2</sub> H), 148.7 (C-3), 130.2 (C-2), 98.4 (C-1'), 80.0 (C-4'), 76.9 (C-5'), 73.9 (8a-CH<sub class="style-scope patent-text">2</sub>), 72.9 (OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub>), 68.5 (C-3'), 66.3 (C-2'), 65.0 (C-8a), 59.0 (OCH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 4</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-2,3,4-tri-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 4 (0.26 mmol) in methanol (20ml) was added 10% palladium on charcoal (20 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 8 psi of hydrogen for 30 minutes at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash chromatography using dichloromethane:methanol (20:1) as eluent to give the title compound (98 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.85 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.60 (d, 1H, H-1', J=1.5 Hz), 4.33 (d, 1H, 8a-CHa, J=9.3 Hz), 3.71 (m, 2H, H-2', and H-3'), 3.52 (s, 3H, 2'--OCH<sub class="style-scope patent-text">3</sub>), 3.50 (s, 3H, 3'--OCH<sub class="style-scope patent-text">3</sub>), 3.41 (m, 5H, 4'--OCH<sub class="style-scope patent-text">3</sub>, H-5' and 8a-CHb), 3.16 (dd, 1H, H-4', J=3 and 9.3 Hz), 2.50 (t, 1H, H-1, J=3.9 Hz), 2.32 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 5</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-3,4-O-dimethyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Sodium hydride (24 mg) was added portionwise to a solution of Intermediate 10 (150 mg) in anhydrous tetrahydrofuran (3 ml) under nitrogen atmosphere at 0° C. The resulting suspension was stirred for 15 minutes and methyl iodide (125 μl) was added. After 2 hours of stirring 1N ammonium chloride (10 ml) and ethyl acetate (20 ml) were added. The aqueous phase was extracted with ethyl acetate (2×20 ml) and the organic phase was washed with brine, dried (magnesium sulphate) and evaporated to dryness. The residue was dissolved in ethyl acetate (10 ml) and 10% palladium on charcoal (100 mg) was added. The mixture was stirred under 30 psi of hydrogen for 45 minutes. The catalyst was filtered off and the residue flash chromatographed eluting with dichloromethane:methanol (30:1) to obtain the title compound (78 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.86 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.65 (dd, 1 H, H-1', J=1.8 and 9.6 Hz), 4.41 (d, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.83-3.70 (m, 2H, H-3' and H-4'), 3.44 (s, 3H, CH<sub class="style-scope patent-text">3</sub> O), 3.39 (s, 3H, CH<sub class="style-scope patent-text">3</sub> O), 3.30 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 2.85 (dd, 1H, H-4', J=3.9 and 9.3 Hz), 2.45 (t, 1H, H-1, J=3.6 Hz); δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 173.8 (CO<sub class="style-scope patent-text">2</sub> H), 184.4 (C-3), 130.5 (C-2), 97.5 (C-1'), 82.4 (C-4'), 73.3 (8aCH<sub class="style-scope patent-text">2</sub>), 73.0 (C-3'), 69.5 (C-5'), 65.0 (C8a), 59.0 (C-4), 57.8 (CH<sub class="style-scope patent-text">3</sub> O), 57.1 (CH<sub class="style-scope patent-text">3</sub> O).</div>
    <heading class="style-scope patent-text">EXAMPLE 6</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-3-O-ethyl-4-O-methyl-62-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Sodium hydride (24 mg) was added portionwise to a solution of Intermediate 10 in anhydrous tetrahydrofuran under nitrogen atmosphere at 0° C. The resulting suspension was stirred for 15 minutes and ethyl iodide (160 μl) was added. After 2 hours of stirring 1N ammonium chloride (10 ml) and ethyl acetate (20 ml) were added. The aqueous phase was extracted with ethyl acetate (2×20 ml) and the organic phase was washed with brine, dried (magnesium sulphate) and evaporated to dryness. The residue was dissolved in ethyl acetate (10 ml) and 10% palladium on charcoal (100 mg) was added. The mixture was stirred under 30 psi of hydrogen for 45 minutes. The catalyst was filtered off and the residue flash chromatographed eluting with dichloromethane:methanol (30:1) to obtain the title compound (57 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.88 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.69 (dd, 1H, H-1', J=2.1 and 9.6 Hz), 4.46 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.93-3.90 (m, 1H, H-3'), 3.81 (dq, 1H, H4', J<sub class="style-scope patent-text">d</sub> =9.6 Hz, J<sub class="style-scope patent-text">q</sub> =6.6 Hz), 3.61 (t, 2H, 3'--O--CH<sub class="style-scope patent-text">2</sub>, J=7.2 Hz), 3.75 (s, 3H, 4--O--CH<sub class="style-scope patent-text">3</sub>), 3.29 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 2.84 (dd, 1H, H4', J=3.3 and 9.6 Hz), 2.43 (t, 1H, H-1, J=3.9 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 173.6 (CO<sub class="style-scope patent-text">2</sub> H), 148.5 (C-3), 130.4 (C-2), 97.7 (C-1'), 82.5 (C-4'), 74.9 (C3a), 73.1 (8aCH<sub class="style-scope patent-text">2</sub>), 70.9 (C-3'), 69.4 (C-4'), 65.4 (C8a), 64.9 (3'--O--CH<sub class="style-scope patent-text">2</sub>), 59.0 (C-4), 57.1 (4'--O--CH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 7</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-4-O-3-O-propyl-β-D-alopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Sodium hydride (24 mg) was added portionwise to a solution of Intermediate 10 (142 mg) in anhydrous tetrahydrofuran (5 ml) under nitrogen atmosphere at 0° C. The resulting suspension was stirred for 15 minutes and allyl bromide (173 μl) was added. After 2 hours of stirring 1N ammonium chloride (10 ml) and ethyl acetate (20 ml) were added. The aqueous phase was extracted with ethyl acetate (2×20 ml) and the organic phase was washed with brine, dried (magnesium sulphate) and evaporated to dryness. The residue was dissolved in ethyl acetate (10 ml) and 10% palladium on charcoal (100 mg) was added. The mixture was stirred under 30 psi of hydrogen for 45 minutes. The catalyst was filtered off and the residue flash chromatographed eluting with dichloromethane:methanol (30:1) to obtain the title compound (90 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.87 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.68 (dd, 1H, H-1', J=2.1 and 9.6 Hz), 4.44 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 3.93-3.85 (m, 1H, H-3'), 3.81 (dq, 1H, H-5', J<sub class="style-scope patent-text">d</sub> =9.3 Hz and J<sub class="style-scope patent-text">q</sub> =6.3 Hz), 3.49 (t, 2H, 3'--O--CH<sub class="style-scope patent-text">2</sub>, J=6.6 Hz), 3.70 (s, 3H, 4'--O--CH<sub class="style-scope patent-text">3</sub>), 3.29 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 2.84 (dd, 1H, H4', J=2.7 and 9.3 Hz), 2.43 (t, 1H, H-1, J=4.2 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 173.6 (CO<sub class="style-scope patent-text">2</sub> H), 148.5 (C-3), 130.4 (C-2), 97.8 (C-1'), 82.6 (C4'), 74.8 (C3a), 73.2 (8a-CH<sub class="style-scope patent-text">2</sub>), 71.8 (3'--O--CH<sub class="style-scope patent-text">2</sub>), 71.0 (C-3'), 69.4 (C-5'), 65.0 (C-8a), 59.0 (C-4), 57.0 (4--O--CH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 8</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-4-O-methyl-3-O-methyloxymethyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 11 (180 mg) in ethyl acetate (20 ml) was added 10% palladium on charcoal (100 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 20 psi of hydrogen for 40 minutes at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash column chromatography on silica gel eluting with methylene chloride:methanol (20:1) to give the title compound (100 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.83 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.72 (AB system, 2H, OCH<sub class="style-scope patent-text">2</sub> OCH<sub class="style-scope patent-text">3</sub>, J<sub class="style-scope patent-text">AB</sub> =6.9 Hz), 4.68 (dd, 1H, H-1', J=2.1 and 9 Hz), 4.33 and 3.36 (2d, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 4.21 (m, 1H, H-3'), 3.79 (m, 1H, H-5'), 3.39 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.38 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 2.84 (dd, 1H H4', J=2.7 and 9.3 Hz), 2.49 (t, 1H, H-1); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 173.8 (COOH), 148.4 (C-3), 130.4 (C-2), 97.8 (C-1'), 95.9 (OCH<sub class="style-scope patent-text">2</sub> OCH<sub class="style-scope patent-text">3</sub>), 82.4 (C4'), 73.3 (8a-CH<sub class="style-scope patent-text">2</sub>), 69.2 (C-3'), 68.8 (C-5'), 65.0 (C-8a), 57.3 (OCH<sub class="style-scope patent-text">2</sub> OCH<sub class="style-scope patent-text">3</sub>), 55.5 (C-7), 47.2 (C-1), 41.6 (C4), 35.8 (C-2'), 18.0 (C6').</div>
    <heading class="style-scope patent-text">EXAMPLE 9</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-3-O-methyl-4-O-propyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of the 3-O-methyl compound from Intermediate 10 (120 mg) in dry tetrahydrofuran (20 ml) at 0√ C. was added sodium hydride (9 mg). The suspension was stirred for 0.5 hours and allyl bromide (10 equivalents) and a catalytic amount of tetrabutylammonium iodide were added. The mixture was stirred for 2 days at room temperature. The reaction was quenched with 1N ammonium chloride and the mixture extracted with ethyl acetate. The organic layer was concentrated to 15 ml and 10% palladium on charcoal was added (100 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 15 psi of hydrogen for 30 minutes at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash column chromatography on silica gel eluting with methylene chloride:methanol (20:1) to give the title compound (60 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.86 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=0.9 and 3.0 Hz), 4.65 (dd, 1H, H-1, J=2.1 and 9.9 Hz), 4.42 and 3.80 (2d, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 3.76 (m, 1H, H-3'), 3.60-3.50 (m, 1H, H5'), 3.45 (s, 3H, OCH3), 3.38 -3.27 (m, 2H, OCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">3</sub>), 2.93 (dd, 1H, H-4', J=2.8 and 9.6 Hz), 2.44 (t, 1H, H-1); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 173.2 (COOH), 148.5 (C-3), 130.3 (C-2), 97.5 (C-1'), 81.2 (C-4'), 73.8 (C-3'), 69.4 (C-5'), 64.9 (C-8a), 34.4 (C-2), 18.0 (C-6').</div>
    <heading class="style-scope patent-text">EXAMPLE 10</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-Azido-3,6-dideoxy-4-O-methylβ-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 16 (0.29 mmol) in water (4 ml) at 0° C. was treated with trifluoroacetic acid (6 ml). After 90 minutes, the mixture was poured into ether:water (1:1; 50 ml). The organic phase was evaporated and the residue purified by flash column chromatography using dichloromethane:methanol (50:1) as eluent to give the title compound (98 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.68 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J-=1.2 and 3.3 Hz), 4.52 (d, 1H, H1', J=1.2 Hz), 4.18 (t, 1H, H-2', J=4.2 Hz), 4.02 and 3.65 (m,m, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>), 3.78 (m, 2H, H-3' and H-5'), 3.46 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.37 (dd, 1H, H4', J=3.3 and 8.7 Hz), 2.67 (sbr, 1H, OH), 2.34 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.9 (CHO), 130.5 (C-2), 97.8 (C-1'), 79.8, 69.7, 69.4 and 59.2 (C-2', C-3', C-4' and C-5'), 74.4 (8a-CH<sub class="style-scope patent-text">2</sub>), 65.6 (C-8a).</div>
    <heading class="style-scope patent-text">EXAMPLE 11</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-4-O-methyl-3-methylthio-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 17 (0.2 mmol) in water (4 ml) at 0° C. was treated with trifluoroacetic acid (6 ml). After 90 minutes, the mixture was poured into ether:water (1:1; 50 ml). The organic phase was evaporated and the residue purified by flash column chromatography using dichloromethane:methanol (50:1) as eluent to give the title compound (68 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.73 (s, 1H, CHO), 6.08 (dd,1H, H-2, J=1.2 and 3.3 Hz), 4.74 (d, 1H, H-1', J=1.5 Hz), 4.09 and 3.64 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 3.96 ((dd, 1H, H-2', J=1.2 and 4.2 Hz), 3.72 (m, 1H, H-5'), 3.45 (dd, 1 H, H-4', J=4.2 and 8.1 Hz), 3.40 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.33 (t, 1H, H-3', J=4.2 Hz), 2.66 (t, 1H, H-1, J=3.9 Hz), 2.34 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 176.6 (CO<sub class="style-scope patent-text">2</sub> H), 148.2 (C-3), 130.7 (C-2), 97.8 (C-1'), 79.5, 70.9, 70.4 and 57.4 (C-2', C-3', C4' and C-5'), 74.0 (8a-CH<sub class="style-scope patent-text">2</sub>), 72.3 (C-3a), 65.6 (C-8a), 58.8 (C-4).</div>
    <heading class="style-scope patent-text">EXAMPLE 12</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-Azido-3,6-dideoxy-4-O-methyl-β-D-glucopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 18 (0.37 mmol) in water (4 ml) at 0° C. was treated with trifluoroacetic acid (6 ml). After 90 minutes, the mixture was poured into ether:water (1:1; 50 ml). The organic phase was evaporated and the residue purified by flash column chromatography using dichloromethane:methanol (50:1) as eluent to give the title compound (119 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 6.04 (dd, 1H,H-2, J=1.2 and 3.3 Hz), 4.07 (d, 1H, H-1', J=7.5 Hz), 3.99 and 3.66 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 3.55 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.30 (m, 3H, H-2', H-3' and H-5'), 2.71 (m, 3H, H4', H-1 and 2'--OH), 2.31 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.9 (CHO), 174.3 (CO<sub class="style-scope patent-text">2</sub> H), 148.6 (C-3), 130.3 (C-2), 102.7 (C-1') 84.2, 72.9, 72.2 and 67.7 (C-2', C-3', C4' and C-5'), 75.2 (8a-CH<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 13</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-4-O-methyl-3-methylthio-β-D-glucopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 19 (0.17 mmol) in water (4 ml) at 0° C. was treated with trifluoroacetic acid (6 ml). After 90 minutes, the mixture was poured into ether:water (1:1; 50 ml). The organic phase was evaporated and the residue purified by flash column chromatography using dichloromethane:methanol (50:1) as eluent to give the title compound (69 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.14 (m, 2H, H-1' and 8a-CHa), 3.62 (m, 4H, 8a-CHb and OCH<sub class="style-scope patent-text">3</sub>), 3.33 (m, 1H, H-5'), 3.24 (dd, 1H, H-2', J=7.5 and 10.8 Hz), 2.80 (dd, 1H, H4, J=9 and 10.2 Hz), 2.71 (t, 1H, H-1, J=3.6 Hz), 2.48 (t, 1H, H-3', J=10.5 Hz), 2.33 (m, 1H1, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.20 (s, 3H, SCH<sub class="style-scope patent-text">3</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 175.8 (CO<sub class="style-scope patent-text">2</sub> H), 148.3 (C-3), 130.7 (C-2), 103.7 (C-1'), 83.2 (OCH<sub class="style-scope patent-text">3</sub>), 74.7 (C-3a), 74.3, 70.9, 60.8 and 55.3 (C-2', C-3', C4' and C-5'), 73.0 (8a-CH<sub class="style-scope patent-text">2</sub>), 65.6 (C-8a), 59.0 (C-4).</div>
    <heading class="style-scope patent-text">EXAMPLE 14</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-Acetylamino-3,6-dideoxy-4-O-methyl-β-D-glucopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 20 (0.26 mmol) and sodium methoxide (0.6 mmol) in dry methanol (3 ml) was stirred for 90 minutes at room temperature. The solvent was evaporated and the residue purified by flash chromatography using dichloromethane:methanol (13:1) as eluent to give the title compound (75 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (hu 1H, CDCl<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 6.09 (m, 2H, H-2 and NH), 4.17 (d, 1H, H-1', J=7.5 Hz), 4.13 (t, 1H, H-3', J=7.2 Hz), 3.87 (m, 1H, H-2'), 3.60 (d, 1H, 8a-CHa, J=9.6 Hz), 3.40 (m, 5H, H-5', 8a-CHb and OCH<sub class="style-scope patent-text">3</sub>), 2.96 (t, 1H, H4', J=9.6 Hz), 2.68 (t, 1H, H-1, J=3.9 Hz), 2.32 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 2.07 (s, 3H, CH<sub class="style-scope patent-text">3</sub> CO); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 174.9 (CO<sub class="style-scope patent-text">2</sub> H), 172.5 (CO<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">3</sub>), 148.3 (C-3), 130.7 (C-2), 103.6 (C-1'), 82.0 (OCH<sub class="style-scope patent-text">3</sub>), 74.8 (8a-CH<sub class="style-scope patent-text">2</sub>), 73.5, 72.0, 58.8 and 56.7 (C-2', C-3', C-4' and C-5'), 73.2 (C-3a), 65.0 (C-8a), 58.9 (C-4).</div>
    <heading class="style-scope patent-text">EXAMPLE 15</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-Azido-4-O-methyl-2,3,6-trideoxy-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Trifluoroacetic acid (0.1 ml) was added to Intermediate 23 (120 mg) in dichloromethane (10 ml) at 0° C. After being stirred for 40 minutes the mixture was quenched with a 5% aqueous sodium hydrogen carbonate solution to pH7. The organic phase was dried and concentrated to give an oil, which was purified by flash column chromatography eluting with hexane:ethyl acetate (10:1) and dichloromethane:methanol (20:1) afforded the title compound (68 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.80 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 4.55 (dd, 1H, H-1', J=1.8 and 9.3 Hz), 3.41 and 4.22 (m and d, 3H, 8aCH<sub class="style-scope patent-text">2</sub> and H-3'), 3.75 (dq, 1H, H-5', J=6.3 and 9 Hz), 3.44 (s, 3H, 4'--OMe), 3.00 (dd, 1H, H4', J=3 and 9 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 174 (CO<sub class="style-scope patent-text">2</sub> H), 148 (C-3), 130.6 (C-2), 97.3 (C-1'), 82.6 (C4'), 69.3 (C-5'), 59.1 (C-3'), 57.6 (4'O--CH<sub class="style-scope patent-text">3</sub>), 35.2 (C-2'), 17.9 (C-6').</div>
    <heading class="style-scope patent-text">EXAMPLE 16</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-(2-tetrahydropyranl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 25 (0.300 g) in ethyl acetate (20 ml) was added 10% palladium on charcoal (26 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 20 psi of hydrogen for 2 hours at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified on a silica gel flash column eluting with 5% dichloromethane in methanol to afford the title compound (0.027 g) as a 3:2 mixture of diastereomers.</div>
    <div class="description-paragraph style-scope patent-text">δ (1H, CDCl<sub class="style-scope patent-text">3</sub>) only major diastereomer: 9.75 (s, 1H, CHO), 6.07 (m, 1H, H-1"), 4.74 (m, 1H, H-2), 4.55 (m, 1H, H-1'); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 206.6 (CHO), 175.9 (CO<sub class="style-scope patent-text">2</sub> H), 150.1 (C-3), 131.6 (C-2), 102.1, 100.5 (C-1"), 98.6 (C-1'), 81.3, 80.6 (C-3', C-4'), 76.4, 76.1 (8aCH<sub class="style-scope patent-text">2</sub>, C-6).</div>
    <heading class="style-scope patent-text">EXAMPLE 17</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3,6-Trideoxy-2,3-difluoro-4-O-methyl-β-D-glucopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 26 (95 mg) in ethyl acetate (25 ml) was added 10% palladium on charcoal (120 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 20 psi of hydrogen for 2 hours. The catalyst was filtered off and a mixture of 2N hydrochloric acid (1 ml) and methanol (5 ml) was added to the filtrate. The mixture was stirred at room temperature for 6 hours and then neutralized with a 5% aqueous sodium hydrogen carbonate solution. The solvent was evaporated to dryness and the residue was flash chromatographed on silica gel eluting with dichloromethane:methanol (20:1) to give the title compound (42 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.69 (s, 1H, CHO), 5.87 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 4.58-4.70 and 4.41-4.52 (2m, 1H, H-2', J<sub class="style-scope patent-text">FH</sub> =52.8 and 17.1 Hz, J<sub class="style-scope patent-text">HH</sub> =8.4 Hz), 4.25 (d, 1H, H-1', J=9 Hz), 4.30-4.40 and 4.10-4.23 (2m, 1H, H-3', J<sub class="style-scope patent-text">FH</sub> =52.5 and 14.1 Hz, J<sub class="style-scope patent-text">HH</sub> =7.8 and 8.1 Hz), 3.69 and 4.01 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.55 (s, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.21-3.31 (m, 1H, H-5'), 2.97-3.07 (dq, 1H, H-4', J<sub class="style-scope patent-text">FH</sub> =13.2 Hz, J<sub class="style-scope patent-text">HH</sub> =8.4 and 8.7 Hz), 2.81 (t, 1H, H-1); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 177.1 (CO<sub class="style-scope patent-text">2</sub>), 147.9 (C-3), 131.2 (C-2), 100.0 (dd, C-1', J<sub class="style-scope patent-text">CF</sub> =11 and 22 Hz), 96.7 and 97.3 (dd, C-2', J<sub class="style-scope patent-text">CF</sub> =18 and 185 Hz), 91.5 and 89.1 (dd, C-3', J<sub class="style-scope patent-text">CF</sub> =18 and 189 Hz), 83.0 (dd, C-4', J<sub class="style-scope patent-text">CF</sub> =6 and 16 Hz), 75.4 (8aCH<sub class="style-scope patent-text">2</sub>), 72.1 (C-8a), 70.0 (d, C-5', J<sub class="style-scope patent-text">CF</sub> =9 Hz), 65.8 (C-3a), 60.6 (4'OMe), 58.4 (C-4).</div>
    <heading class="style-scope patent-text">EXAMPLE 18</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3,6-Trideoxy-4-O-methyl-3-oxo-β-D-glucopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 27 (0.17 mmol) in ethyl acetate (20 ml) was added 10% palladium on charcoal (50 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 20 psi of hydrogen for 1 hour at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash chromatography using dichloromethane:methanol (20:1) as eluent to give the title compound (63 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.48 (dd, 1H, H-1', J=2.7 and 9 Hz), 4.05 and 3.62 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.43 (m, 2H, H-4' and H-5'), 2.65 (m, 3H, CH<sub class="style-scope patent-text">2</sub> --2' and H-1), 2.32 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>), 1.42 (d, 3H, CH<sub class="style-scope patent-text">3</sub> --6', J=5.7 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 204.0 (CO-3'), 176.6 (CO<sub class="style-scope patent-text">2</sub> H), 148.2 (C-3), 130.8 (C-2), 100.3 (C-1'), 87.0 (C-4'), 74.6 (8a-CH<sub class="style-scope patent-text">2</sub>), 71.4 (C-5'), 48,4 (C-2').</div>
    <heading class="style-scope patent-text">EXAMPLE 19</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-4-O-methyl-3-oxo-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a suspension of 10% palladium on charcoal (100 mg) in ethyl acetate (10 ml) was added a solution of Intermediate 28 (141 mg) in ethyl acetate (5 ml) and the mixture was hydrogenated at room temperature under 30 psi of hydrogen for 45 minutes. The catalyst was filtered off and the solvent evaporated to dryness. The residue was flash chromatographed on silica gel eluting with dichloromethane and dichloromethane:methanol (30:1) to obtain the title compound (83 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 6.11 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.16-4.11 (m, 2H, H-1, H-2'), 3.55 (s, 3H, 4'--O--CH<sub class="style-scope patent-text">3</sub>), 3.57 (dd, 1H, H4', J=1.5 and 9.6 Hz), 3.40 (dq, 1 H, H4', J<sub class="style-scope patent-text">d</sub> =9.6 Hz, J<sub class="style-scope patent-text">q</sub> =6.0 Hz), 2.82 (t, 1H, H-1, J=3.4 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 205.0 (CHO), 204.6 (C-3'), 175.6 (CO<sub class="style-scope patent-text">2</sub> H), 148.0 (C-3), 131.2 (C-2), 104.8 (C-1'), 86.1 (C4'), 75.3 (8aCH<sub class="style-scope patent-text">2</sub>), 72.3 (C3a), 71.7 (C-5'), 65.4 (C8a), 59.6 (CH<sub class="style-scope patent-text">3</sub> O).</div>
    <heading class="style-scope patent-text">EXAMPLE 20</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-Dideoxy-4-O-methyl-3-propyloxyimino-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Intermediate 31 (180 mg) was dissolved in ethyl acetate (15 ml) and 10% palladium on charcoal (100 mg) was added. The mixture was stirred under 30 psi of hydrogen atmosphere for 3 hours. The catalyst was filtered off and the solvent evaporated to dryness. The residue was dissolved in tetrahydrofuran (5 ml) and 1N hydrochloric acid (3 ml) was added. The mixture was stirred for 4 hours at room temperature, diluted with water and extracted with ethyl acetate (3×25 ml). The organic phase was washed with brine, dried (magnesium sulphate) and evaporated to dryness. The residue was flash chromatographed on silica gel eluting with dichloromethane and dichloromethane:methanol (30:1) to obtain the title compound (107 mg) as a mixture of Z:E isomers in a 3:1 ratio.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>) peaks of the major component: 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 4.79 (d, 1H, H-1', J=5.1 Hz), 4.59 (dd, 1H, H-2', J=0.6 and 5.1 Hz), 4.17-4.08 (m, 5H, OCH<sub class="style-scope patent-text">2</sub>, H-4', H-5', 8aCH<sub class="style-scope patent-text">2</sub>), 3.55 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.33 (s, 3H, 4--O--CH<sub class="style-scope patent-text">3</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>) peaks of the major component: 204.6 (CHO), 175.9 (CO<sub class="style-scope patent-text">2</sub> H), 151.1 (C=N), 148.0 (C-3), 130.9 (C-2), 101.9 (C-1), 81.6 (C-4'), 76.3, 76.0 (C3a), 74.9 (C-5'), 74.2 (8aCH<sub class="style-scope patent-text">2</sub>), 65.8 (NOCH<sub class="style-scope patent-text">2</sub>), 65.7 (C8a), 59.0 (CH<sub class="style-scope patent-text">3</sub> O).</div>
    <heading class="style-scope patent-text">EXAMPLE 21</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-Benzoyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a-(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 32 (250 mg) in methanol (30 ml), was added 10% palladium on charcoal (120 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 10 psi of hydrogen for 1.5 hours at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash chromatography eluting with hexane:ethyl acetate (4:1) and dichloromethane:methanol (15:1) to give the title compound (140 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 8.04 and 7.61-7.43 (2m, 2H and 3H, Ph), 6.05 (dd, 1H, H-2, J=3.3 and 1.2 Hz), 5.72 (dd, 1H, H-3', J=3 and 0.9 Hz), 4.71 (s, 1H, H-1'), 3.72 and 4.06 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.87-3.94 (m, 2H, H-2' and H-5'), 3.38 (s, 3H, 4'--OMe), 3.41 (m, 1H, H-4'), 2.73 (t, 1H, H-1, J=3.9 Hz.); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.8 (CHO), 175.8 (CO<sub class="style-scope patent-text">2</sub> H), 165.3 (CO<sub class="style-scope patent-text">2</sub> of 3'OBz), 148.2 (C-3), 133.3, 129.6 and 128.4 (CH of Ph), 130.8 (C-2), 129.8 (quartemary of PH), 98.3 (C-1'), 78.3 (C4'), 74.3 (8aCH<sub class="style-scope patent-text">2</sub>), 72.2 (C-3a), 69.8 (C-3'), 69.2 (C-5'), 68.0 (C-2'), 65.6 (C-8a), 58.9 (4'--OMe), 57.7 (C4), 46.1 (C-1).</div>
    <heading class="style-scope patent-text">EXAMPLE 22</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-Benzyloxycarbonyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a,-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A stirred solution of Intermediate 33 (0.4 mmol) in water (4 ml) at 0° C. was treated with trifluoroacetic acid (6 ml). After 30 minutes, the solution was poured into water:ether (1:1;50 ml). The organic phase was evaporated and the residue purified by flash column chromatography using hexane:ethyl acetate (1:2) as eluent to give the title compound (143 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.69 (s, 1H, CHO), 7.37 (m, 5H, Ph), 6.04 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.32 (t, 1H, H-3', J=3.3 Hz), 5.21 and 5.14 (AB sistem, 1H, 1H, CH<sub class="style-scope patent-text">2</sub> Ph, J=11.7 Hz), 4.62 (d, 1H, H-1', J=0.9 Hz), 4.03 and 3.65 (d,d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.87 (d, 1H, H-2', J=4.5 Hz), 3.74 (m, 1H, H-5'), 3.28 (dd, 1H, H4', J=3 and 9 Hz), 2.67 (sbr, 1H, H-1), 2.33 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.9 (CHO), 154.4 (CO3), 134.9 (Cipso), 130.6 (C-2), 128.64, 128.60 and 128.41 (Ar), 98.0 (C-1'), 78.2 (C-4'), 74.3 (8a-CH<sub class="style-scope patent-text">2</sub>), 71.5 (C-5'), 70.0 (OCH<sub class="style-scope patent-text">2</sub> Ph), 69.3 (C-2'), 69.0 (C-3').</div>
    <heading class="style-scope patent-text">EXAMPLE 23</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-butoxyacetyl-4-O-methyl-β-D-altropyranosyl-oxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 35 (300 mg) in ethanol (50 ml) was added 10% palladium on charcoal (220 mg) under nitrogen. The mixture was shaken in Parr apparatus under 15 psi of hydrogen for 1 hour at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash column chromatography eluting with hexane:ethyl acetate (1:1) and dichloromethane:methanol (10:1) to yield the title compound (160 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 6.07 (d, 1H, H-2, J=3.3 Hz), 5.55 (dd, 1H, H-3', J=4.2 and 3.3 Hz) 4.57 (d, 1H, H-1', J=0.6 Hz), 4.12 (AB system, 2H, OCH<sub class="style-scope patent-text">2</sub> CO<sub class="style-scope patent-text">2</sub>, J=12 Hz), 3.68 and 4.01 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.80 (d, 1H, H-2', J=3.9 Hz), 3.68 (m, 1H, H-5'), 3.53 (t, 2H, CH<sub class="style-scope patent-text">2</sub> O, J=6.6 Hz), 3.35 (s, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.24 (dd, 1H, H-4', J=9 and 3 Hz), 2.70 (m, 1H, H-1); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.6 (CHO), 176.4 (CO<sub class="style-scope patent-text">2</sub> H), 169.6 (3'--CO<sub class="style-scope patent-text">2</sub>), 148.2 (C-3), 130.7 (C-2), 98.1 (C-1'), 78.2 (C-4'), 74.2 (8aCH<sub class="style-scope patent-text">2</sub>), 72.1 (C-3a), 71.7 (OCH<sub class="style-scope patent-text">2</sub> CO<sub class="style-scope patent-text">2</sub>), 69.5 (C-5'), 69.0 (C-3'), 68.0 (CH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">2</sub> O), 67.9 (C-2'), 65.6 (C-8a); 58.8 (C-4), 57.7 (4'--OCH<sub class="style-scope patent-text">3</sub>), 46.1 (C-1).</div>
    <heading class="style-scope patent-text">EXAMPLE 24</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ,)] 8a-[(6-Deoxy-4-O-methyl-3'-O-octanoyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 36 (400 mg) in methanol (75 ml) was added 10% palladium on charcoal (275 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 15 psi of hydrogen for 1.5 hours at room temperature. The catalyst was filtered and the solvent evaporated to dryness. The residue was purified by flash chromatography on silica gel eluting with dichloromethane:methanol (20:1). The appropriate fractions were combined and the solvent removed to give the title compound (200 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.68 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.48 (dd, 1H, H-3', J=3 and 4.5 Hz), 4.57 (d, 1H, H-1', J=1.5 Hz), 4.02 (d, 1H, H-8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.72 (m, 3H, H-5', H-2' and H-8aCH<sub class="style-scope patent-text">2</sub>), 3.28 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.26 (dd, 1H, H-4', J=3 and 9 Hz), 2.68 (t, 1H, H-1, J=3.3 Hz), 2.36 (m, 3H, H-14 and CH<sub class="style-scope patent-text">2</sub> CO), 1.36-1.22 (m, 13H, 5CH<sub class="style-scope patent-text">2</sub> and 6'CH<sub class="style-scope patent-text">3</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 205.0 (CHO), 177.1 (COOH), 172.6 (COOR), 148.5 (C-3), 130.5 (C-2), 98.4 (C-1'), 78.2 (C-4'), 74.5 (C8aCH<sub class="style-scope patent-text">2</sub>), 69.6 (C-2'), 69.2 (C-3'), 67.2 (C-5'), 65.6 (CH<sub class="style-scope patent-text">2</sub> CO), 57.6 (OCH<sub class="style-scope patent-text">3</sub>), 34.2, 28.8, 24.9, 22.5 (5CH<sub class="style-scope patent-text">2</sub>), 18.1 (C-6'), 14.0 (CH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 25</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-(2-methylhexanoyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A solution of α-methylhexanoic acid (0.133 ml) and triethylamine (0.313 ml) was added to a solution of Intermediate 24 (0.371 g) and 2-chloro-1-methyl pyridinium iodide (0.267 g). The mixture was refluxed for 2 hours. After cooling, the solvent was evaporated and the residue was chromatographed on a silica gel column eluting with hexane:ethyl acetate (5:1) to afford the 3'-O-acyl derivative (0.43 g), which was dissolved in ethyl acetate (20 ml) and hydrogenated in a Parr apparatus using 10% palladium on charcoal (100 mg). After filtering off the palladium catalyst the solvent was removed and the residue was chromatographed on a silica gel flash column eluting with 5% dichloromethane:methanol to give the title compound (0.235 g) as a 1:1 mixture of diastereoisomers.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.70 (s, 1H, CHO), 6.05 (m, 1H, H-2), 5.47 (m, 1H, H-3'), 4.56 (brs, 1H, H-1'), 4.01 (brd, 1H, 8aCH<sub class="style-scope patent-text">2</sub>), 3.73 (m, 3H, H-2', 5' and 8aCH<sub class="style-scope patent-text">2</sub>), 3.32 (1, 3H, OMe), 3.26 (m, 1H, H4'), 2.70 (m, 1H, H-1), 2.05 (sext., 1H, CHCO<sub class="style-scope patent-text">2</sub>), δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 176.9 and 175.6 (CO<sub class="style-scope patent-text">2</sub> H and CO<sub class="style-scope patent-text">2</sub> C), 148.4 (C-3), 130.5 (C-2), 98.4 (C-1'), 78.1 (C4), 74.5 (8aCH<sub class="style-scope patent-text">2</sub>), 72.4 (C-3a), 69.7, 69.3 and 66.9 (C-2', C-3' and C-5'), 65.6 (C-8a), 58.8 (C4).</div>
    <heading class="style-scope patent-text">EXAMPLE 26</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-methoxyacetyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 37 (200 mg) in ethanol (30 ml) was added 10% palladium on charcoal (170 mg) under nitrogen. The mixture was shaken in Parr apparatus under 15 psi of hydrogen for 1 hour at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash column chromatography eluting with hexane:ethyl acetate (3:1) and dichloromethane:methanol (15:1) to yield the title compound (120 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=3.6 and 1.2 Hz), 5.56 (dd, 1H, H-3', J=4.2 and 3.3 Hz), 4.57 (d, 1H, H-1', J=1.5 Hz), 4.08 (AB system, 2H, OCH<sub class="style-scope patent-text">2</sub> CO<sub class="style-scope patent-text">2</sub>, J=12 Hz), 3.68 and 4.02 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9 Hz), 3.80 (dd, 1H, H-2', J=1.2 and 4.5 Hz), 3.71 (m, 1H, H-5'), 3.35 (s, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.45 (s, 3H, CH<sub class="style-scope patent-text">3</sub> CH<sub class="style-scope patent-text">2</sub> CO<sub class="style-scope patent-text">2</sub>), 3.24 (dd, 1H, H4', J=9 and 3 Hz), 2.57 (t, 1H, H-1, J=3.9 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 175.9 (CO<sub class="style-scope patent-text">2</sub> H), 169.2 (3'--CO<sub class="style-scope patent-text">2</sub>), 148.2 (C-3), 130.7 (C-2), 98.0 (C-1'), 78.2 (C4'), 74.1 (8aCH<sub class="style-scope patent-text">2</sub>), 72.1 (C-3a), 69.5 (OCH<sub class="style-scope patent-text">2</sub> CO,), 69.4 (C-5'), 68.9 (C-3'), 67.9 (C-2'), 65.6 (C-8a), 59.3 (CH<sub class="style-scope patent-text">2</sub> OCH<sub class="style-scope patent-text">3</sub>), 58.9 (C-4), 57.7 (4'--OCH<sub class="style-scope patent-text">3</sub>), 46.0 (C-1).</div>
    <heading class="style-scope patent-text">EXAMPLE 27</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-((E)-2-methyl-2-hexenoyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Zinc dust (300 mg) followed by 1M aqueous potassium dihydrogen phosphate (1 ml) were added to a rapidly stirred solution of Intermediate 39 (131 mg) in tetrahydrofuran (5 ml) at room temperature. The resultant slurry was stirred for, 3 days at room temperature and the solids were removed by filtration and washed with a (5:1) mixture of tetrahydrofuran:water (20 ml). The filtrate and washings were combined, the solvent was removed in vacuo and the residue evaporated twice from toluene. The resulting colourless gum was purified by preparative tic (Merck 5717) eluting with dichloromethane:methanol (10:1) and washing the product off the silica gel with ethyl acetate:methanol (8:1). Removal of the solvent gave the title compound (51 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 6.8 (m, 1H, RO<sub class="style-scope patent-text">2</sub> CC(CH<sub class="style-scope patent-text">3</sub>)=CH--R'), 6.06 (m, 1H, H-2), 5.54 (m, 1H, H-3'), 4.60 (d, 1H, H-1', J=1.2 Hz), 4.09, 3.67 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.6 Hz), 3.84 (m, 1H, H-2'), 3.77 (m, 1H, H-5'), 3.35 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.3 (m, 1H, H4'), 2.68 (m, 1H, H-1), 2.34 (m, 1H, CHMe<sub class="style-scope patent-text">2</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 28</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-(4-Chlorobutyryl)-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 40 (250 mg) in methanol (10 ml) was added 10% palladium on charcoal (165 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 18 psi of hydrogen for 1 hour at room temperature. The catalyst was filtered and the solvent evaporated to dryness. The residue was purified by flash chromatography on silica gel, eluting with dichloromethane:methanol (20:1). The appropriate fractions were combined and the solvent removed to give the title compound (138 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.69 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.49 (dd, 1H, H-3', J=3.6 and 4.5 Hz), 4.57 (d, 1H, H-1', J=1.5 Hz), 4.00 (d, 1H, H-8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.77 (dd, 1H, H-2', J=1.2 and 4.5 Hz), 3.71 (m, 1H, H-5'), 3.69 (d, 1H, H-8aCH<sub class="style-scope patent-text">2</sub>, J=9.3 Hz), 3.6 (t, 2H, CH<sub class="style-scope patent-text">2</sub> O, J=6.3 Hz), 3.33 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.25 (dd, 1H, H4', J=3 and 9 Hz), 2.69 (m, 1H, H-1), 2.56 (t, 2H, CH<sub class="style-scope patent-text">2</sub> Cl, J=7.2 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.4 (CHO), 177.1 (CO<sub class="style-scope patent-text">2</sub> H), 171.5 (COO), 148.3 (C-3), 130.0 (C-2), 98.2 (C-1'), 78.2 (C4'), 74.5 (C8aCH<sub class="style-scope patent-text">2</sub>), 72.2 (C-3a), 69.5 (C-2'), 69.1 (C-3'), 67.6 (C-5'), 65.6 (CH<sub class="style-scope patent-text">2</sub> CO), 58.6 (C-4), 57.7 (OCH<sub class="style-scope patent-text">3</sub>), 46.0 (C-1), 43.6 (CH<sub class="style-scope patent-text">2</sub> Cl), 31.9 (COCH<sub class="style-scope patent-text">2</sub> CH2CH<sub class="style-scope patent-text">2</sub> Cl), 18.1 (C-6')).</div>
    <heading class="style-scope patent-text">EXAMPLE 29</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-(2-methylpropanoyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 41 (0.270 g) in ethyl acetate (25 ml) was added 10% palladium on charcoal (25 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 25 psi of hydrogen for 2 hours at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified on a silica gel flash column eluting with hexane:ethyl acetate (3:1) to afford the title compound (0.119 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J=0.9 and 3.3 Hz), 5.46 (dd, 1H, H-3', J=3.0 and 4.5 Hz), 4.56 (d, 1H, H-1', J=1.5 Hz), 4.00 (brd, 1H, 8aCH<sub class="style-scope patent-text">2</sub>), 3.74 (m, 3H, H-2', 5' and 8aCH<sub class="style-scope patent-text">2</sub>), 3.32 (s, 3H, OMe), 3.26 (dd, 1H, H-4', J=3.0 and 9.0 Hz), 2.70 (m, 1H, H-1), 2.61 (sept, 1H, (CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub> CHCO<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.6 (CHO), 177.0 and 175.9 (CO<sub class="style-scope patent-text">2</sub> H and CO<sub class="style-scope patent-text">2</sub> --C), 148.4 (C-3), 130.5 (C-2), 98.4 (C-1'), 78.2 (C-4'), 74.5 (8aCH<sub class="style-scope patent-text">2</sub>), 72.4 (C-3a), 69.6, 69.2 and 67.1 (C-2', C-3' and C-5'), 58.7 (C-4).</div>
    <heading class="style-scope patent-text">EXAMPLE 30</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-propionyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 42 (274 mg) in ethyl acetate (20 ml) was hydrogenated in a Parr shaker at room temperature for 1.5 hours over 10% palladium on charcoal (150 mg). The catalyst was removed by filtration and the filtrate evaporated to a colourless gum. This was purified by preparative tic (Merck 5717) eluting with dichloromethane:methanol (20:1). The product was washed off the silica gel with ethyl acetate:methanol (5:1) and the solvent removed in vacuo to give the title compound (123 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.2 and 3.6 Hz), 5.48 (dd, 1H, H-3', J=3 and 4.5 Hz), 4.58 (d, 1H, H-1', J=1.2 Hz), 4.01 (d, 1H, A part of 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.3 Hz), 3.81-3.66 (m, 3H, H-2', H-5' and B part of 8aCH<sub class="style-scope patent-text">2</sub> (d)), 3.35 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.26 (dd, 1H, H-4', J=3 and 9 Hz), 2.7 (bt, 1H, H-1, J=3.6 Hz), 2.46-2.26 (m, 3H, RO<sub class="style-scope patent-text">2</sub> CCH<sub class="style-scope patent-text">2</sub> Me and CHMe<sub class="style-scope patent-text">2</sub>), 1.16 (t, 3H, RO<sub class="style-scope patent-text">2</sub> CCH<sub class="style-scope patent-text">2</sub> CH<sub class="style-scope patent-text">3</sub>, J=7.5 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.6 (CHO), 176.4 (CO<sub class="style-scope patent-text">2</sub> H), 173.3 (CO<sub class="style-scope patent-text">2</sub> R), 148.2 (C-3), 130.7 (C-2), 98.3 (C-1'), 78.3, 69.6, 69.2, 67.4 (C-2', C-3', C-4', C-5'), 74.2 (8aCH<sub class="style-scope patent-text">2</sub>), 72.2 (C-3a), 65.6 (C-8a), 58.8 (C4), 57.7 (OCH<sub class="style-scope patent-text">3</sub>), 46.1 (C-1).</div>
    <heading class="style-scope patent-text">EXAMPLE 31</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-4-O-methyl-3-O-(trans-4-methyl-1-cyclohexanecarbonyl)-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 43 (297 mg) in ethyl acetate (20 ml) was added 10% palladium on charcoal (150 mg) under nitrogen. The mixture was shaker in a Parr apparatus for 0.5 hours at room temperature. The catalyst was filtered off and the filtrate evaporated to dryness. The residue was purified by preparative tic (silica gel, Merck 5717) eluting with dichloromethane:methanol (20:1) and extracted from the silica gel using ethyl acetate:methanol (5:1). The solvent was removed in vacuo to give the title compound (149 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 5.45 (dd, 1H, H-3', J=3.3 and 4.5 Hz), 4.56 (d, 1H, H-1', J=1.5 Hz), 4.01 (d, 1H, A part of 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.3 Hz), 3.8-3.64 (m, 3H, H-2', H-5' and B part of 8aCH<sub class="style-scope patent-text">2</sub>), 3.32 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.25 (dd, 1H, H4', J=3.3 and 8.7 Hz), 2.69 (bt, 1H, H-1, J=3.3 Hz), 2.4-2.2 (m, 2H, CHMe<sub class="style-scope patent-text">2</sub> and RO<sub class="style-scope patent-text">2</sub> C--CH(cyclohexane)), 0.88 (d, 3H, H<sub class="style-scope patent-text">3</sub> C-cyclohexane-CO<sub class="style-scope patent-text">2</sub> R, J=6.3 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 234.7 (CHO), 176.6 (CO<sub class="style-scope patent-text">2</sub> H), 175 (RO<sub class="style-scope patent-text">2</sub> C-cyclohexane), 148.3 (C-3), 130.6 (C-2), 98.4 (C-1'), 78.2, 69.7, 69.2, 67 (C-2', C-3', C-4', C-5'), 74.4 (8aCH<sub class="style-scope patent-text">2</sub>), 72.3 (C-3a), 65.6 (C8a), 58.8 (C-4), 57.5 (OCH<sub class="style-scope patent-text">3</sub>), 46.2 (C-1), 43.1 (RO<sub class="style-scope patent-text">2</sub> C--CH(cyclohexane).</div>
    <heading class="style-scope patent-text">EXAMPLE 32</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-trans-Cinnamoyl-6-deoxy-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Zinc dust (400 mg) followed by 1M aqueous potassium dihydrogen phosphate (0.4 ml) were added to a vigorously stirred solution of Intermediate 45 (170 mg) in tetrahydrofuran (4 ml) at room temperature. The resultant slurry was stirred for 2 days at room temperature and the solids were removed by filtration and washed with ethyl acetate. The filtrate and washings were combined, the solvent was removed under vacuum and the residue material partitioned between ethyl acetate (50 ml) and 1N aqueous hydrochloric acid (50 ml). The organic layer was washed with water and brine, then dried (Na<sub class="style-scope patent-text">2</sub> SO4), filtered and evaporated. The residue was filtered through Dowex 50X8-200 ion-exchange resin using methanol as the eluent. The filtrate was concentrated in vacuo and the residue flash chromatographed on silica gel eluting with dichloromethane:methanol (97:3) to give the title compound (105 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 7.72 (d, 1H, Ph--CH=C--CO<sub class="style-scope patent-text">2</sub> R, J=15.9 Hz), 7.58-7.36 (m, 5H, Ph), 6.48 (d, 1H, Ph--C=CH--CO<sub class="style-scope patent-text">2</sub> R), 6.08 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.60 (dd, 1H, H-3', J=3 and 4.5 Hz), 4.66 (d, 1H, H-1', J=1.2 Hz), 4.08, 3.7 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9 Hz), 3.92-3.78 (m, 2H, H-2', H-5'), 3.39 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.35 (dd, 1H, H-4', J=3 and 8.7 Hz), 2.7 (t, 1H, H-1), 2.4-2.26 (m, 1H, CHMe<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.8 (CHO), 176 (--CO<sub class="style-scope patent-text">2</sub> H), 165.8 (RO<sub class="style-scope patent-text">2</sub> C--C=C), 148.2 (C-3), 145.8 (Ph--C=C), 130.7 (C-2), 117.3 (RO<sub class="style-scope patent-text">2</sub> C--C=C), 98.3 (C-1'), 78.3, 69.7, 69.2, 67.8 (C-2', C-3', C-4', C-5'), 74.2 (8aCH<sub class="style-scope patent-text">2</sub>), 72 (3a), 65.6 (8a), 58.9 (C-4), 57.7 (OCH<sub class="style-scope patent-text">3</sub>), 46.1 (C-1).</div>
    <heading class="style-scope patent-text">EXAMPLE 33</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-methacryloyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">Zinc dust (300 mg) followed by 1M aqueous potassium dihydrogen phosphate (0.3 ml) were added to a rapidly stirred solution of Intermediate 47 (95 mg) in tetrahydrofuran (4 ml) at room temperature. The resultant slurry was stirred for 2 days at room temperature and the solids were removed by filtration and washed with ethyl acetate. The filtrate and washings were combined, the solvent was removed under vacuum and the residue was partitioned between ethyl acetate (50 ml) and 1N aqueous hydrochloric acid (50 ml). The organic layer was washed successively with water and brine, then dried over sodium sulphate, filtered and evaporated. The residue was filtered through Dowex 50X8-200 ion-exchange resin using methanol as the eluent. The filtrate was concentrated by evaporation and the residue was flash chromatographed on silica gel eluting with dichloromethane:methanol (96:4). Removal of the solvent gave the title compound (60 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 6.14 (bs, 1H, Ha--C=C), 6.07 (m, 1H, H-2), 5.62 (m, 1H, Hb--C=C), 5.54 (m, 1H, H-3'), 4.60 (d, 1H, H-1', J=0.9 Hz), 4.03,3.69 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.3 Hz), 3.84 (d, 1H, H-2', J=4.5 Hz), 3.76 (m, 1H, H-5'), 3.35 (s, 3H, --OCH<sub class="style-scope patent-text">3</sub>), 3.31 (dd, 1H, H-4', J=3 and 9 Hz), 2.69 (m, 1H, H-1), 2.34 (m, 1H, CHMe<sub class="style-scope patent-text">2</sub>), 1.97 (s, 3H, H<sub class="style-scope patent-text">3</sub> C--C=C); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.8 (CHO), 176 (--CO<sub class="style-scope patent-text">2</sub> H), 166 (R--CO<sub class="style-scope patent-text">2</sub> R'), 148.4 (C-3), 135.9 (--C=CH<sub class="style-scope patent-text">2</sub>), 130.7 (C-2), 126.3 (--C=CH<sub class="style-scope patent-text">2</sub>), 98.4 (C-1'), 78.3, 69.8, 69.2, 67.8 (C-2', C-3', C-4', C-5'), 74.4 (8aCH<sub class="style-scope patent-text">2</sub>), 72 (C3a), 65.7 (C-8a), 58.9 (C4), 57.7 (OCH<sub class="style-scope patent-text">3</sub>), 46.2 (C-1).</div>
    <heading class="style-scope patent-text">EXAMPLE 34</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)]8a-[(6-Deoxy-4-O-methyl-3'-O-octyloxycarbonyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 48 (320 mg) in methanol (40 ml) was added 10% palladium on charcoal (175 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 15 psi of hydrogen for 1.5 hours at room temperature. The catalyst was filtered and the solvent evaporated to dryness. The residue was purified by flash chromatography on silica gel, eluting with dichloromethane:methanol (20:1). The appropriate fractions were combined and the solvent removed to give the title compound (168 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.66 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=0.9 and 3.3 Hz), 5.28 (dd, 1H, H-3', J=3 and 3.9 Hz), 4.63 (d, 1H, H-1', J=0.9 Hz) 4.13 (t, 2H, CH<sub class="style-scope patent-text">2</sub> OCO, J=6.6 Hz), 4.02 and 3.66 (2d, 2H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.6 Hz), 3.86 (dd, 1H, H-2', J=1.2 and 4.2 Hz), 3.74 (m, 1H, H-5'), 3.37 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.27 (dd, 1H, H-4, J=3 and 9 Hz), 1.4-1.1 (m, 6CH<sub class="style-scope patent-text">2</sub> and 6'CH<sub class="style-scope patent-text">3</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 205.1 (CHO), 177.3 (COOH), 154.5 (OCOO), 148.5 (C-3), 130.5 (C-2), 98.2 (C-1'), 78.2 (C-4'), 74.5 (C8aCH<sub class="style-scope patent-text">2</sub>), 72.6 (C-3a), 71.1 (C-2'), 69.3 (C-3'), 69.1 (C-5'), 68.6 (CH<sub class="style-scope patent-text">2</sub> --OCOO), 57.9 (OCH<sub class="style-scope patent-text">3</sub>), 31.6, 29.1, 29.0, 28.5, 25.5, 22.5 (6CH<sub class="style-scope patent-text">2</sub> --), 17.9 (C-6'), 14.0 (CH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 35</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ) ]8a-[(6-Deoxy-4-O-methyl-3-O-octanoylaminocarbonyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 49 (200 mg) in ethyl acetate (20 ml) was added 10% palladium on charcoal (100 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 15 psi of hydrogen for 30 minutes at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was chromatographed on a silica gel flash column eluting with methylene chloride and methylene chloride:methanol (15:1) to give the title compound (135 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.72 (s, 1H, CHO), 6.07 (dd, 1H, H2, J=1.2 and 2.4 Hz), 5.32 (m, 1H, H-3'), 4.80 (t, 1H, CH<sub class="style-scope patent-text">2</sub> --NH--CO<sub class="style-scope patent-text">2</sub>), 4.57 (d, 1H, H-1', J=1.2Hz), 4.02 and 3.66 (2d, 2H, 8a-CH2, J=9.6 Hz), 3.74 (m, 1H, H-5'), 3.38 (s, 3H, 4'OCH<sub class="style-scope patent-text">3</sub>), 3.28 (dd, 1H, H-4', J=2.8 and 8.7 Hz), 3.80 (m, 2H, CH<sub class="style-scope patent-text">2</sub> NHCO<sub class="style-scope patent-text">2</sub>), 2.70 (t, 1H, H-1); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 175.9 (COOH), 155.5 (OCONH, 148.2 (C-3), 130.7 (C-2), 93.7 (C-1), 78.5 (C-4'), 72.2 (8a-CH<sub class="style-scope patent-text">2</sub>), 69.6 (C-3'), 69.2 (C-5'), 65.6 (C-8a), 58.8 (C-2), 57.7 (C-7'), 18.2 (C-6').</div>
    <heading class="style-scope patent-text">EXAMPLE 36</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-benzylaminocarbonyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 50 (100 mg) in ethyl acetate (15 ml) was added 10% palladium on charcoal (50 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 15 psi of hydrogen for 10 minutes. The catalyst was filtered off and the solvent evaporated to dryness. The residue was chromatographed on a silica gel flash column using methylene chloride and methylene chloride:methanol (20:1) as eluents to give the title compound (56 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.70 (s, 1H, CHO), 7.28 (m, 5H, 3'--Ph), 6.06 (d, 1H, H-2, J=3.3 Hz), 5.37 (m, 1H, H-3'), 5.17 (t, 1H, Ph--NH--CO<sub class="style-scope patent-text">2</sub>), 4.55 (s, 1H, H-1'), 4.38 (m, 2H, Ph--CH<sub class="style-scope patent-text">2</sub> --NH), 3.99 and 3.66 (2d, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J<sub class="style-scope patent-text">AB</sub> =9.3 Hz), 3.87 (d, 1H, H-2', J=4.5 Hz), 3.39 (s, 3H, 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.28 (dd, 1H, H-4', J=2.7 and 8.4 Hz), 2.71 (t, 1H, H-1).</div>
    <heading class="style-scope patent-text">EXAMPLE 37</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(6-Deoxy-3-O-dimethylaminocarbonyl-4-O-methyl-β-D-altropyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 51 (0.165 g) in ethyl acetate (20 ml) was added 10% palladium on charcoal (20 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 20 psi of hydrogen for 2 hours at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified on a silica gel flash column eluting with 5% dichloromethane in methanol to give the title compound (0.060 g).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.71 (s, 1H, CHO), 6.07 (dd, 1H, H-2, 1.2 and 3.3 Hz), 5.36 (dd, 1H, H-3', J=3 and 4.5 Hz), 4.57 (d, 1H, H-1', J=1.2 Hz), 4.02 (m, 1H, 8aCH<sub class="style-scope patent-text">2</sub>), 3.85 (m, 1H, H-2'), 3.75 (m, 1H, H-5'), 3.66 (m, 1H, 8aCH<sub class="style-scope patent-text">2</sub>), 3.37 (s, 3H, MeO), 3.28 (dd, 1H, H-4', J=3.3+9.0 Hz), 2.94 (s, 6H, Me<sub class="style-scope patent-text">2</sub> N), 2.70 (m, 1H, H-1); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.9 (CHO), 176.2 (CO<sub class="style-scope patent-text">2</sub> H), 155.5 (CON), 148.4 (C-3), 130.7 (C-2), 98.6 (C-1'), 78.5 (C-4'), 74.3 (8aCH<sub class="style-scope patent-text">2</sub>), 72.4 (C-3a), 69.9, 69.4, 68.7 (C-2', C-3', and C-5'), 65.7 (C-8a), 58.9 (C-4).</div>
    <heading class="style-scope patent-text">EXAMPLE 38</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,6-Dideoxy-4-O-methyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 33 (200 mg) in dry tetrahydrofuran (10 ml) at 0° C. and under nitrogen atmosphere, sodium hydride (25 mg) and imidazole (2 mg) were added. The solution was stirred for 10 minutes and carbon disulfide (0.12 ml) was added. After 20 minutes methyl iodide (0.25 ml) was added and the stirring continued for 30 minutes. 1N ammonium chloride was added and the reaction mixture extracted with ethyl acetate, the organic phase washed with brine, dried over magnesium sulphate and the solvent evaporated to dryness. The residue was flash chromatographed eluting with hexane:ethyl acetate (4:1) to obtain 214 mg of xanthate. 200 mg of this compound were dissolved in dry toluene (8 ml) under nitrogen atmosphere and heated at 110° C. A solution of tributyltin hydride (0.12 ml) in dry toluene (10 ml) was added dropwise over 2.5 hours with stirring. Methanol was added and the reaction mixture evaporated to dryness. The major compound of the crude was purified by flash chromatography on silica gel eluting with ethyl acetate:hexane (15:85) to obtain a foam. This foam was dissolved in ethyl acetate (10 ml). Palladium on charcoal was added (50 mg) and the suspension stirred under hydrogen atmosphere (30 psi) for 2 hours. The catalyst was filtered off and the solvent removed. The crude was flash chromatographed on silica gel eluting with dichloromethane:methanol (96:4) to yield the title compound (41 mg) as a foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.82 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.2 and 4.2Hz), 4.71 (dd, 1H, H-1', J=2.4 and 9.9 Hz), 4.32 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 4.24 (dd, 1H, H-3', J=3.0 and 6.6 Hz), 3.80-3.60 (m, 1H, H-5'), 3.40 (s, 3H, CH<sub class="style-scope patent-text">3</sub> O), 3.55 (d, 1H, 8aCH<sub class="style-scope patent-text">2</sub>, J=9.0 Hz), 2.85 (dd, 1H, H-4', J=3.0 and 9.3 Hz), 2.49 (t, 1H, H-1, J=3.6 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.6 (CHO), 173.3 (CO<sub class="style-scope patent-text">2</sub> H), 148.4 (C-3), 130.5 (C-2), 97.6 (C-1'), 82.1 (C-4'), 73.5 (8aCH<sub class="style-scope patent-text">2</sub>), 68.5, 66.1, 63.8, 61.1, 57.3.</div>
    <heading class="style-scope patent-text">EXAMPLE 39</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4aβ, 7β, 7aα, 8aβ)] 8a-[(2,3,6-Trideoxy-4-O-methyl-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 52(a) (180 mg) in ethyl acetate (40 ml) was added 10% palladium on charcoal (150 mg) under nitrogen. The mixture was shaken in a Parr apparatus under 15 psi of hydrogen for 1 hour at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash column chromatography eluting with hexane:ethyl acetate (3:1) and dichloromethane:methanol (10:1) to yield the title compound (82 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.84 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.33 (m, 2H, H-1' and H-8aCH<sub class="style-scope patent-text">2</sub>), 3.34 (m, 4H, H-8aCH<sub class="style-scope patent-text">2</sub> and 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.28 (dq, 1H, H-5', J=6.3 and 9Hz), 2.80 (m, 1 H, H-4'), 2.50 (t, 1H, H-1, J=3.9 Hz); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.6 (CHO), 174.1 (CO<sub class="style-scope patent-text">2</sub> H), 148.4 (C-3), 130.4 (C-2), 101.2 (C-1'), 79.8 (C-4'), 74.8 (C-5'), 73.1 (8aCH<sub class="style-scope patent-text">2</sub>), 65.1 (C-8a), 59.0 (C-4), 56.9 (4'--OCH<sub class="style-scope patent-text">3</sub>), 47.1 (C-1), 41.0 and 41.5 (C-5 and C-6).</div>
    <heading class="style-scope patent-text">EXAMPLE 40</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3,6-dideoxy-4-O-methyl-β-D-altropyranoxyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">10% palladium on charcoal (100 mg) was added to a solution of Intermediate 53 (100 mg) in ethyl acetate (30 ml) under nitrogen. The mixture was shaken in a Parr apparatus under 15 psi of hydrogen for 1 hour at room temperature. The catalyst was filtered off and the solvent evaporated to dryness. The residue was purified by flash column chromatography eluting with hexane:ethyl acetate (3:1) and dichloromethane:methanol (15:1) to give the title compound (60 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J=1.2 and 3.3 Hz), 4.35 (s, 1H, H-1'), 3.64 and 4.09 (2brd, 2H, BaCH<sub class="style-scope patent-text">2</sub>, J=9Hz), 3.90 (m, 1H, H-2'), 3.35 (m, 4H, H-5' and 4'--OCH<sub class="style-scope patent-text">3</sub>), 3.21 (m, 1H, H-4'), 2.67 (m, 1H, H-1), 2.41 (m, 1H, H-3'a); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204 (CHO), 175.9 (CO<sub class="style-scope patent-text">2</sub> H), 148.4 (C-3), 130.6 (C-2), 100.6 (C-1'), 76.6 (C-4'), 74.4 (C-2'), 74.0 (8aCH<sub class="style-scope patent-text">2</sub>), 67.6 (C-5'), 65.6 (C-8a), 58.8 (C-4), 57.1 (4'--OCH<sub class="style-scope patent-text">3</sub>).</div>
    <heading class="style-scope patent-text">EXAMPLE 41</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-(((2,3,6-Trideoxy-3-(tert-butoxycarbonyl)amino-b-D-allopyranosyl)oxy)methyl)-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of intermediate 22 (100 mg) in ethyl acetate (15 ml), di-tert-butyl dicarbonate (0.04 ml) and palladium (10%) on charcoal (30 mg) were added under nitrogen. The mixture was shaken in a Parr apparatus (PH<sub class="style-scope patent-text">2</sub> =20 psi) for 2 hours at room temperature. The catalyst was filtered and the solvent evaporated to dryness. The residue was purified by flash column chromatography on silica gel eluting with dichloromethane:methanol 20:1 to give pure title compound (20 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 13.20 (br s, 1H, COOH), 9.60 (s, 1H, CHO), 6.53 (br s, 1H, NH), 6.04 (d, 1H, H-2, J=2.7 Hz), 4.82 (br s 1H, OH), 4.48 (d, 1H, H-1', J=6.3 Hz), 3.82 (m, 1H, H-4'), 3.70 (d, 1H, H-8a, J=9.0 Hz), 3.61 (dq, 1H, H-5', J=8.1, 6.6 Hz), 3.48 (d, 1H, H-8a, J=9.0 Hz), 3.17 (m, 1H, H-3'), 2.58 (t, 1H, H-1, J=3.3 Hz), 2.21 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.8 (CHO), 176.0 (COO--), 175.7 (COOH), 148.1 (C-3), 130.7 (C-2), 97.8 (C-1'), 73.7 (C-8a), 72.0 (C-5')+(C-4'), 46.47 (C-3').</div>
    <heading class="style-scope patent-text">EXAMPLE 42</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-(((2,3,6-Trideoxy-4-O-acetyl-3-acetylthio-b-D-allopyranosyl)oxy)methyl)-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">A solution of Intermediate 54 (100 mg) in dichloromethane (10 ml) at 0° C. was treated with trifluoroacetic acid (0.1 ml). After 1 hour, the mixture was washed with sodium bicarbonate saturated solution (3 ml). The organic layer was treated with brine (3 ml) and dried over magnesium sulphate, filtered and concentrated. The residue was purified by flash column chromatography on silica gel, using dichlromethane:methanol (20:1), to give pure title compound (18 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>)- 9.77 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=3.3 and 1.2 Hz), 4.72 (dd, 1H, H-1', J=8.4 and 4.2 Hz), 4.48 (dd, 1H, H-3', J=6.3 and 4.5 Hz), 4.30 (dd, 1H, H-4', J=8.7 and 4.5 Hz), 4.12 (d, 1H, H-8a, J=9.3 Hz), 3.70 (dq, 1H, H-5', J=8.1 and 6.0 Hz), 3.49 (d, 1H, H-8a, J=9.3 Hz), 2.60 (t, 1H, H-1, J=3.9 Hz), 2.35 (s, 3H, COCH<sub class="style-scope patent-text">3</sub>), 2.33 (m, 1H, CH(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>) 2.00 (s, 3H, COCH<sub class="style-scope patent-text">3</sub>); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.9 (CHO), 193.5 (SCOCH<sub class="style-scope patent-text">3</sub>), 174.7 (COOH), 169.8 (OCOCH<sub class="style-scope patent-text">3</sub>), 148.4 (C-3), 130.6 (C-2), 98.7 (C-1'), 73.7 (C-8a), 72.2 (C-4'), 70.5 (C-5'), 40.4 (C-3'), 30.7 (CH<sub class="style-scope patent-text">3</sub> --COS), 20.8 (CH<sub class="style-scope patent-text">3</sub> --COO).</div>
    <heading class="style-scope patent-text">EXAMPLE 43</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-(3-Acetamido-2,3,6-trideoxy-4-O-methyl-β-D-allopyranosyloxy)methyl-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of intermediate 23 (0.75 mmol) in ethyl acetate (20 ml), palladium (10%) on charcoal was added (75 mg) under nitrogen. The mixture was shaken in a Parr apparatus (PH<sub class="style-scope patent-text">2</sub> =30 psi) for 4 hours at room temperature. The catalyst was filtered and the solution was treated with pyridine (3 ml) and acetic anhydride (0.2 ml) and stirred overnight at room temperature. After this time, was washed with hydrochloric acid (2N), sodium bicarbonate and brine. After removal of the solvent, the residue was purified by flash chromatography using dichloromethane:methanol 20:1 to give the title compound (207 mg).</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.74 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.5 and 3.6 Hz), 5.85 (d, 1H, NH, J=5.7 Hz), 4.50 (dd, 1H, H-1', J-2.8 and 7.8 Hz), 4.24 (m, 1H, H-3'), 4.08 and 3.45 (d, d, 1H, 1H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=9.1 Hz), 3.87 (m, 1H, H-5'), 3.32 (s, 3H, OMe), 3.04 (dd, 1H, H-4', J=4.2 and 7.5 Hz), 2.60 (t, 1H, H-1, J=3.9 Hz), 2.04 (s, 3H, CH<sub class="style-scope patent-text">3</sub> CO); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.9 (CHO), 174.8 and 170.8 (CO<sub class="style-scope patent-text">2</sub> and CON), 148.3 (C-3), 130.7 (C-2), 98.2 (C-1'), 79.6 (C-4'), 73.5 (8a-CH<sub class="style-scope patent-text">2</sub>), 69.3 (C-5'), 65.3 (C-8a), 59.0 (C-4).</div>
    <heading class="style-scope patent-text">EXAMPLE 44</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-benzoyl-2,6-dideoxy-4-O-methyl-β-allopyranosyloxy) methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 55 (180 mg) in ethyl acetate (25 ml), palladium (10%) on charcoal (50 mg) was added. The mixture was shaken in a Parr apparatus (PH<sub class="style-scope patent-text">2</sub> =20 psi) for 1 hour at room temperature. The catalyst was filtered and the solvent evaporated to dryness. The residue was purified by flash chromatography with mixtures of hexane:ethyl acetate to give the title compound (60 mg) as a white foam.</div>
    <div class="description-paragraph style-scope patent-text">δ (<sup class="style-scope patent-text">1</sup> H, CDCl<sub class="style-scope patent-text">3</sub>): 9.8 (s, 1H, CHO), 8.03-7.5 (m, 5H, arom), 6.04 (dd, 1H, H-2, J=1.4 and 2.5 Hz), 5.7 (c, 1H, H-3'), 4.7 (dd, 1H, H-1'), 4.36, 3.42 (dd, 2H, 8a-CH<sub class="style-scope patent-text">2</sub>, J=10.8 Hz), 3.9 (m, 1H, H-5'), 3.39 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 3.00 (dd, 1H, H-4'), 2.50 (t, 1H, H-1); δ (<sup class="style-scope patent-text">13</sup> C, CDCl<sub class="style-scope patent-text">3</sub>): 204.7 (CHO), 173.64 (COOH), 165.53 (OCO--Ph), 148.5 (C-3), 130.5 (C-2), 133.2, 130.0, 129.6, 128.4 (Carom), 97.78 8C-1'), 80.87 (C-4'), 73.5 (8a-CH<sub class="style-scope patent-text">2</sub>), 69.9 (C-5'), 66.17 (C-3'), 65.1 (C-8a), 57.5 (C4).</div>
    <heading class="style-scope patent-text">EXAMPLE 45</heading>
    <div class="description-paragraph style-scope patent-text">[1R-(1α, 3aβ, 4β, 4aβ, 7β, 7aα, 8aβ)] 8a-[(3-O-acetyl-2,6-dideoxy-4-O-methyl-β-allopyranosyloxy) methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano-s-indacene-3a(1H)-carboxylic acid</div>
    <div class="description-paragraph style-scope patent-text">To a solution of Intermediate 56 (221 mg) in ethyl acetate (20 ml), palladium (10%) on charcoal (50 mg) was added. The mixture was shaken in a Parr apparatus (PH<sub class="style-scope patent-text">2</sub> =20 psi) for 1 hour at room temperature. The catalyst was filtered and the solvent evaporated to dryness. The residue was purified by flash chromatography using hexane:ethyl acetate 3:7 to give the title compound (100 mg) as a colourless oil.</div>
    <div class="description-paragraph style-scope patent-text">δ (1H, CDCl<sub class="style-scope patent-text">3</sub>): 9.82 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.44 and 2.5 Hz), 5.5 (c, 1H, H-3'), 4.63 (dd, 1H, H-1', J=2.5 and 9.36 Hz), 4.32, 3.39 (d, d, 2H, 8a-CH,2, J=11 Hz), 3.72 (m, 1H, H-5'), 3.39 (s, 3H, OCH<sub class="style-scope patent-text">3</sub>), 2.88 (dd, 1H, H-4', J=3.6 Hz9, 2.5 (t, 1H, H-1), 2.1 (s, 2H, CH<sub class="style-scope patent-text">3</sub> CO); δ (13C, CDCl<sub class="style-scope patent-text">3</sub>): 204.5 (CHO), 174.7 (COOH), 170.143 (COCH<sub class="style-scope patent-text">3</sub>), 148.3 (C-3), 130.56 (C-2), 97.67 (C1'), 80.78 (C4'), 73.8 (8aCH<sub class="style-scope patent-text">2</sub>), 69.5 (C5'), 65.6 (C3'), 65.19 (C8a), 57.56 (C4).</div>
    <heading class="style-scope patent-text">EXAMPLE 46</heading>
    <div class="description-paragraph style-scope patent-text">Characteristics of IMI 362184</div>
    <div class="description-paragraph style-scope patent-text">IMI 362184 is a mutant of Sordaria araneosa (ATCC 36386, NRRL 3193) isolated following N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis of ascospores of this strain. The characteristics of IMI 362184 are essentially similar to those described in British Patent Specification No. 1,162,027 for NRRL 3196, except that IMI 362184 produces 4'-demethylsordarin as a major product under the same conditions used for sordarin production by NRRL 3196.</div>
    <heading class="style-scope patent-text">EXAMPLE 47</heading>
    <div class="description-paragraph style-scope patent-text">Characteristics of IMI 362947</div>
    <div class="description-paragraph style-scope patent-text">IMI 362947 is a mutant of Sordaria araneosa (ATCC 36386, NRRL 3193) isolated following N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis of ascospores of this strain. The characteristics of IMI 362947 are essentially similar to those described in British Patent Specification No. 1,162,027 for NRRL 3196, except that IMI 362947 does not produce ascospores readily on agar. The strain also differs from NRRL 3196 in that it produces sordaricin as a major product under the same conditions used for sordarin production by NRRL 3196.</div>
    <heading class="style-scope patent-text">EXAMPLE 48</heading>
    <div class="description-paragraph style-scope patent-text">Characteristics of NCIMB 40675</div>
    <div class="description-paragraph style-scope patent-text">NCIMB 40675 is an aerobic, Gram-positive, non-motile irregular rod that produces lemon yellow, translucent, round, entire, convex colonies with a diameter of between 0.5-1 mm when grown on tryptic soy agar supplemented with 2% (w/v) yeast extract for 48 hours at 28° C. The organism grows well at temperatures up to 37° C., but not at 45° C. Metachromatic granules were not observed and the strain is catalase positive, oxidase negative and does not metabolise glucose fermentatively. The strain can utilise the following sources of carbon: α-D-glucose, D-fructose, p-hydroxyphenyl-acetic acid, D-mannitol, methylpyruvate, lactamide, D-trehalose and sucrose. The organism can only weakly utilise D-gluconic acid, pyruvic acid and salicin as sole carbon sources. Colony and microscopic morphology resembles that of coryneform bacteria. The genus Corynebacterium was excluded on the grounds that the peptidoglycan of NCIMB 40675 contains ornithine rather than the meso-isomer of 2,6-diaminopimelic acid or diaminobutyric acid. Also, the organism contains a complex mixture of branch chain fatty acids atypical of Corynebacterium species, namely, 12-methyltetradecanoic, 14-methylhexadecanoic and 14-methylpentadecanoic acids. The presence of α-branched-β-hydroxylated fatty acids was not determined. On the basis of these results NCIMB 40675 most closely resembles one of the following actinobacterial genera: Aureobacterium, Curtobacterium or Cellulomonas.</div>
    <div class="description-paragraph style-scope patent-text">To clarify the taxonomic position of NCIMB 40675, a 1100 base pair partial sequence of the 16S rRNA gene was compared against 24 other species representing a range of actinobacteria and related genera. Results from this analysis indicate a close relationship between NCIMB 40675 and the genera Aureobacterium and Curtobacterium, but not Cellulomonas or Corynebacterium. More precise identification for the strain could be obtained by performing a phylogenetic analysis comparing variable regions of the 16S rRNA gene for a range of Aureobactedum and Curtobacterium species in addition to further chemotaxonomic and physiological tests.</div>
    <div class="description-paragraph style-scope patent-text">Pharmacy Examples</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
1.      Conventional oral tablet                                          
______________________________________                                    
Drug substance      100 mg                                                
  Microcrystalline cellulose     160 mg                                   
  Crosscarmellose sodium           20 mg                                  
  Magnesium stearate                5 mg                                  
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The drug substance is blended with microcrystalline cellulose, crosscarmellose sodium and magnesium stearate, then compressed into tablets.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
2.       Chewable oral tablet                                             
______________________________________                                    
       Drug substance                                                     
                   100 mg                                                 
  Xylitol                    865 mg                                       
  Peppermint flavour            5 mg                                      
  Aspartame                    10 mg                                      
  Polyvinylpyrollidone         15 mg                                      
  Magnesium stearate            5 mg                                      
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">The drug substance, xylitol, aspartame and polyvinylpyrollidone are blended together and granulated with water, then dried. This granule is mixed with the peppermint flavour and magnesium stearate, then compressed into tablets.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
3.      Aqueous Oral Solution                                             
______________________________________                                    
Drug substance        100 mg                                              
  Hydroxypropylmethyl cellulose 150 mg                                    
  Sodium propylhydroxybenzoate   1 mg                                     
  Sodium methylhydroxybenzoate   2 mg                                     
  Orange flavour                10 mg                                     
  Sodium saccharin               5 mg                                     
  Sucrose                       800 mg                                    
  Suitable buffers                 qs                                     
  Purified water to              5 mls                                    
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">Dissolve the drug substance and all the excipients in most of the purified water and mix. Make to volume and mix. Suitable buffers may be added to control the pH in the region of maximum stability.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
4.      Non-Aqueous Oral Suspension                                       
______________________________________                                    
Drug substance        100 mg                                              
  Aspartame                    50 mg                                      
  Grapefruit flavour           25 mg                                      
  Mannitol                      800 mg                                    
  Colloidal silica               10 mg                                    
  Fractionated coconut oil        5 mls                                   
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">Disperse the drug substance and mannitol in the bulk of the fractionated coconut oil by high shear mixing. Add the remaining ingredients and mix. Make to volume with fractionated coconut oil and mix.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
5.       Ointment                                                         
______________________________________                                    
       Drug substance                                                     
                  200 mg                                                  
  White Soft Paraffin        9800 mg                                      
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">Melt the white soft paraffin, add the drug and mix. Continue to mix until the ointment starts to congeal.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">______________________________________                                    
6.       Injection                                                        
______________________________________                                    
       Drug substance                                                     
                    40 mg                                                 
  Suitable buffers                  qs                                    
  Suitable antioxidants             qs                                    
  Suitable chelating agents         qs                                    
  Water for injections to         2 mls                                   
______________________________________                                    
</pre>
    
    <div class="description-paragraph style-scope patent-text">Dissolve the drug substance in most of the water for injections. Suitable buffering agents may be added to control the pH to the region of optimum stability. Suitable antioxidants and chelating agents may be added to improve the stability of the injection. Make to mark with water for injections. Fill into ampoules or vials, then sterilise by autoclaving. Alternatively, sterilise by filtration and fill aseptically.</div>
    <div class="description-paragraph style-scope patent-text">Antifungal Activity</div>
    <div class="description-paragraph style-scope patent-text">Compounds of formula (I) have been tested for anti fungal activity in a standard in vitro screen and the minimum inhibiting concentration (MIC; μg/ml) determined for each compound against a variety of clinically relevant pathogens. The results obtained with representative compounds of the invention are given below.</div>
    <div class="description-paragraph style-scope patent-text">The compounds of the invention are essentially non-toxic at therapeutically useful levels. For example the compounds of example 7, 10 and 89 when administered at a dose of 50 mg/kg sc were active in protecting male mice infected with C. albicans 4711E. At this dose no adverse effects were observed in the treated mice.</div>
    <div class="description-paragraph style-scope patent-text">
      </div> <pre xml:space="preserve" listing-type="tabular" class="style-scope patent-text">__________________________________________________________________________
            MICs μg/ml                                                 
  Example No.                                                             
ORGANISM    3    5   7   8   9   10  11  15  24  39  42                   
__________________________________________________________________________
C. albicans 1208E                                                         
            4.000                                                         
                 ≦0.001                                            
                     0.015                                                
                         0.250                                            
                             8.0 1.0 1.0 ≦0.001                    
                                             0.60                         
                                                 0.060                    
                                                     0.060                
  C. albicans 2005E           0.250    ≦0.001  ≦0.001 0.030 
                                                        2.0       0.12    
                                                     0.250   ≦0.001
                                                        ≦0.001     
                                                     0.004   ≦0.001
  C. albicans 2402E           2.00     ≦0.001  0.008     0.250     
                                                     8.0       1.00       
                                                     1.00    ≦0.001
                                                        0.030      0.060  
                                                      0.060               
  C. albicans 4711            --      ≦0.001  0.004     0.120      
                                                     4.0       0.500      
                                                     1.00    ≦0.001
                                                        --        --      
                                                     0.015                
  C. tropicalis 2808E         1.00     0.004      0.003     2.00     16.0 
                                                          --    2.00      
                                                     0.004       0.060    
                                                       0.250   1.00       
                                                      C. psuedotropicalis 
                                                     371E   0.250         
                                                     ≦0.001  0.004 
                                                         0.120    2.0     
                                                       --   1.00          
                                                     ≦0.001        
                                                     0.004      0.008     
                                                     ≦0.001        
                                                      C. glabrata 2375E   
                                                             &gt;125  1.000  
                                                         8.00      16.00  
                                                       &gt;125   62          
                                                     31.00   1.00         
                                                     500        8.00      
                                                     31.00                
  C. glabrata 2376E           &gt;125  1.00       8.00      16.00    &gt;125    
                                                     62     31.00   1.00  
                                                           500            
                                                     8.00    31.00        
                                                      C. neoformans 2867E 
                                                             31.00        
                                                     31.00      125       
                                                     31.00    125         
                                                     4.0    0.050   31.00 
                                                           0.25           
                                                     62.00   &gt;125         
__________________________________________________________________________
</pre>
    
    
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(10)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM59564111" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <claim-statement class="style-scope patent-text">We claim:</claim-statement>
    <div class="claim style-scope patent-text"> <div num="1" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">1. A compound of the formula (I) ##STR14## and pharmaceutically acceptable salts and solvates or metabolically labile derivatives thereof,<div class="claim-text style-scope patent-text">wherein R<sup class="style-scope patent-text">1</sup> represents hydrogen, halogen, hydroxyl or C<sub class="style-scope patent-text">1-4</sub> alkoxy;</div> <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">2</sup> represents hydrogen, halogen, hydroxyl, C<sub class="style-scope patent-text">1-10</sub> alkoxy, C<sub class="style-scope patent-text">1-10</sub> alkylthio, C<sub class="style-scope patent-text">1-6</sub> alkoxyC<sub class="style-scope patent-text">1-4</sub> alkoxy, arylC<sub class="style-scope patent-text">1-6</sub> alkyloxy, arylC<sub class="style-scope patent-text">3-6</sub> alkenyloxy, azido, NR<sup class="style-scope patent-text">5</sup> COR<sup class="style-scope patent-text">5</sup> where each R<sup class="style-scope patent-text">5</sup> is independently hydrogen or C<sub class="style-scope patent-text">1-6</sub> alkyl, OR<sup class="style-scope patent-text">6</sup> (where R<sup class="style-scope patent-text">6</sup> is a cyclic ether containing 4 to 8 atoms linked to the oxygen atom via a ring carbon atom adjacent to the ring oxygen atom or a group ##STR15## where Y is oxygen, sulphur or NH, X is either a bond, an oxygen atom or a moiety NR<sup class="style-scope patent-text">8</sup> in which R<sup class="style-scope patent-text">8</sup> is hydrogen or C<sub class="style-scope patent-text">1-6</sub> alkyl, and R<sup class="style-scope patent-text">7</sup> is C<sub class="style-scope patent-text">1-10</sub> alkyl optionally containing one or two double bonds, aryl, arylC<sub class="style-scope patent-text">1-4</sub> alkyl, arylC<sub class="style-scope patent-text">2-4</sub> alkenyl, haloC<sub class="style-scope patent-text">1-6</sub> alkyl or C<sub class="style-scope patent-text">1-6</sub> alkoxyC<sub class="style-scope patent-text">1-4</sub> alkyl, and R<sup class="style-scope patent-text">3</sup> represents hydrogen, or R<sup class="style-scope patent-text">2</sup> and R<sup class="style-scope patent-text">3</sup> may together with the carbon atom to which they are attached represent C═O or C═NOR<sup class="style-scope patent-text">9</sup> where R<sup class="style-scope patent-text">9</sup> is C<sub class="style-scope patent-text">1-6</sub> alkyl; and</div> <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">4</sup> represents hydroxyl, C<sub class="style-scope patent-text">1-6</sub> alkoxy or ##STR16## (where R<sup class="style-scope patent-text">7</sup> is as defined above); with the proviso that when R<sup class="style-scope patent-text">1</sup> represents a hydroxyl group in the axial configuration and R<sup class="style-scope patent-text">4</sup> is methoxy then R<sup class="style-scope patent-text">2</sup> cannot represent a group in the axial configuration selected from hydroxyl and OCOCH═<sup class="style-scope patent-text">z</sup> CH--CH═<sup class="style-scope patent-text">E</sup> CHCH<sub class="style-scope patent-text">3</sub>.</div> </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="2" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">2. A compound of the general formula (1a) ##STR17## and pharmaceutically acceptable salts and solvates (e.g. hydrates) thereof, wherein R<sup class="style-scope patent-text">1</sup> to R<sup class="style-scope patent-text">4</sup> are as defined in formula (I) above.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="3" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">3. A compound as claimed in claim 1 wherein R<sup class="style-scope patent-text">1</sup> represents hydrogen or hydroxyl.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="4" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">4. A compound as claimed in claim 1 wherein R<sup class="style-scope patent-text">2</sup> is in the axial configuration and R<sup class="style-scope patent-text">3</sup> is hydrogen.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="5" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">5. A compound as claimed in claim 1 wherein R<sup class="style-scope patent-text">2</sup> is C<sub class="style-scope patent-text">1-6</sub> alkoxy, C<sub class="style-scope patent-text">1-6</sub> alkylthio, azido or OCOR<sup class="style-scope patent-text">7</sup>.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="6" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">6. A compound as claimed in claim 1 wherein R<sup class="style-scope patent-text">4</sup> is C<sub class="style-scope patent-text">1-4</sub> alkoxy.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="7" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">7. A method of treatment of the human or non-human animal body to combat fungal diseases which method comprises administering to said body an effective amount of a compound as claimed in claim 1.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="8" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">8. A pharmaceutical composition comprising a compound as claimed in claim 1 in admixture with one or more physiologically acceptable carriers or excipients.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="9" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">9. A compound of formula (V) ##STR18## or a protected derivative thereof.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="10" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">10. A process for the preparation of a compound of formula (V) which comprises<div class="claim-text style-scope patent-text">(a) cultivating a microorganism capable of producing the compound of formula (V) and thereafter isolating the compound of formula (V) from the culture,</div> <div class="claim-text style-scope patent-text">(b) the biotransformation of sordarin.</div> </div>
    </div>
  </div> </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH0615555B2/en"><a id="link" href="#" class="style-scope state-modifier">JPH0615555B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-08-14</span>
                    <span class="td style-scope patent-result">1994-03-02</span>
                    <span class="td style-scope patent-result">三共株式会社</span>
                    <span class="td style-scope patent-result">
  Antibiotic Zofimarin
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3189443B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3189443B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-11-20</span>
                    <span class="td style-scope patent-result">2001-07-16</span>
                    <span class="td style-scope patent-result">萬有製薬株式会社</span>
                    <span class="td style-scope patent-result">
  Antifungal substance BE-31405
 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Alarcon, B. et al `Screening for New Compounds with Antiherpes Activity`. CA 102:39536, 1984.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Alarcon, B. et al Screening for New Compounds with Antiherpes Activity . CA 102:39536, 1984.
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hauser, D et al `Sordarin 1. Isolation and Degradation of Sordarin` CA 75:49503, 1971.
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      Hauser, D et al Sordarin 1. Isolation and Degradation of Sordarin CA 75:49503, 1971.
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (20)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6436930B1/en"><a id="link" href="#" class="style-scope state-modifier">US6436930B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2002-08-20</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Thio derivatives of sordarin as antifungal agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040242904A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040242904A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-14</span>
                    <span class="td style-scope patent-result">2004-12-02</span>
                    <span class="td style-scope patent-result">Angelo Basilio</span>
                    <span class="td style-scope patent-result">Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040254204A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040254204A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-18</span>
                    <span class="td style-scope patent-result">2004-12-16</span>
                    <span class="td style-scope patent-result">Pfizer Inc</span>
                    <span class="td style-scope patent-result">Bicyclic derivatives for the treatment of abnormal cell growth 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6436395B1/en"><a id="link" href="#" class="style-scope state-modifier">US6436395B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-18</span>
                    <span class="td style-scope patent-result">2002-08-20</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2196364T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2196364T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-18</span>
                    <span class="td style-scope patent-result">2003-12-16</span>
                    <span class="td style-scope patent-result">Merck &amp; Co Inc</span>
                    <span class="td style-scope patent-result">
  SORDARINA AND ITS DERIVATIVES FOR USE AS ANTIFUNGIC AGENTS IN CROPS.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6040463A/en"><a id="link" href="#" class="style-scope state-modifier">US6040463A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-10-07</span>
                    <span class="td style-scope patent-result">2000-03-21</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6096511A/en"><a id="link" href="#" class="style-scope state-modifier">US6096511A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-06-10</span>
                    <span class="td style-scope patent-result">2000-08-01</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Protein elongation factor 2 as a target for antifungal and antiparasitic agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5972996A/en"><a id="link" href="#" class="style-scope state-modifier">US5972996A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">1999-10-26</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5965612A/en"><a id="link" href="#" class="style-scope state-modifier">US5965612A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">1999-10-12</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordaricin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2300407C/en"><a id="link" href="#" class="style-scope state-modifier">CA2300407C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">2010-01-26</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU731679B2/en"><a id="link" href="#" class="style-scope state-modifier">AU731679B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">2001-04-05</span>
                    <span class="td style-scope patent-result">Merck Sharp &amp; Dohme Corp.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordaricin derivatives 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6136853A/en"><a id="link" href="#" class="style-scope state-modifier">US6136853A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-10-03</span>
                    <span class="td style-scope patent-result">2000-10-24</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MA26628A1/en"><a id="link" href="#" class="style-scope state-modifier">MA26628A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-11</span>
                    <span class="td style-scope patent-result">2004-12-20</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome Sa</span>
                    <span class="td style-scope patent-result">
  MORPHOLINO ETHERS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6410528B1/en"><a id="link" href="#" class="style-scope state-modifier">US6410528B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-11</span>
                    <span class="td style-scope patent-result">2002-06-25</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome S.A.</span>
                    <span class="td style-scope patent-result">Morpholino ethers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000024728A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000024728A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-10-26</span>
                    <span class="td style-scope patent-result">2000-05-04</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Microbial transformation product 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AUPQ120899A0/en"><a id="link" href="#" class="style-scope state-modifier">AUPQ120899A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-25</span>
                    <span class="td style-scope patent-result">1999-07-22</span>
                    <span class="td style-scope patent-result">Fujisawa Pharmaceutical Co., Ltd.</span>
                    <span class="td style-scope patent-result">Novel compound 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6645960B1/en"><a id="link" href="#" class="style-scope state-modifier">US6645960B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-11</span>
                    <span class="td style-scope patent-result">2003-11-11</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome S.A.</span>
                    <span class="td style-scope patent-result">Antifungal sordaricin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1228048A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1228048A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-11</span>
                    <span class="td style-scope patent-result">2002-08-07</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome S.A.</span>
                    <span class="td style-scope patent-result">Sordaricin derivatives having antifungal activity 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003007878A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003007878A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-18</span>
                    <span class="td style-scope patent-result">2003-01-30</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Antifungal agents of sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN108085273B/en"><a id="link" href="#" class="style-scope state-modifier">CN108085273B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-12-11</span>
                    <span class="td style-scope patent-result">2022-01-21</span>
                    <span class="td style-scope patent-result">暨南大学</span>
                    <span class="td style-scope patent-result">Antifungal streptomyces and metabolite thereof, preparation method and application of metabolite 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5854280A/en"><a id="link" href="#" class="style-scope state-modifier">US5854280A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-29</span>
                    <span class="td style-scope patent-result">Antifungal sordaridin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6054478A/en"><a id="link" href="#" class="style-scope state-modifier">US6054478A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-25</span>
                    <span class="td style-scope patent-result">Antifungal sordaridin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0568546B1/en"><a id="link" href="#" class="style-scope state-modifier">EP0568546B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-04-12</span>
                    <span class="td style-scope patent-result">Bridged cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4981792A/en"><a id="link" href="#" class="style-scope state-modifier">US4981792A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-01-01</span>
                    <span class="td style-scope patent-result">Immunosuppressant compound 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0494622A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0494622A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-15</span>
                    <span class="td style-scope patent-result">Bridged cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0503520A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0503520A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-09-16</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992012158A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992012158A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-23</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992012157A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992012157A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-23</span>
                    <span class="td style-scope patent-result">Bridged cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0712859A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0712859A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-22</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0711784A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0711784A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-15</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1993007151A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1993007151A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-04-15</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0083019A2/en"><a id="link" href="#" class="style-scope state-modifier">EP0083019A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-07-06</span>
                    <span class="td style-scope patent-result">Process for optically active anthracycline glycosides, the novel 4-deoxy-aclacinomycins A and B and pharmaceutical preparations 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0524677A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0524677A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-01-27</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1993018040A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1993018040A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-16</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1993018039A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1993018039A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-16</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        EP94500174<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0711783A1/en"><a id="link" href="#" class="style-scope state-modifier">EP94500174A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1996014327A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/EP1995/004332</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1995-11-06</span>
                    <span class="td style-scope patent-result">Antifungal sordaridin derivatives 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">1997-07-17</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: GLAXO WELLCOME S.A., SPAIN</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARTIN, JOSE JULIO;GOMEZ, JOSE RRAMON RUIZ;GOMEZ DE LAS HEROS, FEDERICO;AND OTHERS;REEL/FRAME:008815/0136;SIGNING DATES FROM 19970409 TO 19970418</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2002-10-31</span>
                    <span class="td nowrap style-scope patent-result">FEPP</span>
                    <span class="td nowrap style-scope patent-result">Fee payment procedure</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2003-09-26</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Fee payment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 4</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2005-03-11</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: DIVERSA CORPORATION, CALIFORNIA</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GLAXO WELLCOME, S.A.;REEL/FRAME:015886/0488</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20050228</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2007-10-25</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Fee payment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 8</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2007-11-05</span>
                    <span class="td nowrap style-scope patent-result">REMI</span>
                    <span class="td nowrap style-scope patent-result">Maintenance fee reminder mailed</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-12-05</span>
                    <span class="td nowrap style-scope patent-result">REMI</span>
                    <span class="td nowrap style-scope patent-result">Maintenance fee reminder mailed</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-04-25</span>
                    <span class="td nowrap style-scope patent-result">LAPS</span>
                    <span class="td nowrap style-scope patent-result">Lapse for failure to pay maintenance fees</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-05-21</span>
                    <span class="td nowrap style-scope patent-result">STCH</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent discontinuation</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-06-12</span>
                    <span class="td nowrap style-scope patent-result">FP</span>
                    <span class="td nowrap style-scope patent-result">Lapsed due to failure to pay maintenance fee</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20120425</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3406780645" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3406780645" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=760981505" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>